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The liver has several robust and potent mechanisms of repair after damage despite slow 
homeostatic turnover. In cases of extreme toxic damage, where the hepatocyte 
compartment is severely compromised and unable to proliferate, a bi-potent ductal 
population arises that is able to expand and differentiate into both hepatocytes and 
ductal cells. The regulation of the activation of this ductal progenitor population is 
poorly understood. We have taken advantage of 3D organoid cultures that model the 
activation of bi-potent ductal progenitors to identify potential candidates involved in 
organoid establishment and maintenance. Using knock down experiments, we 
identified the epigenetic modifiers Arid1a and Tet1 as important candidates for ductal 
progenitor maintenance and establishment, respectively, in vitro. Further in vitro 
analysis of several genetic models of Arid1a showed that reduction but not ablation of 
Arid1a results in enhanced proliferation and survival of organoid culture. In addition, 
Arid1a defective organoids lacked the ability to differentiate into functional 
hepatocytes in vitro. Therefore, Arid1a is important for regulating the differentiation 
and proliferative nature of ductal progenitors in vitro. On the other hand, we found that 
reduction or loss of Tet1 resulted in abolished establishment and maintenance of 
organoid culture, suggesting an important role of Tet1 in the activation of the progenitor 
state from a mature ductal cell. In line with this, we found that a hypomorphic mouse 
model of Tet1 showed a significantly reduced ductal regenerative response when 
challenged with acute liver damage. Furthermore, chronically damaged hypomorphic 
mice maintained significant fibrosis over WT mice. Finally, ductal specific genetic 
ablation of Tet1 coupled with lineage tracing showed that Tet1 mutant ductal cells 
formed significantly smaller regenerative hepatocyte clusters. As a result, Tet1 is 
crucial for the activation and function of ductal bi-potent progenitors both in vivo and 
in vitro. Taken together, the role of Arid1a and Tet1 in organoid culture and liver 
regeneration suggests that regulation of the epigenetic landscape is crucial to determine 
cell fate decisions during the damage-regeneration response.       
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1.1 Liver Anatomy and function 
 
The liver is the largest internal organ in the body and is instrumental in maintaining 
chemical homeostasis. The organ itself has a lobular structure, in humans it is made up 
of four main lobes, and relies on a complex cellular organisation to carry out its plethora 
of functions (Abdel-Misih and Bloomston, 2010). The main resident cell types that 
make up the cellular menagerie present in the liver are the epithelial hepatocytes and 
cholangiocytes (which shall be referred to as ductal cells for the rest of this work), as 
well as stellate cells, Kupffer cells and endothelial cells (Thurman, Kauffman and 
Jungermann, 1986). 
The functional units of the liver are called hepatic lobules. These are polygonal 
structures defined by a central vein through which blood exits the liver and joins the 
hepatic vein. Blood enters the liver through the portal vein and hepatic artery, and these 
together with the biliary duct which is made up of ductal cells, form the portal triad 
located on the periphery of each hepatic lobule. Blood moves from the portal region to 
the central vein via a specialised fenestrated network of vasculature known as the 
sinusoids, made up of endothelial cells (Wisse et al., 1985). Fenestration throughout 
the sinusoid facilitates fast and efficient transport of metabolites to and from 
hepatocytes and the blood stream. Stellate cells are located in an interstitial space 
between the sinusoidal endothelium and the hepatocytes called the space of Disse. 
Kupffer cells are located in the sinusoidal endothelial wall allowing direct access to the 
blood stream (Figure 1.1).  
To overcome the relative simplicity of the histological features of the liver the 
organ takes advantage of several unique cell types that together carry out the large 
number of biological features. Hepatocytes are the most populous cell type in the liver 
making up roughly 80% of the human liver parenchyma (Blouin, Bolender and Weibel, 
1977). Hepatocytes carry out the majority of the metabolic functions of the liver such 
as storage and regulation of glucose (via glycogen), detoxification of endogenous and 
exogenous chemicals, lipid and cholesterol metabolism, synthesis of clotting agents and 
bile production. Hepatocyte functions are regulated through a system of metabolic 
zonation (Gebhardt, 1992). The metabolic zones are structured along the hepatic lobule 
and are classically numbered 1 – 3 moving from the portal triad to the central vein. 
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Several converse pathways are restricted to opposing ends of the zonation to avoid 
intracellular futile cycles. The concept is nicely demonstrated with the regulation of 
glucose metabolism. Gluconeogenesis is carried out largely in the periportal zones 
(Zone 1) whereas much of the glycolysis is restricted to perivenous zones (Zone 3) 
(Kietzmann, 2017). Separating gluconeogenesis and glycolysis into distinct metabolic 
zones means overall glucose flux can be controlled by regulating the two pathways in 
independent cells rather than having to reverse flux single in a metabolically 
homogenous model (Gebhardt, 1992).  Therefore, metabolic zonation is exquisitely 
suited to ensure systemic glucose homeostasis throughout cycles of feeding and 




 Ductal cells are ciliated cuboidal epithelial cells that form the bile ducts making 
up 3-5% of the liver and although significantly less metabolically active than 
Figure 1.1 – The structure of the hepatic lobule.   A) A schematic of the polygonal nature of the hepatic lobule. 
B) A schematic of the cross-section (indicated in dashed box in (A)) of the hepatic lobule showing the localisation 
of the resident cell types of the liver.    
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hepatocytes are essential for bile secretion (Kanno et al., 2000). The hepatocyte 
compartment carries out production of bile itself and transports it through a specialised 
lumen in their apical membrane known as the bile canaliculus.  Bile then moves to the 
bile ductules through the canal of Hering, before being transported to the gall bladder 
and ultimately reaching the small intestine via the common bile duct. However, the role 
of the bile duct is not limited to transport and ductal cells carry out several important 
modifications to the bile composition before secretion. For instance, ductal cells 
express the cystic fibrosis transmembrane regulator (CTFR) that facilitates the efflux 
of Cl- into the duct lumen (Cohn et al., 1993). This in turn powers the HCO3-/Cl- 
exchanger AE2, resulting in bicarbonate transport into the lumen. The overall effect on 
the bile is an increase in pH, which is crucial to neutralise acidic gastric fluid in the gut 
(Alpini et al., 1996). The secretion of bile itself into the gut is crucial for the uptake of 
fat and fat-soluble metabolites, as well as providing a route to expel waste products 
such as excess bilirubin. More detailed metabolic roles of ductal cells and bile are 
reviewed in detail elsewhere (Boyer, 2013).  
Kupffer cells are specialised macrophages that stand as guardians to protect 
against infection from bacteria rich blood originating from the gut.  They make up 80-
90% of the total macrophages in the body and thus underlines the liver’s importance in 
the systemic innate immune system (Bilzer, Roggel and Gerbes, 2006). Furthermore, 
Kupffer cells are crucial for haemoglobin turnover as they are able to target defective 
blood cells or haemoglobin rich vesicles that fragment from the erythrocytes over time, 
facilitating recovery of haem and regulating the level of systemic haemoglobin, which 
has been shown to be a source of oxidative stress (Terpstra and van Berkel, 2000; 
Willekens et al., 2005).  Stellate cells are involved in storage of several metabolites 
such as vitamin A and lipids, as well as controlling the composition of the extracellular 
matrix (ECM) in the space of Disse (Wake, 1971). Interestingly, upon damage, stellate 
cells activate to a myofibroblast like state and are responsible for the production of 
fibrotic collagen (Mederacke et al., 2013; Iwaisako et al., 2014; Tsuchida and 
Friedman, 2017). Harmony between all cell types within the hepatic lobule described 
above is required for efficient liver function with each performing specialised roles.  
In order to work efficiently, the liver takes advantage of significant intercellular 
and intracellular heterogeneity and therefore, tight homeostatic and regenerative 
pathways are required to maintain the complex tissue organisation in the face of damage 
or cellular stress.   
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1.2 Liver homeostasis and regeneration 
 
Throughout life a delicate balance needs to be struck between proliferation and cell 
death. The proliferative burden of an organ is largely dependent on the cellular 
turnover. Hepatic cellular turnover in rats was elegantly measured by following the 
incorporation of H3 into hepatic nuclei after a pulse of tritiated-thymidine showing a 
cellular lifespan of between 200 and 400 days (MacDonald, 1961). Considering a 
lifespan of a rat is three years the liver may only self-renew ~3 times throughout the 
duration of the animal’s life. More recent studies, taking advantage of lineage tracing 
strategies to follow either Sox9+ ductal cells or Axin2+ central vein hepatocytes without 
damage have shown that each cell type is restricted to their respective compartments 
(B D Tarlow, Finegold and Grompe, 2014; Wang et al., 2015). Taken together, in the 
absence of damage, the liver epithelium is supported by slow self-renewal within each 
epithelial compartment.  
However, the relative quiescence of the liver hides a raft of regenerative 
potential in response to damage powered by extensive plasticity within the epithelial 
compartment (Aloia, Mckie and Huch, 2016). Although the unique regenerative 
capacity of the liver was first immortalised in the eternal torture of Prometheus from 
Greek mythology, it was validated and came to prominence in modern science through 
the seminal work of Higgins and Anderson (1931) (Higgins, Anderson, 1931). They 
were instrumental in characterising partial hepatectomy (PHx) procedures where up to 
60% of the liver is removed. Remarkably, after such a surgery the liver is able to 
regenerate lost tissue volume and rescue liver function within days. This rapid 
regeneration is facilitated by an elegantly orchestrated pattern of compensatory 
proliferation in all resident cell types of the liver (Michalopoulos and DeFrances, 1997). 
Early studies followed proliferation by autoradiography and found that hepatocytes 
were the first to proliferate after PHx with a peak of proliferation after 24 hours, 
followed by the other cell types such as the ductal cells and sinusoidal cells (Grisham, 
1962; Rabes et al., 1976). It is important to note that during this potent regenerative 
response that occurs in recovery from PHx the liver does not regrow the removed lobes, 
but rather the remaining healthy lobes increase their size and capacity to compensate 
the lost function of the resected lobes (Taub, 2004). Therefore, regeneration after PHx 
is largely response from healthy tissue to a gross change in organ size. Indeed, this 
effect can be both positive and negative, as studies have shown that while transplants 
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from smaller animals to larger animals result in the donor organ growing in size 
transplants from larger animals to smaller animals results in a decrease in donor liver 
size after xenograft (Francavilla et al., 1988; Starzl et al., 1993). This remarkable 
‘hepatostat’ function that maintains liver size as a proportion of body size may provide 
interesting insights for surgical applications but does not reflect the regenerative 
response characteristic of acute or chronic liver pathologies (Miyajima, Tanaka and 
Itoh, 2014; Cordero-Espinoza and Huch, 2018).    
The liver has a prominent role in the detoxification of toxins produced within 
the body as well as exogenous factors. This coupled with the high metabolic load of 
hepatocytes leads to high cellular stress. Elevated levels of such damage lead to 
pathologies such as non-alcoholic fatty liver disease and liver cirrhosis which together 
form a significant clinical burden (Lim and Kim, 2008; Asrani et al., 2013). In cases of 
toxic damage, the liver can regenerate through an emergent stem/progenitor cell with 
atypical ductal morphology, classically referred to as the oval cell, able to proliferate 
and differentiate into both hepatocytes and ductal cells (Evarts et al., 1987, 1989). The 
oval cell was first identified and characterised after hepatoxic oncogenic treatments in 
rats that severely compromised the hepatocyte compartment (Farber, 1956; Solt, 
Medline and Farber, 1977; Shinozuka et al., 1978).    
The existence and cellular source of the bi-potent progenitor pool has been a 
controversial issue over the past three decades. The extensive proliferative potential of 
hepatocytes evident after PHx suggests that hepatocytes may harbour stem cell capacity 
that could be the foundation of such an adult stem cell population. In line with this, 
early studies showed that hepatocytes had massive clonogenic potential. Taking 
advantage of a mouse model of hereditary tyrosinemia type I, leading to liver disease 
as a result of fumarylacetoacetate hydrolase deficiency (Fah-/-), Overturf and colleagues 
were able to show that only 1000 normal hepatocytes were required to repopulate a 
diseased liver and restore normal liver function in mice (Overturf et al., 1996). A 
subsequent study by the same group then pushed this substantial ability by serially 
transplanting normal hepatocytes into 6 sequential Fah-/- hosts ultimately showing that 
hepatocytes could undergo 69 cell divisions, similar to that of a haematopoietic stem 
cell (Overturf et al., 1997).  
With the advent of lineage tracing technology more recent studies attempted to 
identify and characterise the molecular and differentiation potential of any facultative 
hepatocyte stem cell. Interestingly, in a similar manner to their metabolic potential, 
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hepatocytes are heterogeneous in their stem cell function. One study labelled the 
hepatocyte compartment by repopulating a diseased liver (Fah-/-) with fluorescently 
labelled but otherwise normal hepatocytes and after chemical damage found labelled 
ductal cells suggesting that hepatocytes harbour a capacity of regeneration through a 
bi-potent progenitor mechanism (Tarlow et al., 2014). Furthermore, a periportal 
hepatocyte population expressing some ductal markers such as Sox9 was identified and 
these were termed hybrid hepatocytes. Lineage tracing from these hybrid hepatocytes 
after damage showed that they were bi-potent and could repopulate both the ductal and 
hepatocyte compartment (Font-Burgada et al., 2015). A larger but likely overlapping 
periportal Mfsdf2+ hepatocyte population was also identified that shared similar 
characteristics to the earlier characterised hybrid hepatocytes (Pu et al., 2016). A further 
unipotent hepatocyte stem cell population was identified surrounding the central vein, 
the hepatocytes were found to be responsive to Wnt and expressed Axin2. The Axin2+ 
population was shown to be integral in the slow homeostasis of the hepatocyte 
compartment only (Wang et al., 2015). Furthermore, a recent subsequent study has 
shown that after central vein specific liver damage an emergent mid-lobular Axin2+ 
population drives hepatocyte regeneration (Zhao et al., 2019). Finally, a population of 
hepatocytes that are distributed across all lobular regions that express high levels of 
telomerase reverse transcriptase (TERT) have been shown to support hepatocyte 
homeostasis and regeneration in response to damage (Lin et al., 2018).  
In summary, there is a growing body of evidence that the hepatocyte 
compartment has the capacity not only to maintain its own homeostasis but upon 
damage to facilitate the regeneration of both hepatocytes and ductal cells. They are 
therefore good candidates to be the foundation of a bi-potent progenitor regenerative 
response.  
However, this proved to be only half the story as early experiments by Farber 
treating rats with carcinogens that drastically impaired hepatocyte function, either in 
isolation or in conjunction with PHx identified an emergent population of cells with 
atypical ductal morphology that were described as “small oval cells” (Farber, 1956; 
Evarts et al., 1989; Fausto and Campbell, 2003). The cell population from then on 
coined as oval cells, was found to arise near the ducts of the liver, specifically the canals 
of Hering, and could be a potential alternative cellular source for liver regeneration. 
However, despite the early identification of oval cells and their potential regenerative 
capacity their biology and significance in liver regeneration has only started to become 
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clear over the last twenty years with the advent of in vitro cell culture techniques as 
well in vivo cell tracing by lineage tracing.  
Several groups demonstrated the regenerative capacity of oval cells by 
identifying and isolating of the ductal progenitors using in vitro. Two studies identified 
that Epithelial Cell Adhesion Marker (EpCAM) and CD133 (Prom1) marked a ductal 
population that act as bi-potent oval cells when transplanted in the injured liver 
(Rountree et al., 2007; Yovchev et al., 2007; Suzuki et al., 2008) Furthermore, Lgr5 
was found to be expressed upon liver damage and upon isolation cells were grown as 
3D organoids maintaining their bi-potential capacity in vitro and in vivo (Huch, Dorrell, 
et al., 2013). Despite identification and isolation of ductal bi-potent cells in vitro, their 
lineage potential in vivo during liver damage was not answered by these studies and has 
remained in question. Further doubt was cast on the significance of oval cells through 
several studies that followed the fate of ductal cells after damage by labelling all ductal 
cells or conversely, marked the whole hepatocyte compartment to identify emergent 
unmarked cells which originate from non-parenchymal cells found that there was no 
contribution to the hepatocyte pool from the ductal compartment. Together suggesting 
the in vitro progenitor capacity of oval cells described by the studies above could be an 
artefact of in vitro culture and do not represent a bona fide progenitor population in vivo 
(B. D. Tarlow, Finegold and Grompe, 2014; Schaub et al., 2014; Yanger et al., 2014). 
However, most recently these conflicting studies have been reconciled by three 
seminal studies which found that the cellular context during liver damage was crucial 
for oval cell function. By taking advantage of novel genetic models and modes of liver 
damage the studies were able to severely compromise the hepatocyte compartment 
which led to drastic inhibition hepatocyte proliferation. This ultimately proved key to 
unlocking the oval cell’s regenerative capacity in vivo. Hepatocyte impairment was 
carried out by either hepatocyte specific genetic ablation of Mdm2 or β1-Integrin, 
hepatocyte specific overexpression of p21, or by severe chronic damage by 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC) treatment. Mdm2 is an E3 ubitquitin 
ligase responsible for the degradation of TP53 and in its absence there was shown to be 
wide spread apoptosis and senescence in the hepatocyte compartment resulting in the 
rapid activation of ductal derived progenitors that repopulate the hepatocyte pool (Lu 
et al., 2015). In a similar manner liver damage combined with hepatocyte specific 
deletion of β1-Integrin, which results in impaired signalling through the epidermal 
growth factor (EGF) and hepatocyte growth factor (HGF) pathways (Speicher et al., 
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2014), resulted in significant ductal contribution to the hepatocyte compartment. 
Interestingly, liver damage combined with hepatocyte specific over expression of p21 
which is a hallmark of non-alcoholic steatosis and chronic hepatitis C infection 
(Marshall et al., 2005; Richardson et al., 2007), resulted in a similar significant ductal 
contribution to hepatocyte regeneration. Finally, it was shown that massive chronic 
DDC induced liver damage without any genetic alteration resulted in the activation of 
ductal derived bi-potent progenitors (Deng et al., 2018). Shorter DDC damage 
experiments did not result in the same ductal progenitor activation suggesting that 
hepatocyte impairment must be severe for the ductal bi-potent cell response. 
Since the first description of liver regeneration it has become clear that the 
epithelial compartment is highly plastic, and that the regenerative response is 
determined by the mode, severity and cellular context of the liver damage (summarised 
in Figure 1.2). It is only in the most severe cases of liver damage (where the hepatocyte 
compartment is impaired from division or its proliferative capacity is exhausted) that a 
ductal bi-potent progenitor becomes activated to facilitate repair.  Considering that such 
an extensive failure of the hepatocyte compartment is a common feature of chronic liver 
diseases in the clinical setting, understanding how the activation of ductal progenitors 






Figure 1.2 – The liver demonstrates several modes of regeneration in a damage and cellular context 
dependent manner. A) During homeostasis the liver is maintained by slow division of mature cell types. B) In 
response to acute chemical or physical damage liver regeneration is facilitated by increased proliferation in 
mature cell compartments or in some cases by specialised hepatocyte populations such as the Sox9+ hybrid 
hepatocyte. C) After chronic damage where hepatocytes are unable to proliferate a ductal progenitor emerges 
which can repopulation the hepatocyte and ductal compartments. 
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1.3 Modelling adult stem cell function  
 
Since the first descriptions of liver adult stem/progenitor cells there has been extensive 
study in the field leading to the characterisation of many animal models of liver damage 
enabling investigation of several aspects of their involvement in the liver’s regenerative 
response (described in section 1.2). However, studies into the regulation of ductal 
regeneration have been hampered by the lack of faithful in vitro models. A solution has 
arisen over the past decade with the introduction of three-dimensional (3D) culture 
systems that have revolutionised the study of adult stem cell dynamics and function. 
Such culture systems allow the growth of both adult pluripotent (embryonic or 
otherwise induced) and neonatal stem cells into an organoid culture. Organoids are 
defined as a 3D cell structure that intrinsically assemble into defined organised patterns 
that resemble or at least recapitulate some of the features of the organ of origin (Huch 
and Koo, 2015).  
 Liver organoids can be derived from both adult and embryonic stem cells that 
ultimately affect the system’s role and function. Accordingly, hepatoblasts have long 
been the subject of intense study as the embryonic bi-potent cell population responsible 
for the generation of both hepatocytes and ductal cells making them excellent targets 
for study (Miyajima, Tanaka and Itoh, 2014; Gordillo, Evans and Gouon-Evans, 2015). 
Hepatoblasts arise from the ventral foregut at the same time as the emergent pancreas 
at E8.5 of mouse development (Rodríguez-Seguel et al., 2013). The developing liver is 
segregated from nascent pancreatic precursors via a tightly regulated concentration 
gradient of FGF and BMP laid down by the mesoderm (Gualdi et al., 1996; Rossi et 
al., 2001). The higher concentrations of FGF and BMP define hepatic specification, 
whereas precursors in lower concentrations are destined for a pancreatic fate (Deutsch 
et al., 2001; Serls et al., 2005). After specification the nascent hepatoblasts follow a 
precise set of cues in order to mature and form the foetal liver. At E9.5 there is a 
migration of hepatoblasts into the septum transversum mesenchyme that requires 
signalling from developing endothelial cells (Matsumoto et al., 2001). This migration 
leads to the formation of the liver bud from which the foetal liver forms. As the liver 
parenchyme develops it receives mitogenic signals in the form of HGF, MidKine and 
Pleiotropin that facilitate growth of the hepatoblast compartment (Onitsuka, Tanaka 
and Miyajima, 2010). CD49f/Thy1+ mesenchymal cells then directly contact the 
hepatoblasts to drive further maturation (Hoppo et al., 2004). There is also evidence 
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that blood cells present in the liver as a result of its role in haematopoiesis during 
development provide signals via oncostatin M that promote hepatocyte fate (Kamiya et 
al., 1999; Matsui et al., 2002).             
By mimicking the cell signals that drive hepatoblast development it has been 
possible to direct induced pluripotent stem cells to hepatic fate and then derive both 
ductal cells and hepatoctyes in 3D culture systems (Snykers et al., 2009; Sampaziotis 
et al., 2015). It has also been shown that rather than mimicking chemical signals it is 
possible to drive liver development of induced pluripotent stem cells in a dish via co-
culture with mesenchymal and endothelial cells. This remarkable organoid culture 
system rapidly self-organises into a liver bud like structure with evidence of hepatic 
function once ectopically transplanted into animal hosts (Takebe et al., 2013). Despite 
the remarkable capacity of these models to generate tissue for future cell therapy 
strategies, they do not model the bi-potent liver stem cell directly. Instead these models 
only transiently exhibit a hepatoblast fate before differentiating into mature cell types. 
It may be possible to adjust these models to provide the correct signalling to capture a 
hepatoblast population and indeed several groups have described conditions in which 
hepatoblast like cells can be cultured (Tanimizu et al., 2003, 2004; Takayama et al., 
2013). Although these studies may provide useful models of hepatoblast function, they 
are unlikely to persist postnatally and are not the bi-potent population emergent after 
liver damage (Hindley, Cordero-Espinoza and Huch, 2016). Therefore, understanding 
their regulation may have limited application beyond the embryo.  
Capturing the adult liver progenitor state was first described through the 
isolation of the emergent Lgr5+ population upon toxic liver damage (Huch, Dorrell, et 
al., 2013). These progenitors were grown in a 3D Matrigel matrix in media 
supplemented with EGF, HGF, FGF and Rspondin1. Rspodin1 is the Lgr5 ligand and 
results in increased sensitivity to the Wnt pathway. The Lgr5+ cells once isolated and 
grown in the 3D conditions organise into cystic organoid structures with a single cell 
layer epithelium. They were found to express markers of progenitor (Lgr5, Trop2, 
Tbx3), ductal (Krt19, Epcam) and hepatocyte (Ttr, Hnf4α) fates. Remarkably induction 
of liver damage was not required for organoid derivation, and the study also showed 
that placing an isolated ductal tree fragment into culture resulted in molecularly 
indistinguishable organoids. This crucial experiment showed that ductal cells have the 
capacity to form Lgr5+ progenitors and that the culture conditions are enough to model 
the signalling in the activation of the progenitor state after liver damage in vitro. A 
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subsequent study then showed that with little modification the isolation of single 
EpCAM+ ductal cells from healthy human liver biopsies were able to grow into 
organoids that were phenotypically similar to the mouse equivalents (Huch et al., 
2015). This highlights the innate ductal capacity to acquire a progenitor fate.      
In order to truly model adult stem cell behaviour the liver organoid cultures 
described by Huch et al. needed to satisfy two criteria to fulfil the role of a stem cell: 
(1) the ability to self-renew; and (2) the ability to differentiate into the function cells of 
the tissue of origin (Lajtha, 1979). In the original studies organoid cultures were grown 
in culture for up to 1 year whilst maintaining genetic stability, thus fulfilling the self-
renewal criteria (Huch, Dorrell, et al., 2013; Huch et al., 2015). Once switched to 
defined culture conditions, which involved the inhibition of the notch and TGF-β 
pathways and the addition of BMP-7 for human cultures, the liver organoids could 
differentiate towards the hepatocyte fate. These differentiated organoids could also be 
transplanted into Fah-/- mice and fully mature to functional hepatocytes in vivo. This 
shows that ductal derived organoids are able to differentiate into both mature epithelial 
cell types of the liver fulfilling the second criteria for bona fide adult stem cells.  
An important feature of adult ductal derived liver organoids is stability of the 
progenitor state in vitro. The organoids remain bi-potent and proliferative and don’t 
freely differentiate until induced. Taken together with the fact that we can activate the 
progenitor state from otherwise healthy ductal tissue means we can elegantly dissect 
the mechanisms of ductal progenitor activation and differentiation by manipulating 
culture conditions. These features highlight the power of liver organoids as a model of 
ductal progenitors and a tool to study their dynamics.  
Recently two groups described the derivation of 3D liver organoids from 
primary mouse and human hepatocytes (Hu et al., 2018; Peng et al., 2018). 
Remarkably, the hepatocyte organoids were able to be expanded long term as well as 
differentiate into both hepatocytes and ductal like cells. Hence hepatocyte organoids 
exhibit similar stem cell capacity as ductal organoids. It is perhaps not surprising that 
organoid systems have been derived from both hepatocytes and ductal cells due the 
heterogeneous and plastic nature of liver regeneration (described in section 1.2), where 
there is extensive evidence of both ductal and hepatocyte compartments having 
progenitor capacity (Choi et al., 2014; Tarlow et al., 2014; Yanger et al., 2014; Font-
Burgada et al., 2015; Lu et al., 2015; Raven et al., 2017). In line with this, the 
hepatocyte organoid gene expression profile has been shown to closely resemble that 
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of proliferating hepatocytes after PHx. Furthermore, the culture conditions of the 
hepatocyte organoids are remarkably similar to their ductal derived counterparts. 
Hepatocyte organoids and ductal organoids are grown with EGF, FGF, HGF and 
Rspodin1 with hepatocyte organoids needing further activation of the WNT and TNF-
α pathways. This significant overlap suggests that the hepatocyte or ductal derived 
progenitor population rely on very similar signalling to support their expansion.  
In any case with the advent of 3D organoid culture techniques there are now 
excellent models of both hepatocyte and ductal liver progenitors that will allow 
investigation of their dynamics. During our studies we have focussed on ductal 
organoids as a model of ductal driven liver regeneration specifically and further 
mention of liver organoid culture within this document will refer to the ductal derived 
organoids characterised by Huch and colleagues.  
As with any model system liver organoids are simplified representations of 
aspects of liver regeneration that help us to answer more complicated biological 
questions (Mead and Karp, 2019). Therefore, it is important to discuss the limitations 
of organoids as a model in order to properly design experiments and understand their 
results (Huch et al., 2017). For instance, liver function and regeneration (see chapters 
1.1 and 1.2) are dependent on several different cell types. However, organoids only 
represent the ductal component in isolation, therefore, can only be used to study ductal 
cell biology. It could be argued as you are able to differentiate the ductal organoids to 
a hepatocyte-like fate you are also able to model hepatocyte function. While this 
differentiation capacity was shown by Huch and colleagues, the emergent hepatocyte-
like population are unlikely to represent truly mature hepatocytes as are found in vivo 
(Huch, Dorrell, et al., 2013). Following, it was shown ductal organoid derived 
hepatocytes are unable to fully repopulate Fah-/- mouse livers, a process that was shown 
to be highly efficient when using fully mature hepatocytes. It may be possible to refine 
the differentiation protocol to fully recapitulate hepatocyte differentiation but even in 
this case the organoids would not be able to model the other niche or stromal 
components of the liver. Taken together, in their current state organoids are suited to 
be used as a hypothesis generating tool for studying cell intrinsic functions of ductal 
cells.  
 Another important factor to discuss is how comparable the culture conditions 
are compared to what ductal cells may encounter physiologically.  Liver organoids are 
grown in media rich in growth factors such as EGF and FGF as well as high levels of 
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WNT agonists. In addition to these soluble factors the organoids themselves are grown 
an extracellular matrix generated from mouse sarcoma cells called “Matrigel”, the 
components of which are poorly defined. These conditions are vastly pro-proliferative 
so we must be wary that liver organoids could be an artificial cell population that 
superficially resembles in vivo ductal progenitors born out these highly specific culture 
conditions (Reya and Clevers, 2005; Scaltriti and Baselga, 2006; Ornitz and Itoh, 2015). 
On the other hand, it is important to note that the culture conditions were not chosen 
for their proliferative properties but rather due to the involvement of the invoked 
signalling pathways in liver development and regeneration. For instance, recently it was 
been shown that in response to liver damage that central vein endothelial cells become 
a potent source of WNT ligand, which helps to drive proper regeneration (Wang et al., 
2015). Therefore, the growth conditions of organoids attempt to mimic the extracellular 
cues that are active during liver regeneration and that drive ductal progenitor activity 
essentially replacing the niche cell signalling.  
Liver organoid culture is a developing technology which can provide great 
insights into liver biology. However, as explained above there are limitations and as a 
model it is a vast simplification of the properties of bona fide ductal progenitors. 
Although, this does not mean they are not useful, only that those limitations need to be 
accounted for. In this work, we make use of the vast advantage of liver organoids being 
an in vitro system amenable to high throughput analysis to screen for potential 
regulators and pathways involved in ductal driven regeneration. Crucially, we then 
attempt to validate those candidates in animal models of regeneration in order to 
validate and learn the physiological role of the candidate in question. Therefore, we can 
avoid spurious conclusions generated as a result of some aspect of the model whilst 
maintaining the massive benefit of the in vitro organoid system.  
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1.4 Epigenetic regulation of chromatin accessibility and cell fate 
   
Throughout this work we have focussed on understanding the epigenetic regulators 
involved in the activation of ductal progenitors in response to liver damage. To set the 
scene I will give a brief description of the field of epigenetics before discussing the 
motivation and reasoning for focussing on epigenetic mechanism. The seminal work 
by Waston, Crick and Franklin characterised the double helix structure of DNA and its 
capacity to store information, thus giving birth to the ‘central dogma’ of modern 
biology (Watson and Crick, 1953). The theory states that information stored in DNA is 
transcribed into transient RNA molecules which are further translated to functional 
proteins (Crick, 1970). The regulation and machinery behind these processes has been 
the subject of intense study since the central dogma was first postulated. However, it 
rapidly became clear that the linear flow of information could not wholly explain gene 
regulation and that there were significant interactions between proteins/RNA and the 
genome that were required to facilitate gene expression changes, going against the flow 
of information originally postulated in the central dogma (Chen et al., 2017). As a 
result, scientists began to study how modification of DNA and its associated proteins 
affect gene expression, developing the field of epigenetics. 
 DNA is made up of three main structural features: (1) the negatively charged 
phosphate backbone; (2) a deoxyribose; (3) and a base. Together these form the 
functional unit of DNA - the nucleotide (Levene, 1919). There are four different bases 
found in DNA: Guanine (G); Adenine (A); Thymine (T); and Cytosine (C). There is 
also a fifth base exclusively found in RNA - Uracil (U). The human genome is a linear 
string DNA sequence formed through phosphodiester linkages between the phosphate 
backbone of one nucleotide to the deoxyribose of the proceeding nucleotide (Travers 
and Muskhelishvili, 2015). The double helical nature of the DNA is facilitated by 
Watson-Crick base pairing between bases G-C and A-T that bring two complimentary 




Figure 1.3 – Epigenetic methods of gene regulation.  A schematic demonstrating the three main methods of 
epigenetic regulation: (1) DNA modification; (2) post-translational modification of histones; and (3) ATP-
dependent histone reshuffling. 
 
An average eukaryotic cell contains roughly 2m of DNA, to store such a large 
linear molecule inside a nucleus the DNA must undergo a high level of packing and 
compaction. At the lowest level of organisation 147 bp of DNA is wrapped around an 
octamer of histone proteins which together form nucleosomes (Kornberg, 1974; 
Richmond and Davey, 2003). Each histone octamer is made up of two of each of the 
four histone monomers H2A, H2B, H3 and H4. Histone proteins have a unique structure 
with a positively charged N terminal tail domain which is enriched in arginine and 
lysine residues (Phillips and Johns, 1965). The positive charge of histones is crucial to 
bind with the negatively charged DNA backbone. The further linker histone H1 can 
bind the DNA in between nucleosomal units and helps form higher order nucleosome 
arrangements such as chromatin fragments and ultimately the 3D organisation of 
chromosomes (Kornberg and Lorch, 1999). The level of packing at specific genomic 
loci will affect the accessibility of those regions and thus will have a drastic effect on 
gene expression. For instance, having a tightly packed enhancer region or 
transcriptional start site (TSS) will stop the efficient binding of transcription factors 
(TFs) or the transcriptional machinery to the respective gene and reduce its expression 
(Knezetic and Luse, 1986; Lorch, LaPointe and Kornberg, 1987; Kireeva et al., 2005; 
Bondarenko et al., 2006).  
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Epigenetics is the study of the modifications that alter the chromatin 
accessibility at specific genomic loci and modulate gene expression. These epigenetic 
modifications can either be directly on the DNA or affect the associated chromatin 
proteins, but crucially they do not alter the DNA sequence. There are broadly three 
categories of modification: (1) deposition of chemical DNA modifications; (2) post-
translational modification of histones; (3) and nucleosome rearrangements and 
depletion. Each type of modification will have dedicated proteins or protein complexes 
that write, read and erase the specific modification in response to external stimuli, 
facilitating a dynamic system of gene regulation. 
The most abundant chemical modification of DNA in humans is methylation. 
This involves the covalent addition of a methyl group to the cytosine ring most 
commonly generating 5-methylcytosine (5mC). Modified cytosines are largely found 
in the context of CG dinucleotides called CpG sites, 80% of CpG sites are methylated 
in the human genome (Ehrlich et al., 1982). Methylation of CpG sites and promoter 
regions enriched in CpG sites (referred to as CpG islands) is heavily associated with 
gene silencing (Bird, 2002). The mechanism by which this happens is context 
dependent and as such is not fully understood (Miranda and Jones, 2007). For instance, 
in some cases where TFs bind CpG islands, methylation can reduce their binding 
efficiency. This was shown to be the case for c-myc, a TF associated with proliferation 
and a prominent oncogene, where DNA methylation inhibits c-myc binding and action 
(Prendergast, Lawe and Ziff, 1991). Perhaps the most prominent mechanism of 
methylation mediated gene repression is through modulation of the adjacent histone 
modifications. Promoters permissive for transcription are usually associated with 
nucleosomes with lysine 4 of histone H3 (H3K4) methylated. Methylation of CpG 
islands has been shown to inhibit the binding of H3K4 methyltransferases and therefore 
stop the generation of the permissive modification (Birke et al., 2002; Ayton, Chen and 
Cleary, 2004; Lee and Skalnik, 2005). Furthermore, a family of methyl- binding 
proteins (MBP) exists which include MeCP2, MBD1, MBD2 and MBD3 that can bind 
methylated CpG sites (Hendrich and Bird, 1998; Hendrich et al., 1999). Their mode of 
action is not wholly understood, however several MBPs have been shown to mediate 
repression by recruiting histone deacetylases and other co-repressors to methylated 
regions (Jones et al., 1998; Nan et al., 1998; Zhang et al., 1999; Kondo et al., 2005). 
Finally, DNA methylation can affect nucleosome positioning and depletion. Promoter 
regions of actively expressed genes are often depleted of nucleosomes facilitating 
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efficient binding of the transcriptional machinery. Studies have shown that DNA 
methylation results in increased histone occupancy in such nucleosome depleted 
regions (NDRs) resulting in reduced gene expression (Davey, Pennings and Allan, 
1997; Patel, Graunke and Pieper, 1997). The underlying mechanism is a subject of 
study, but it has been shown that MeCP2 can bind chromatin remodelling proteins such 
as Brahma, the catalytic subunit of the SWI/SNF remodelling complex (Harikrishnan 
et al., 2005). As a result, MeCP2 may target methylated regions for remodelling by 
recruiting remodelling complexes.  
In mammals, DNA methylation is carried out by a family of DNA 
methyltransferases (DNMTs) which take advantage of S-adenosyl-methionine to 
provide methyl- groups. DNMT1 is largely concerned with the maintenance of DNA 
methylation by preferentially binding hemi-methylated DNA generated through cell 
division (Bestor, 1992; Pradhan et al., 1999). On the other hand, de novo methylation 
is carried out by DNMT3a and DNMT3b (Okano, Xie and Li, 1998; Hsieh, 1999; 
Okano et al., 1999). A catalytically inactive family member also exists (DNMTL) 
which is not directly involved in methylation but may provide a mechanism of targeting 
regions to be methylated. DNMTL can bind both DNMT3a and unmethylated H3K4 (a 
mark of inactive genes) suggesting that it can target Dnmt3a induced methylation to 
inactive genes (Jia et al., 2007; Ooi et al., 2007).  
DNA can become unmethylated either passively or actively. Passive 
demethylation is reliant on the fact that the genome wide methylation pattern is not 
maintained during DNA replication with the new strand of DNA being bereft of any 
methylation. As mentioned above DNMT1 with its binding partner UHRF1 replaces 
the lost methylation (Bostick et al., 2007; Sharif et al., 2007). Active demethylation has 
recently become a prominent new mechanism with the characterisation of the ten-
eleven translocation (Tet) family of genes. The family is made up of three members 
(Tet1, 2 and 3) which all can oxidise 5mC primarily to 5 hydroxymethylcytosine 
(5hmC) and further oxidative products in a stepwise fashion (Tahiliani et al., 2009). 
The oxidative products of 5mC can then be removed through cell division or a base 
excision repair (BER) dependent mechanism (Rasmussen and Helin, 2016). The 
function and physiological role of the Tet family will be discussed in detail in section 
1.5.  
DNA methylation has a wide range of physiological roles, from inactivation of 
x-linked genes to stable silencing of genomic mobile elements such as transposons and 
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viral elements (Mohandas, Sparkes and Shapiro, 1981; Woodcock et al., 1997; Walsh, 
Chaillet and Bestor, 1998; Bourc’his and Bestor, 2004; Hellman and Chess, 2007). 
Perhaps the most prominently studied role of DNA methylation is the massively 
dynamic CpG methylation that occurs during mammalian development (Hemberger, 
Dean and Reik, 2009). There are two major phases of global demethylation: right after 
fertilization as the emergent zygote goes through early pre-implantation development 
to the morula stage; and a second wave between E10.5 and E13.5 during primordial 
germ cell specification (Rougier et al., 1998; Lee et al., 2002; Santos et al., 2002; 
Hajkova et al., 2008). In both cases the global demethylation is crucial to facilitate 
totipotent and pluripotent states in the developing embryo (Surani, Hayashi and 
Hajkova, 2007). In line with this it has been shown that DNA methylation is crucial in 
reprogramming fully differentiated cells into induced pluripotent stem cells (Simonsson 
and Gurdon, 2004; Mikkelsen et al., 2008). DNA methylation is essential for lineage 
restrictions during development and to reverse or change cell fate the methylome must 
be erased or modulated via demethylation.  
As explained above, histone octamers are the foundation for the fundamental 
units of DNA organisation, therefore, it is not surprising that post translational 
modification of the histone monomers can drastically alter the chromatin organisation 
and modulate gene transcription. Histones can be methylated, phosphorylated, 
acetylated, sumoylated, ubiquitinated, ADP ribosylated and deiminated at a wide array 
of positions in each of the four monomers (Li, Carey and Workman, 2007). The 
combination of modifications within one histone or nucleosome forms a histone code 
that will recruit activators or repressors of transcription as well as chromatin 
remodellers to modulate gene transcription. The effect of specific histone modifications 
can be highly contextual based on the composition of the overall histone code. 
However, there are some well described modifications of gene activation and 
repression. Active genes are usually associated with mono- or tri-methylation of histone 
H3 lysine-4 (H3K4me1 or H3K4me3) and acetylation of lysine-27 (H3K27ac). 
Whereas silenced genes are associated with trimethylation of histone H3 lysine-27 and 
-9 (H3K27me3 and H3K9me3) (Bannister and Kouzarides, 2011).  
The mode of action by which histone modifications can affect chromatin 
accessibility can be either: the chemical modification alters the interaction dynamics 
between the DNA and nucleosome; or the histone code will recruit certain modulators 
of gene transcription. For example, acetylation of a histone lysine will remove the 
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positive charge of the residue and thereby heavy acetylation may increase DNA 
accessibility by reducing the electrostatic attraction between the nucleosome and DNA 
(Reinke and Hörz, 2003). A case of this can be found in the promoter region of β-globin 
that has been shown to be associated with histones that are heavily acetylated resulting 
in an increased sensitivity to DNAse activity. This suggests that a reduction in the 
positive nature of histones may cause DNA to dissociate from nucleosomes more easily 
and facilitate more transcription (Kiefer et al., 2008).  On the other hand, modulators 
of gene transcription can ‘read’ and bind to the histone code directly via a variety of 
specialised protein domains such as the Royal family, which include: chromodomains; 
tudor domains; and MBT domains. These domains are all specialised to bind 
methylated lysine residues (Maurer-Stroh et al., 2003; Kim et al., 2006). An example 
of a histone reader is heterochromatin protein 1 (HP1). It is recruited to H3K9me3 via 
its N-terminal chromodomain and once bound HP1 can then dimerise and facilitate 
higher order chromatin structure and repress gene expression (Bannister et al., 2001; 
Lachner et al., 2001).   
Regardless of the mode of modulation the histone modifications themselves are 
deposited by a series of histone acetyltransferases (HATs), histone methyltransferases 
(HMTs), protein arginine methyltransferases (PRMTs), or removed by histone 
deactylases (HDACs) and lysine demethylases (KDMs) (Bannister and Kouzarides, 
2011). The activity of these ‘writers’ and ‘erasers’ are tightly controlled by external 
stimuli and facilitate the dynamic nature of histone modifications and resultant 
chromatin accessibility. These enzymes are often found as subunits of larger chromatin 
remodelling complexes such as the NuRD and Polycomb complexes (Zhang et al., 
1999; Basta and Rauchman, 2015; Chittock et al., 2017).  
The final level of epigenetic regulation is the gross movement of nucleosomes 
to increase or decrease chromatin accessibility (Saha, Wittmeyer and Cairns, 2006). 
Two major complexes involved in this task are the Switch/Sucrose non-fermentable 
(SWI/SNF) complex (also known as the BAF complex and discussed in more detail in 
section 1.6) and the Imitation switch (ISWI) complex. Both complexes work in a 
similar manner with a central ATP dependent subunit and several associated subunits 
that will direct the activity of the catalytic component (Vignali et al., 2000). Both 
chromatin remodelling complexes have remarkably varied physiological functions, 
from development to splicing, and this is likely due to their diverse complex 
compositions which can specify different functions. For instance, Snf2, the catalytic 
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subunit of the ISWI complex, is essential for early embryonic development where 
genetic ablation results in failure to develop beyond E7.5 (Stopka and Skoultchi, 2003). 
Whilst Brm, one catalytic subunit of the BAF complex, has been shown to promote 
inclusion of variant exons of the Cd44 gene by facilitating pausing of transcription 
elongation (Batsché, Yaniv and Muchardt, 2006).         
Chromatin remodellers largely work either by replacing core histones with 
specific histone variants that alter the nucleosome dynamics or by increasing or 
decreasing nucleosome occupancy at specific genomic loci by nucleosome sliding or 
ejection. As an example, the SWR1 family of chromatin remodellers have been shown 
to be required for the exchange of histone H2 with the variant H2A.Z which creates a 
less stable nucleosome and can facilitate increased transcription of associated genes 
(Mizuguchi et al., 2004).  
It is important to note that each of these levels of epigenetic regulation do not 
work in isolation and there is significant cross talk, where gene modulation is usually 
facilitated by coordinated alterations of all modes of chromatin regulation discussed 
here. Therefore, for a cell to change fate either naturally through development or 
artificially through reprogramming, it requires the action of several regulators of 
chromatin accessibility (Hemberger, Dean and Reik, 2009).  
As a result, the basic modes of epigenetic regulation as explained above provide 
powerful tools to facilitate significant changes in cell fate. Such examples of epigenetic 
regulation of cell fate and development are ample during embryogenesis an early 
development (Boland, Nazor and Loring, 2014). For instance, it was shown that histone 
modifications play a crucial role in the expression of key cardiomyocyte specific 
lineage markers in a time dependent manner. More specifically, cardiac lineage specific 
genes begin with high levels of the repressive H3K27me3 during pluripotency. 
However, as cardiac development progresses there is a gradual loss of H3K27me3 
mediated repression leading to expression marked by concomitant increase in 
H3K4me3 (Paige et al., 2012). This elegantly ensures the correct and one-way 
development and differentiation of cardiomyocyte tissue over time. However, despite 
several examples of epigenetic mediated cell fate changes in development the role of 
epigenetic players in the regulation of adult stem cell fate has remained poorly 
understood. This is likely down to two major factors, the lack of in vitro models of adult 
stem cell function and second being the lack of evidence that epigenetic state could be 
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transient and whether there were the pathways that could modulate chromatin in the 
adult in response to environmental cues.  
In the first instance, the isolation and culture of murine embryonic stem cells in 
1981 was a seminal moment for the study of development, as from a single cell 
population there was the potential to study the development of tissues of any of the 
three germ layers (Martin, 1981). Therefore, embryonic stem cells provided a model 
system allowing for the detailed dissection of the changes in chromatin state through 
development and the epigenetic players that control them. However, it has only been 
with the advent of organoid technology over the past decade that we have become able 
to model adult stem biology in the same way (Clevers, 2016). However, advance 
research has been further slowed by the fact that each adult stem cell population of 
interest requires their own specific organoid (or other in vitro) model system whereas 
much of development could be modelled starting from embryonic stem cells by altering 
the growth conditions (Murry and Keller, 2008). Furthermore, whilst there has been 
rapid development in this field and several different models of different adult stem cell 
populations there is no guarantee that all different regenerative tissues could be 
modelled in such an in vitro system (Clevers, 2016). In any case, the development of 
organoids to model adult stem cells has allowed us to probe their biology and begin to 
investigate how epigenetic regulators, which have such prominent roles during 
development, can also be involved in adult systems of regeneration. 
The second barrier to the study of epigenetics has been somewhat down to the 
lack of knowledge surrounding the mechanisms that allow chromatin state to change 
dynamically in response to signalling in the adult. Classically epigenetic regulation has 
been seen as a mechanism of stable lineage commitment during development. For 
example, the dosage of genes on the x chromosome needs to be tightly controlled, those 
with the XX genotype must express half the amount of X-linked genes as compared to 
those with a single X chromosome in order to develop correctly. This is achieved 
through an epigenetic mechanism where long non-coding RNA XIST interacts with a 
single X chromosome of an XX pair in a random manner. XIST can then recruit the 
Polycomb repression complex 2 (PRC2) to mediate genetic repression (Boland, Nazor 
and Loring, 2014). This repressive epigenetic state is stable and is inherited throughout 
development. However, it is now clear that the chromatin state as a static arrangement 
is wrong, and the chromatin landscape is extremely dynamic and there are epigenetic 
pathways that allow tight regulation throughout development and into the adult. For 
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instance, dynamic histone modification has been shown to be crucial for the correct 
cyclical nature of mammalian hair follicle stem cell growth. Ezh2, a component of 
PRC2 and H3K27me3 methyltransferase is essential for proper hair follicle stem cell 
proliferation. Loss of Ezh2 leads to increased expression of cell cycle inhibitors and 
concomitant decreased stem cell proliferation (Tarayrah and Chen, 2013). Moreover, 
beyond the better functional understanding of dynamic epigenetics there have also been 
significant developments in the knowledge surrounding the epigenetic regulators 
themselves. For instance, the Tet family of genes was only first discovered in 2009 
before which it was thought that the only method of DNA demethylation was passively 
by DNA replication (Tahiliani et al., 2009). However, the discovery of the Tet proteins 
show that DNA methylation can be removed in an active and gene specific fashion 
underlining a powerful new method to dynamically regulate the methylome. Therefore, 
it is clear that recent work has expanded the number of epigenetic regulators and their 
functions which underline the dynamic and plastic nature of chromatin state.  
The activation of mature ductal cells to a bi-potent liver progenitor in response 
to liver damage is one such example of cell fate changes where epigenetics may play a 
significant role. Furthermore it has even been postulated in that the change in cell fate   
resembles a reversion to an embryonic hepatoblast-like state (Miyajima, Tanaka and 
Itoh, 2014). It is therefore likely that epigenetic remodelling will need to take place to 
facilitate the change in cell fate. Taking advantage of liver organoids as a model for 
ductal progenitors and the increased understanding of the dynamic nature of chromatin 
state and the epigenetic regulators that control them, we are for the first time, able to 
break through the classical barriers to study explained above and assess the epigenetic 
mechanisms surrounding ductal cell activation in response to liver damage.  
Throughout the course of this work we focus on the epigenetic regulators Tet1 




1.5 The physiological role of Tet1 and 5-methylcytosine oxidation 
 
The hunt for the mammalian DNA demethylase has been long and full of controversies 
(Ooi, Bestor and Pfeifer, 2008). The first evidence of such an enzyme was described by 
Gjerset and Martin in 1982 where they described a protease sensitive DNA methylation 
activity was found in the nuclear extracts of mouse erythroleukemic cells (Gjerset and 
Martin, 1982). However, the protein responsible for this activity could not be isolated 
and characterised. More than a decade later another group described an RNAase 
sensitive fraction with demethylation activity suggesting that the native demethylase is 
actually a ribozyme or RNA dependent complex (Weiss et al., 1996). However, there 
was evidence against such a model and again no further characterisation was possible 
(Swisher et al., 1998). Later studies then implicated a Thymine DNA glycosylase, the 
BER pathway and the methyl binding protein MBP2 in active demethylation 
(Bhattacharya et al., 1999; Barreto et al., 2007; Cortázar et al., 2007). In all cases there 
were conflicting reports and questions as to the involvement of these candidates in rapid 
DNA demethylation (Hendrich et al., 2001; Jin, Guo and Pfeifer, 2008). The enigma 
was finally cracked by Tahilani and colleagues who characterised the founding member 
of the Tet family, Tet1 (Tahiliani et al., 2009).  
Tet1 is part of a family of three proteins with the ability to oxidise 5mC to 5hmC 
and the further cytosine oxidative derivatives 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC) in a step wise manner (Ito et al., 2011; Rasmussen and Helin, 
2016)(Figure 1.4). They are large proteins with several conserved structural domains 
between them. Each TET protein consists of a double stranded β-helix domain, binding 
sits for its cofactors Fe2+ and 2-oxogluturate and a cysteine enriched domain (Hu et al., 
2013; Hashimoto et al., 2014). The conserved domains make up the catalytic 
diooxegenase activity of the TETs. Structural studies have shown that the catalytic 
domain has significant substrate specificity for methylated CpG sites (Hu et al., 2015). 
TET1 and 3 also have a classical CXXC zinc finger domain that can facilitate DNA 
binding (Zhang et al., 2010; Xu et al., 2012). 
Tet1 dependent oxidation of 5mC does not ultimately result in an unmodified 
base in isolation but demethylation is facilitated by a passive or active mechanism. The 
passive mechanism is dependent on the cell cycle. The maintenance of 5mC throughout 
the cell cycle is facilitated by Dnmt1, which can bind hemi-methylated DNA (explained 
in section 1.4). However, when Dnmt1 is bound to hemi-methylated DNA containing 
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5hmC its activity is significantly reduced, therefore, DNA may not re-methylated 
through cell division resulting in unmodified cytosine on both strands of DNA in two 
rounds of DNA replication (Valinluck and Sowers, 2007; Hashimoto et al., 2012). 
However, recent evidence has shown that Dnmt1 partners Uhrf1/2 can bind 5hmC DNA 
in vivo and could drive the maintenance of 5mC through cell divisions by diluting the 
5hmC modification (Frauer et al., 2011; Zhou et al., 2014). Furthermore, Dnmt3a/b 
have also been shown to have no significant bias against CpG sites containing 5hmC 
and could facilitate the maintenance of the 5mC after oxidation (Hashimoto et al., 2012; 
Ji et al., 2014). Taken together further investigation of this passive mechanism is 
needed to understand whether it plays a significant role in TET dependent DNA 
methylation in vivo.    
Active demethylation removes modified cytosines independently from the cell 
cycle. This is achieved through thymine DNA glycosylase (TDG) mediated base 
excision and repair through the BER pathway. TDG was originally described to remove 
mismatched pyrimidines, however, since the characterisation of the oxidative products 
5fC and 5caC it was shown that TDG can excise the modified cytosine leaving an abasic 
site in the DNA (Krokan, Standal and Slupphaug, 1997; He et al., 2011; Maiti and 
Drohat, 2011). The removal of the modified cytosine then triggers the BER pathway to 
repair the site creating an unmodified cytosine (Parikh, Mol and Tainer, 1997). It is 
important to note that 5hmC is not removed by the same mechanism as it is not a 
substrate for TDG (Maiti and Drohat, 2011). Therefore, it is either removed by a passive 
mechanism or by further oxidation by the TETs.  
Interestingly, the TETs do not have equal preference for each oxidation step 
from the conversion of 5mC to 5caC. Structural studies of human TET2 have shown 
that the hydroxyl- and carbonyl- groups of 5fC and 5caC respectively generate 
increased bonding within the catalytic active site resulting in a less reactive complex. 
5fC and 5caC substrates are held further away from the critical Fe2+ cofactor (Hu et al., 
2013, 2015). As a result, it is not surprising that the rate of reaction of the conversion 
of 5mC to 5hmC has been shown to be significantly faster than subsequent oxidation 
steps (Ito et al., 2011)(Figure 1.4). In line with the kinetics of TET activity it has been 
found that there is a stable pool of 5hmC, and to a lesser extent 5fC, likely due to 
processivity of the TETs (Bachman et al., 2014, 2015). 5hmC forms the largest 
population of the 5mC oxidative products but interestingly it cannot be removed by the 
TDG/BER active demethylation and can only result in demethylation by cell cycle 
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dependent passive demethylation or by further action of the TETs, which is likely to 
increase the stability. 
 
Figure 1.4 – The TET family oxidises 5mC in a step-wise manner facilitating the active removal of 
methylated cytosine. A schematic showing the chemical structure of the oxidative derivatives of 5mC, these 
include, 5hmC, 5fmC, and 5caC, and their subsequent mode of removal. Gradient indicates reflects rate of 
reaction. Adapted from Rasmussen and Helin (2016). 
 
Following the discovery that the 5hmC and 5fC modifications are stable 
(explained above), it is interesting to speculate that they themselves are epigenetic 
modifiers and can modulate chromatin accessibility in a similar manner to the varied 
mechanisms of regulation that are mediated by 5mC (see section 1.4). To facilitate such 
a function the epigenetic modification would need ‘readers’ that can bind the 
modification and either directly mediate chromatin regulation or recruit further proteins 
to facilitate a function. Specific binding partners of 5hmC have not yet been well 
characterised but several proteins have been found to bind 5fC with high affinity 
(Iurlaro et al., 2013; Spruijt et al., 2013). These include transcription factors in the 
forkhead box family, several components of the chromatin remodelling NuRD complex 
as well as proteins involved in the DNA damage response (Iurlaro et al., 2013). The 
latter is likely due to the components required for the TDG/BER dependent 
demethylation. In any case, it suggests that 5fC may act as an independent chromatin 
modifier that can alter chromatin accessibility. 
As the hunt for specific effectors of the 5hmC modifier continues it is important 
to note that it has been shown that several mediators of 5mC do not bind 5hmC. 
Therefore, despite the current lack of specific activity 5hmC can remove the repressive 
nature of 5mC by displacing the negative mediators of transcription that were initially 
recruited. For instance, methyl- binding proteins MBD1, MBD2 and MBD4 bind 5hmC 
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with significantly lower affinity when compared to 5mC (Jin, Kadam and Pfeifer, 2010; 
Hashimoto et al., 2012). Therefore, we may consider 5hmC as a permissive 
modification for transcription. Interestingly, it also means that full demethylation is not 
required to remove the repressive effects of 5mC and through oxidation 5mC mediated 
repression can be reversed.  
The TETs and TET dependent 5mC oxidation have varied physiological roles 
from development to adulthood, but commonly they are involved in cell fate transitions. 
Throughout development there are two phases of global demethylation (see section 
1.4): first during early preimplantation development; and second during primordial 
germ cell (PGC) specification. It has been shown that both TET1 and TET2 are crucial 
for DNA demethylation and epigenetic reprogramming to PCG fate (Hackett et al., 
2013). Using null mutant mice it was shown that TET1/2 are dispensable for postnatal 
development but similar genetic ablation of TET3 (or all three members) results in early 
termination of preimplantation development (Dawlaty et al., 2011, 2013, 2014; Gu et 
al., 2011; Quivoron et al., 2011; Kang et al., 2015). This suggests that the role of each 
individual TET is not overlapping and they have non-redundant functions at different 
stages of development. Beyond embryonic development the TETs have been implicated 
in somatic reprogramming to iPSCs where their ablation dramatically reduces 
reprogramming efficiency, suggesting that TET dependent 5mC oxidation is crucial for 
the acquisition of iPSC fate (Doege et al., 2012; Costa et al., 2013). The TETs have 
also been shown to be crucial in both the maintenance of self-renewal in the intestinal 
stem cell (ISC) and the activation of axonal growth in mature neurons (Kim et al., 2016; 
Weng et al., 2017). In the first instance, it was shown that 5hmC was enriched in the 
ISC compartment and was quickly lost during intestinal differentiation and cell 
migration along the villus. In line with this, the authors demonstrated that when Tet1 
null mutants were backcrossed to generate a pure background significant postnatal 
lethality was apparent due to collapse of the intestine of mutant mice. Further analysis 
showed that Tet1 was crucial for maintained expression of lgr5 and other Wnt targets 
such as Axin2 resulting in loss of stem cell capacity in the ISC compartment (Kim et 
al., 2016). In neurons, Tet1 was recently shown to be crucial for the activation of 
regeneration upon injury where Tet1 knockdown resulted in reduced regeneration of 
retinal ganglion neurons after axonal damage (Weng et al., 2017).  
These studies demonstrate the remarkably dynamic role of Tet1 (and the family 
as a whole) in cell fate changes and plasticity during embryogenesis as well as in adult 
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systems of tissue homeostasis and regeneration. The ductal response to liver damage 
relies on activation of mature ductal cells to acquire a bi-potential Lgr5+ progenitor 
state (Huch, Dorrell, et al., 2013)(See section 1.2). Tet1 was shown to be involved in 
remarkably similar processes in the adult by the two studies by Weng et al and Kim et 
al, heavily implicating Tet1 as a candidate to modulation the acquisition of the 
progenitor state after liver damage (Kim et al., 2016; Weng et al., 2017). However, the 




1.6 The role of Arid1a and the BAF complex in development and epithelial 
regeneration. 
 
The Switch/Sucrose non-fermentable (SWI/SNF) complex is a large multi-subunit 
chromatin remodelling complex originally discovered in yeast (Neigeborn and Carlson, 
1984; Stern, Jensen and Herskowitz, 1984). The exact number of subunits is dependent 
on species, the mammalian SWI/SNF complexes are made up of ~12 subunits including 
one of two subunits with ATPase activity (Brg1 or Brm) and several associated factors 
together known as the Brm/Brg1 Associated Factor (BAF) complex (Tang, Nogales and 
Ciferri, 2010). The BAF complex works by using energy derived from ATP hydrolysis 
to shuffle nucleosomes, allowing the complex to change the chromatin landscape at a 
particular locus (Havas et al., 2000).  
The first insight into the mechanism of nucleosome movement was the 
discovery that the ATPases are part of the superfamily 2 (SNF2) group of DNA and 
RNA translocases and helicases (Eisen, Sweder and Hanawalt, 1995; Singleton and 
Wigley, 2002). In line with this, it was shown that several chromatin remodellers were 
able to translocate across linear DNA in a 3’5’ direction (Whitehouse et al., 2003; 
Saha, Wittmeyer and Cairns, 2005, 2006). Structural studies of the BAF complex 
ATPase and related SNF2 family members found that the enzymes are made up of two 
subdomains: a torsion domain that can translocate DNA; and a tracking domain that 
ensures directionality of movement (Kim et al., 1998; Velankar et al., 1999; Dürr et al., 
2005). The subunits bind two internal sites of the nucleosome before the torsion domain 
changes conformation and pulls DNA from the proximal linker region creating a ‘wave’ 
within a cleft between the two domains of the ATPase (Saha, Wittmeyer and Cairns, 
2005). The increased torsion of the under twisted wave of DNA is then resolved 
towards the distal linker region of DNA guided by the tracker domain acting as a 
‘rachet’ (Havas et al., 2000; Gavin, Horn and Peterson, 2001). Therefore, the action of 
ATP hydrolysis is nucleosome movement along DNA by a ‘wave/rachet’ mechanism 
(Saha, Wittmeyer and Cairns, 2006). 
 As explained in section 1.4 nucleosomes form a substantial barrier to 
transcription, therefore targeted nucleosome repositioning activity of the BAF complex 
can dramatically alter gene expression (Kireeva et al., 2005; Bondarenko et al., 2006). 
However, the complex has also been shown to bind other regulators of chromatin 
accessibility and transcription. For instance, the BAF complex is essential for the 
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repression of neural genes through the REST transcription factor (Battaglioli et al., 
2002). Moreover, the complex has been shown to recruit HDACs to regulate G1/S 
transition of the cell cycle (Zhang et al., 2000). Taken together, there is growing 
evidence that the BAF complex can modulate gene expression in several ways beyond 
its native nucleosome shuffling activity. As a result of the pleiotropic modes of action 
it is not surprising that the BAF complex is a prolific transcriptional regulator activating 
and repressing a plethora of genes (Ho et al., 2009a; Euskirchen et al., 2011). The 
ATPase associated factors can be split into core factors which are invariable, and the 
other factors which have distinct structural or functional homologues that are able to 
switch forming complexes with different compositions (Wang, Côté, et al., 1996; 
Wang, Xue, et al., 1996; Kadoch and Crabtree, 2015).  
The regulation of neural development is an excellent example of BAF 
specialisation and composition dependent function and involves three distinct BAF 
complexes: esBAF; npBAF; and nBAF (Ho and Crabtree, 2010). Early development 
has been shown to be dependent on a specific set of BAF components together known 
as the esBAF. The components include Brg1 (not Brm) and a Baf155 homodimer as 
well as a full complement of core invariable components (Ho et al., 2009a). 
Accordingly mouse knock out models demonstrate Brg1 is essential for zygotic genome 
activation and proliferation of the inner cell mass, whereas mutation of Brm results in 
viable mice (Reyes et al., 1998; Bultman et al., 2000, 2006). Furthermore, genetic 
ablation of Baf155 results in preimplantation lethality in mammalian development 
(Kim et al., 2001). The npBAF complex is then crucial for the differentiation of neural 
progenitors from embryonic stem cells. The npBAF can include: either Brm or Brg1; a 
Baf155/Baf170 heterodimer; Baf60c; and Baf45a. In line with this, both Brg1 and 
Baf45a are crucial for proper NOTCH and sonic hedgehog signalling, as well as 
proliferation of neural progenitors (Lessard et al., 2007). Finally, as neural progenitors 
mature they replace Baf45a and Baf53a with Baf45b and Baf53b forming the nBAF 
complex. These changes are crucial for the BAF complex to interact with CREST that 
regulates dendritic outgrowth (Lessard et al., 2007; Wu et al., 2007). The involvement 
of unique BAF complexes is best described in neural development but has also been 
implicated in cardiac development and may be a common mechanism for directing 
tissue specific differentiation (Lickert et al., 2004; Z. Wang et al., 2004; Huang et al., 




Figure 1.5 – Specialisation of the BAF complex modulates specific gene networks driving neural 
development. A schematic showing the composition of the BAF complex during neural development, crucial 
components of the embryonic BAF (esBAF), neural progenitor BAF (npBAF) or neural BAF (nBAF) are 
indicated in red. Adapted from Ho and Crabtree (2010). 
 
 A/T rich interacting domain (Arid) 1a (also known as BAF250a) is one 
component of the complex characterised by its DNA binding ARID domain (Tang, 
Nogales and Ciferri, 2010). Arid1a has two functional homologues Arid1b and Arid2, 
all three are mutually exclusive forming a core component of the BAF complex 
(Kortschak, Tucker and Saint, 2000; X. Wang et al., 2004; Wilsker et al., 2005; Xu, 
Flowers and Moran, 2012). Arid1a and Arid1b have both been implicated in 
maintaining the self-renewal of embryonic stem cells suggesting that they are 
functionally overlapping (Gao et al., 2008; Yan et al., 2008). In accordance with this it 
has been shown that there is significant synthetic lethality between Arid1a and Arid1b 
(Kelso et al., 2017). Furthermore, genome wide analysis of targets of each of three Arid 
family members found that Arid1a and Arid1b have overlapping targets (Raab, Resnick 
and Magnuson, 2015). On the other hand, Arid2 plays a more independent role as it 
forms a unique variation of the BAF complex together with Baf180 known as the 
polybromo BAF (pBAF complex). The pBAF complex has been implicated in cardiac 
and osteoblast development as well as being frequently mutated in cases of renal cancer 
(Z. Wang et al., 2004; Huang et al., 2008; Xu, Flowers and Moran, 2012; Porter and 
Dykhuizen, 2017).    
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Mathur and colleagues showed that genetic ablation of Arid1a leads to loss of binding 
of the BAF complex at 79% of canonical BAF binding sites and a concomitant with a 
loss of H3K27ac in enhancer regions (Mathur et al., 2017). Therefore, Arid1a is crucial 
for the recruitment and function of the BAF complex. Reflecting the central role of 
Arid1a it is not surprising that it has been found to be one of the most commonly 
mutated components in cancer with mutations being seen in liver cancer (both 
hepatocellular and cholangiocarcinoma), colon, gastric and pancreatic cancer, 
suggesting that Arid1a is a prolific tumour suppressor (Wang et al., 2011, 2014; 
Biankin et al., 2012; Muzny et al., 2012; Chan-on et al., 2013).  
Recently Arid1a has also been implicated in liver damage and epithelial 
regeneration. Hepatocyte specific genetic ablation of Arid1a resulted in spontaneous 
and progressive phenotypes reminiscent of steatohepatitis as well as increased 
appearance of liver cancer in response to oncogenic treatment (Fang et al., 2015). 
Moreover, another study showed that ubiquitous mutation of Arid1a enhances 
regeneration in the liver and skin epithelium in response to damage (Sun et al., 2016). 
The enhanced regeneration was a result of boosted proliferation through inactivation of 
E2f4, a repressor of cell cycle progression. Taken together Arid1a may guard against 
unregulated cell proliferation by cooperation with E2f4 and this may form the basis of 
the tumour suppressor activity.  
However, these studies do not interrogate the role of Arid1a in ductal progenitor 
regeneration specifically and as it is mutated heavily in cholangiocarcinoma, which is 
a largely ductal cancer, it would be interesting to study the effect of Arid1a in a ductal 
population. As explained above tissue specific gene expression can be facilitated by 
unique compositions of BAF components, thus by manipulating Arid1a in a ductal 
specific manner we would be able to understand whether an Arid1a containing complex 
is required for the plasticity required in ductal driven liver regeneration.       
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1.7 Project Aims 
 
1. To use liver organoids as a model of ductal cell-driven regeneration to find 
candidate epigenetic regulators in their activation by taking advantage of gene 
expression analysis and siRNA knockdown. 
2. To assess the role of Arid1a in ductal progenitor maintenance and 
differentiation by manipulating liver organoid culture conditions to induce 
hepatocyte-like differentiation. 
3. To take advantage of several animal models of liver damage and Tet1 deletion 
to understand its role in ductal cell driven regeneration. 
4. To apply optical clearing tools to whole liver tissue to facilitate the visualisation 




2. Materials and Methods 
 
2.1 Organoid studies 
 
2.1.1 Organoid derivation and maintenance 
 
Organoids were isolated and maintained according to conditions optimised by Huch et 
al. 2013. In brief, livers were dissected from adult mice and dissociated using an 
enzymatic mix of collagenase (Sigma, C9407) and dispase (Gibco, 17105041) at 37°C 
(Collagenase 0.0125%, Dispase 0.0125%, 1% FBS dissolved in DMEM/F12). After 3 
hours of digestion biliary ducts were manually picked and placed in 3D culture using 
matrigel (Corning, 356231) to form a matrix. Biliary ducts at this stage were cultured 
with organoid isolation medium (Table 2.1). After 4-7 days of these initial culture 
conditions media was changed to normal organoid expansion medium (Table 2.1).  
Organoids were also derived from single cells by taking advantage of a fluorescence 
activated cell sorting strategy. Livers were digested as describe above to generate a 
biliary duct enriched solution, the solution was then further dissociated to single cells 
by incubation with Tryple 5x solution (Life technologies, A12177-01) for 10 minutes 
at 37°C. The resulting solution was filtered twice through a 40um cell strainer to 
remove large clumps of cells and counted with a haemocytometer. Single cells were 
transferred to polypropylene FACS tubes and blocked in 2% FBS in DMEM/F12 (Life 
technologies, 31966021) for 10 minutes at 4°C. Cells were then labelled with 
fluorophore conjugated antibodies described in Table 2.7, for 30 minutes at 4°C at a 
concentration of 1 μl of antibody/1x106 cells in 1% FBS in DMEM/F12. Cells were 
then washed twice in 1% FBS in DMEM/F12, sorted using a MoFlo cell sorter and 
collected in advanced DMEM (Life technologies, 12634028) supplemented with Rho 
kinase inhibitor (Ri) at a concentration of 10 μM. The organoid forming fraction was 
defined as EpCAM+Cd45-Cd11b-Cd31- and were seeded at experimental dependent 
densities in matrigel with organoid isolation medium (Table 2.1). Again, after 4-7 days 
of these initial culture conditions media was changed to normal organoid expansion 
medium (Table 2.1).  All medium compositions are made in Advanced DMEM/F12 
supplemented with a cocktail growth factors, see Table 2.1 for concentrations and 
manufacturer’s details. After organoids were established in culture they were passaged 
once per week by removing the matrigel and mechanically dissociating the organoid 
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structures before reseeding in matrigel at a ratio of 1:4 to 1:6. All cell culture was 
maintained at 37°C and 5% CO2 unless otherwise stated.  
 
Table 2.1 – 3D organoid growth media recipes 
 
 
2.1.2 siRNA Transfection  
 
To perform siRNA knockdown 1x104 cells either EpCAM+ cells freshly isolated from 
healthy liver or established organoids were transfected with a pool of 4 ON-Targetplus 
siRNA (Dharmacon, custom plate) for each candidate gene or with the 4 independent 
Tet1 siRNA using Lipofectamine RNAimax (Life Technologies, 13778075) according 
to manufacturer’s instruction. After that, cells and Lipofectamine-RNA mix were spun 
at 600g at 32°C for 45 minutes and then incubated for 4 hours at 37°C. Cell suspension 
was then collected, spun for 5 minutes at 300g and seeded in matrigel in Isolation 
medium in order to allow organoid formation. Organoid formation efficiency was 




Table 2.2 – siRNA sequence library 
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Table 2.2 – siRNA sequence library (cont.) 
 
2.1.3 Organoid differentiation  
 
Organoids were differentiated towards a hepatocyte fate by switching medium to a 
defined differentiation medium (Table 2.1) 2 days after seeding in expansion medium. 
The differentiation medium is refreshed every two days. At day 10 after onset of 
differentiation the media is further supplemented with Dexamethasone (3 μM). 
Organoids were then analysed 4 days after the addition of dexamethasone. 
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2.1.4 Terminal hepatocyte differentiation assays  
 
Albumin secretion was determined by ELISA (Universal biologicals, EMA3201-1). 
Differentiation media was refreshed 24 hours prior to the experimental endpoint and 
then removed. The media was centrifuged at 20,000g for 15 minutes at 4°C and the 
supernatant removed discarding any cellular debris. We then determined albumin 
concentration in the supernatant by ELISA, following the manufacturer’s protocol. 
Cellular cytochrome p450 activity was determined by incubation with a flourogenic 
substrate (Promega, V8901). Organoids were removed from their matrigel by washing 
thoroughly with cold phosphate-buffered saline (PBS) twice and incubation in cell 
recovery solution (Corning, 354253) for 20 minutes at 4°C. The isolated organoids 
were then washed once in hepatozyme (Thermo Fisher, 17705021) medium 
supplemented with 10% FBS and finally incubated for 8 hours at 37°C (5% CO2) in 
hepatozyme medium supplemented with EGF, gastrin, HGF and PFBE substrate. After 
incubation, the cells and media were collected and spun down at 600g. The supernatant 
was removed and incubated in a 1:1 mix with the luciferin detection reagent for 20 
minutes at room temperature, protected from light. After which luminescence was 
detected using a benchtop luminometer (Glomax, 1901-002) with 0.25 seconds of 
signal integration. Finally, the cell pellet was dissociated into single cells by incubation 
1x Triple (Life technologies, 12605010) for 5 minutes at 37°C before being counted 
with a haemocytometer. Enzyme activity was expressed as Relative luminescence units 
(RLU) per 1x106 cells.  Low Density Lipoprotein (LDL) uptake was determined by 
incubation with a fluorescent analogue of LDL, 1,1’-dioctadecyl-3,3,3’,3’-tetramethyl-
indocarbocyanine perchlorate LDL (Di-Ac-LDL)(Bioquote, BT-902). Organoid 
growth media (either differentiation or expansion) was supplemented with Di-Ac-LDL 
at a concentration of 10 μg/mg and incubated overnight at 37°C (5% CO2). Organoid 
nuclei were then stained using DRAQ5 (Thermo scientific, 62251) diluted 1/500 in 
PBS and imaged using confocal microscopy (Leica SP5).  
 
2.1.5 RNA extraction and RT-qPCR 
 
RNA was extracted from the tissue, organoids or freshly sorted EpCAM+Cd45-Cd11b-
Cd31- cells by the RNeasy mini or micro kit (Quiagen, 74004) following the 
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manufactures protocol. cDNA was generated in a two-step reaction with 50-250 ng of 
RNA using M-MLV Reverse transcriptase, RNAse H minus, point mutant (Promega, 
M3682) following manufacturers protocol. Finally, qPCR was carried out with primers 
to detect specific gene expression (Table 2.3) using the iTaq universal SYBR green 
supermix (Bio-Rad, 172-5124) using the manufacturers protocol.   
 
Table 2.3 – qPCR/ChIP detection primer sequences 
 
 
2.1.6 Fluorescence activated cell sorting (FACS) 
 
Organoids were prepared for FACS by removing them from matrigel by washing with 
cold advanced DMEM. The organoids were then dissociated into single cells by 
incubation with 1x Tryple solution for 5 minutes at 37°C, the cell suspension is 
periodically further mechanically dissociated using a narrowed glass Pasteur pipette.  
Once a single cell suspension is achieved the Tryple solution is inhibited by washing 





2.1.7 Western Blot 
 
Cell lysates were prepared by using RIPA buffer (10mM Tris-Hcl PH 8.0m 1mM 
EDTA, 1% Triton X-100, 0.1% SDS. 150mM NaCl) supplemented with proteinase 
inhibitor cocktail (Roche, 11836153001) and sonicated for 5 minutes using a Bioruptor 
sonicator (Diagenode) at 4°C. Lysates were cleared by centrifugation at 10,000g for 15 
minutes at 4°C. Samples were loaded on Precast Mini Protean TGX gels (Bio-Rad, 
4561083) and then transferred to a nitrocellulose membrane. Membranes were blocked 
in 5% milk and incubated overnight with ARID1A (1:5000), TET1 (1:5000) or ACTIN 
(1:2000) antibodies at 4°C. After that anti rabbit or mouse horseradish peroxidase 
(HRP) conjugated secondary antibodies were used and antibody-protein complexes 
were visualised using ECL (GE Healthcare, RPN2106). 
 
2.1.8 Chromatin immunoprecipitation (ChIP) 
 
Organoids were harvested and removed from matrigel and dissociated into single cells 
as described above. At least three million cells were used to purify enough chromatin 
for the ChIP. The cells were fixed in 1% formaldehyde (Sigma, F8775) for 15 minutes 
at room temperature after which the fixation was stopped by addition of glycine to a 
final concentration of 125 mM. The cells were then lysed by sonication in IP buffer 
made up by 1:2 mix of SDS buffer and dilution buffer (Table 2.4).  10-25 ug of 
chromatin was incubated with the 2-5 ug of the primary antibody for 16 hours at 4°C. 
Next the chromatin was incubated with beads coated with the appropriate secondary 
antibody (50% slurry) for 2 hours at 4°C. The chromatin was then washed with low salt 
then high salt buffer (Table 2.4). The DNA was then eluted by incubating with 110 μl 
elution buffer (Table 2.4) for 16 hours at 65°C. DNA enrichment was then analysed by 




Table 2.4 – ChIP solution recipes 
 
 
2.1.9 RNA sequencing and analysis 
 
EpCAM+ freshly isolated cells were embedded in matrigel and collected at different 
time points after culture (time 12h, 24h, 48h and 6 days, with this last time point named 
as organoids). The starting time point, 0h was collected after seeding in matrigel but 
prior to adding any medium. Total RNA was extracted using RNeasy micro kit 
according to manufacturer instructions. RNA libraries were prepared by using 
Smartseq2. RNA sequencing was performed using Illumina Hiseq sequencer. High 
quality reads were mapped to Mus Musculus GRCm38 genome reference with STAR 
aligner (v 2.5.0c). Feature counts (version 1.4.6-p5) was used together with the version 
GRCm38.84 to calculate gene expression values as raw read counts. RPKM was also 
calculated. HTSFilter was applied to remove non-expressed genes or genes showing 
too much variability. Heatmap of expression were performed based on scaled RPKM 
values. Hierarchical clusterisation was performed by calculating Pearson Correlation 
among genes and by applying the average clusterisation method. The Trimmed Means 
of M-values (TMM) normalisation strategy was used to analyse data across the different 
samples. Differentially expression (comparing each time point to the previous one) was 
calculated using edgeR with FDR ≤ 0.05. Clustering was done taking in account 
Differentially Expressed genes at least in one comparison (comparing each time point 
to the previous one and organoids vs 0h) applying a cutoff of RPKM >1 based on 
average RPKM of duplicates. Numbers indicate normalised expression values after 
applying a scaling procedure on the average RPKM.  
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2.2 Animal studies  
 
2.2.1 Animal breeding and maintenance  
  
The University of Cambridge Animal Welfare and Ethical Review Body (AWERB) 
have regulated this research under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review. Both male and female mice 
were used throughout this work and were of a mixed background. Mice were kept under 
standard handling procedures in a pathogen free environment with a 12-hr day/night 
cycle. Sterile food and water were given to the mice ad libitum. Breeding the mice with 
the alleles described in Table 2.5 generated experimental genotypes.  
 





Ear biopsies of new litters were taken and then incubated in lysis buffer (Bioquote, 102-
T) overnight at 60°C. After lysis DNA solutions were diluted 10 fold and stored at 4C 
until analysis.  Genotype was determined by PCR using allele specific primers (Table 
2.6). PCR reactions were carried out using GoTaq PCR kit (Promega, M5001) 








2.2.3 Tamoxifen injection 
 
Mice were injected with 0.1-0.2 mg/g up to 4 times (refer to experimental scheme for 
specific tamoxifen regimen) via intraperitoneal injection. A working dilution of 20 
mg/ml of tamoxifen was prepared by initially dissolving tamoxifen (Sigma, T5648) in 
ethanol at a concentration of 3 g/ml before diluting to a final concentration of 20 mg/ml 
in sterile sunflower oil (Sigma, S5007) with strong agitation at 37°C until fully 
dissolved.    
 
2.2.4 CCl4 treatment  
 
Mice were given either a single dose of 1 ml/kg CCl4 via intraperitoneal injection. CCl4 
(Sigma, 270652) was diluted 1/10 in corn oil (Sigma, C8267) to generate a working 
solution for injection.   
 
2.2.5 DDC treatment 
 
Mice were transferred to wheat free cages and fed chow supplemented with 0.1% 3,5-
diethoxycarbonyl-1, 4-dihydrocollidine (DDC)(Custom animal diets LLC, AD5001) ad 
libitum for 5-7 days. Mouse weights were recorded every day throughout DDC feeding. 
Chronic DDC experiments were carried out by repeating a 5 day 0.1% DDC dose after 
mice were switched back to maintenance diet for 3-4 days for a total of eight times.    
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2.2.6 AAV8-p21 delivery 
 
AAV8.TBG.p21.BGH viral particles were provided as a gift from Professor Forbes 
(University of Edinburgh). 7.5x1011 viral particles were suspended in 100 ul of sterile 
PBS and delivered into mice by tail vein injection using BD ultrafine insulin needles.  
 
2.2.7 Serum preparation and analysis 
 
Blood samples were allowed to clot at room temperature for 45 minutes. They were 
then spun down at 2000g for 15 minutes at room temperature to separate the blood clot 
from the serum. Finally, the supernatant (serum fraction) was removed and analysed 
for GLDH, AST, ALT and bile acid concentrations, performed by the Clinical 
pathology lab at the University of Cambridge Veterinary School.    
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2.3 Histology, immunohistochemistry and immunofluorescence  
 
2.3.1 Tissue preparation and embedding 
 
Mice were euthanised by lethal exposure to a high concentration of CO2. After sacrifice, 
blood samples were taken via cardiac puncture and kept at 4°C until further processing. 
Mice were then dissected and the livers, small intestine (SI) and pancreata were 
harvested and stored in PBS at 4°C. Small biopsies were taken of each organ harvested, 
snap frozen on dry ice and stored at -80°C for downstream genetic and gene expression 
analysis. Livers were split into the individual lobes, then further divided into ~5 mm3 
pieces and fixed in 10% neutral buffered formalin (NBF)(Fisher scientific, 5701) 
overnight at 4°C. SI samples were initially flushed with clean PBS and NBF then fixed 
submerged in NBF overnight at 4°C. Finally, pancreas samples were dived into two 
and submerged in NBF overnight at 4°C. Fixed tissues were then washed in PBS 3x for 
5 minutes each and then embedded in paraffin, optimal cutting temperature (OCT) 
compound (VWR, 3611603E) or agarose. For paraffin embedded samples, fixed 
samples were dehydrated through ascending concentrations of Ethanol (70%, 96% and 
100%) and xylene, each for 2 hours at room temperature. After incubation in xylene 
samples were transferred to molten paraffin (Thermo scientific, 6774006) and 
incubated overnight at 55°C. Finally, samples were transferred to moulds, submerged 
in molten paraffin and allowed to cool and solidify at 4°C for 10 minutes. For OCT, 
embedding, samples were incubated in 30% sucrose (Fisher scientific, S/8600/60) 
overnight at 4°C. Samples were then transferred to plastic moulds, submerged in OCT 
compound and frozen on dry ice, samples were then stored at -20°C until sectioning. 
For agarose embedding, samples were submerged in molten 4% low melt agarose (Bio-
Rad, 161-3111) and allowed to cool and solidify at 4°C.  
 
2.3.2 Immunohistochemistry  
 
Paraffin embedded samples were sectioned at 5 μm with a microtome (Leica, RM2235), 
sections were then transferred to superfrost (Thermo Scientific, 12372098) slides and 
dried overnight at 60°C. Sections were then deparaffinised with 2 incubations of xylene 
for 5 minutes at room temperature. The sections were then hydrated via incubation in 
descending concentrations of ethanol (100%, 96%, 70% and 50%) and finally H20 each 
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for 5 minutes at RT.  After rehydration, samples were then subject to antibody 
dependent antigen retrieval techniques (Table 2.7). Sections were then transferred to a 
humidified chamber and blocked in 1% Bovine serum Albumin (BSA)(Sigma, A7906), 
2% Foetal Bovine serum (FBS) and 1% Triton-X (Sigma, T8787) diluted in tris-
buffered saline (TBS) for 1.5 hours at room temperature. Primary antibodies were then 
incubated on sections at an assay dependent concentration (Table 2.2) diluted in a 1/100 
dilution of the blocking buffer overnight at 4°C. After antibody incubation sections 
were rinsed 3x in TBS and blocked for endogenous peroxidase activity by incubation 
in 3% H2O2 diluted in methanol for 20 minutes at room temperature. Sections were then 
rinsed in TBS and antibody binding was detected by using the DAB-Bright system 
(Immunologic, BS04-110) following manufacturer’s instructions. After detection 
nuclei were counterstained by incubation in Haematoxylin (Sigma, MHS16) for 8 
minutes at room temperature, sections were then washed of excess haematoxylin by 
washing under a running tap. Finally, slides were dehydrated in ascending 
concentrations of ethanol (50%, 70%, 96% and 100%) before clearing in xylene and 
mounting in DPX mounting medium (Fisher scientific, 15538321). Images were 
acquired using brightfield microscopy (Leica DM4000b) and analysed using Imagej. 
 
2.3.3 Haematoxylin and eosin stain 
 
Tissue sections were prepared and rehydrated as described above. Nuclei were then 
stained in Haematoxylin for 1 minute at room temperature before being rinsed under a 
running tap for 5 minutes. The sections were partially dehydrated by incubation with 
50%, 70% and 96% ethanol for 5 minutes each. Sections were then quickly incubated 
in eosin (Sigma, HT110316) for 10-15 seconds before being rinsed in 96% ethanol 
twice. Finally, sections were fully dehydrated by incubation in 100% ethanol and 
cleared in two washes in xylene before being mounted in DPX mounting medium and 




Table 2.7 – Antibody information 
 
 
2.3.4 Picrosirius Red stain 
 
Tissue sections were prepared and rehydrated as described above. Rehydrated sections 
were then incubated in Picrosirius red solution (Abcam, ab150681) for 1 hour at room 
temperature after which they were quickly rinsed in acetic acid twice. After washing, 
sections were incubated in absolute ethanol three times for five minutes each before 
being cleared with xylene and mounted with DPX mounting medium and a coverslip. 
Images were acquired using brightfield microscopy and analysed using ImageJ. 
Fibrotic area was calculated using an ImageJ macro developed in house.  
 
2.3.5 Thick OCT section immunofluorescence  
 
Thick frozen sections (100-50 µm) were cut from OCT embedded samples using a 
cryostat (Leica, CM3050s), transferred to a 24 multi well plate and washed in PBS 
twice to remove excess OCT compound. Sections were blocked in 5% DMSO (Sigma, 
D8418), 2% Donkey serum (Sigma, D9663), 1% Triton-X diluted in PBS overnight at 
4°C. Sections were then incubated in primary antibody at specific concentrations (Table 
2.7) diluted in 1% DMSO, 2% Donkey serum and 0.5% Triton-X diluted in PBS for 72 
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hours at 4°C. After antibody incubation sections were washed five times in 1% DMSO 
and 0.5% Triton-X diluted in PBS for 1 hour each at room temperature. Fluorophore 
conjugated secondary antibodies were incubated with sections at a 1/250 dilution in 2% 
Donkey serum, 1% DMSO and 0.5% Triton X in PBS for 48 hours at 4C and protected 
from light. After secondary antibody incubation sections were incubated with Hoechst 
33342 (Thermo scientific, H3570) diluted 1/1000 in PBS for 1 hour at room 
temperature. Sections were then incubated in ascending concentrations of glycerol 
(10%, 30%, 50%, 70% and 90%) for 1 hour each at room temperature. Sections were 
finally transferred to slides, mounted in Vectashield (Vector laboratories, H-1000) with 
a cover slip and sealed with nail polish.  Images were acquired using confocal 
microscopy (Leica SP8) and analysed using ImageJ. 
 
2.3.6 Thin OCT section immunofluorescence 
 
Thin frozen sections (10 µm) were cut from OCT embedded samples using a cryostat 
and transferred to superfrost+ slides (VWR, 631-0108). After sectioning samples were 
washed in PBS twice to remove excess OCT compound, placed in a humidified 
chamber and blocked in 2% Donkey serum, 5% DMSO and 1% Triton-X for 1.5 hours 
at room temperature. Sections were then incubated in primary antibodies at antibody 
specific concentrations (Table 2.7) diluted in a 100-fold dilution of the blocking buffer, 
overnight at 4°C. Sections were then rinsed PBS 3x and then incubated in fluorophore 
conjugated secondary antibodies diluted 1/250 in 2% donkey serum, 1% DMSO and 
0.5% Triton-X in OBS for 2 hour at room temperature. After which, sections were 
rinsed in PBS three times and incubated in Hoescht 33342 diluted 1/1000 in PBS for 5 
minutes at room temperature. After a final wash in PBS sections were mounted with 
Vecatshield and a coverslip and sealed using nail polish. Images were acquired using 
confocal microscopy and analysed using ImageJ.  
 
2.3.7 Organoid immunofluorescence 
 
Organoids were removed completely from the matrigel matrix by several washes with 
cold Advanced DMEM. The organoids were then fixed with 4% paraformaldehyde at 
4°C for 20 minutes. The fixative was removed by washing the organoids in PBS three 
times. Blocking and permeabilisation was carried out by incubating the fixed organoids 
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in 0.3 % Triton-X, 1% BSA, 1% DMSO, 2% Donkey serum dissolved in PBS for 2 
hours at room temperature. The organoids were then incubated with the primary 
antibody at the relevant concentration dissolved in a 1/100 dilution of blocking buffer 
at 4°C overnight (Table 4).  After washing the organoids in 1/100 dilution of the 
blocking buffer three times the appropriate fluorophore conjugated secondary 
antibodies were added at a concentration of 1/250, dissolved in 0.05% BSA in PBS and 
incubated for 2 hours at room temperature. Organoids were washed in PBS then 
incubated with Hoechst 33342 dissolved 1/1000 in PBS for 5 minutes at room 
temperature. The organoids were rinsed one further time in PBS and imaged suspended 




2.4 Liver wholemount staining protocols 
 
2.4.1 Tissue preparation 
 
Liver samples were prepared as described above, however, livers were also flushed to 
remove excess blood from the vasculature prior to removal from the mouse. This was 
performed by initially making an incision in the lower aorta before injecting 10 ml of 
heparinised PBS (10 U/l)(Sigma, H3149) using a 10ml syringe and a 21g needle into 
the left ventricle of the heart. After perfusion with PBS livers were removed, fixed and 
embedded in agarose as described above.  
 
2.4.2 Vibratome sectioning  
 
Agarose embedded samples were placed in the vibratome (Leica, VT1000s) bath that 
was then flooded with PBS. Sections were then taken at several thicknesses (50, 100, 
400 μm and 1 mm), transferred to PBS and stored at 4°C until further processing.  
 
2.4.3 See Deep brain optical tissue clearing 
 
See deep brain (SeeDB) optical clearing was optimised for liver sections based from 
protocols published by Ke et al. (2013) and Lloyd et al. (2016) (Ke, Fujimoto and Imai, 
2013; Lloyd-Lewis et al., 2016). Liver sections of varying sizes were initially blocked 
in 10% BSA and 1% Triton-X in PBS overnight at 4°C. Sections were then incubated 
in primary antibodies, diluted in blocking buffer, for 4 days at 4°C. After primary 
antibody incubation samples were washed for 3 times for 1 hour with 0.1% Triton-X in 
PBS at room temp. Appropriate fluorophore conjugated secondary antibodies were 
incubated with sections and were incubated for 2 days at 4°C. Samples were then 
washed in 0.1% Triton-X in PBS three times for 1 hour at room temperature and then 
incubated with Hoescht 3342 diluted 1/1000 in PBS for 60 minutes at room 
temperature. Samples were then immersed in ascending concentrations of fructose 
(Fisher scientific, 10579760) with 0.5% α-thiolglycerol (Sigma, M1753) every 12 
hours (20, 40, 60 and 80%) at room temperature whilst being agitated. Sections were 
then incubated in 100% fructose for 24 hours followed by incubation in SeeDB solution 
(115% w/v) for a final 24 hr. Sections were imaged mounted in SeeDB solution by 
confocal microscopy.  
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2.4.4 CUBIC optical tissue clearing 
 
CUBIC clearing was adapted from protocols published by Susaki et al. (2015) and 
Lloyd et al. (2016) (Susaki et al., 2015; Lloyd-Lewis et al., 2016). Tissues of varying 
size were submerged in reagent 1 or 1a (A less harsh variant of reagent 1, unpublished 
from protocol on http://cubic.riken.jp/) for 5 days whilst being agitated at 37°C. CUBIC 
reagents were refreshed daily. After incubation, sections were blocked in 10% donkey 
serum and 0.5% Triton-X in PBS overnight at 4°C. The next day primary antibodies 
were added, and samples incubated for 4 days at 4°C. After primary antibody 
incubation samples were washed for 3 times for 1 hour with 0.1% Triton-X in PBS at 
RT. Appropriate fluorophore conjugated secondary antibodies were incubated with 
sections and were incubated for 2 days at 4C. Samples were then washed in 0.1% 
Triton-X in PBS three times for 1 hour at room temperature and then incubated with 
Hoescht 3342 diluted 1/1000 in PBS for 60 minutes at room temperature. Samples were 
them immersed in CUBIC reagent 2 and agitated for 48 hours at 37°C before being 
imaged by confocal microscopy. Imaging was carried out with sections mounted in 




2.5 Statistical analysis  
 
Unless otherwise stated all appropriate statistical analysis was carried out in statistical 
program R and visualised using the ggplot2 package (R Core Team, 2018). 




The siRNA knock-down screen in section 3.1 and some in vitro data in sections 3.2 and 
3.3 was carried out in close collaboration with Dr Luigi Aloia. His contribution is stated 
in External Contributions and at the end of relevant figure legends, when not stated, the 
results have been produced entirely by me. 
    
3.1 Identification of Arid1a and Tet1 as candidates involved in ductal progenitor 
dynamics  
 
We began the search to find potential candidate genes by analysing gene expression 
changes in response to liver damage. In order to focus on the liver’s ductal regenerative 
response, we analysed a previously generated gene expression dataset derived from 
livers that had been damaged using carbon tetrachloride (CCl4). CCl4 is a potent 
cytotoxic agent which causes massive death of central vein hepatocytes resulting in a 
ductal and hepatocyte proliferative response to facilitate regeneration of the lost tissue 
(Weber, Boll and Stampfl, 2003) In this experiment mice were subject to a single dose 
of CCl4 (1 ml/kg) delivered via intraperitoneal injection and allowed to recover for 
either 2.5, 6 or 12 days (labelled T2.5, T6 or T12 respectively). At each time-point 
whole liver biopsies were taken for gene expression analysis performed via microarray 
and compared to mock injected undamaged controls (labelled T0) (Figure 3.1a).  
 Analysis of the raw G-median intensity (a read out of gene expression) showed 
a remarkable spike of gene expression in several components of the BAF complex 6 
days after CCl4 induced liver damage (Figure 3.1b). These included components 
involved in DNA binding (Arid1a, Arid1b and Arid2), and the crucial ATP hydrolysis 
activity (Brg1 and Brm). Interestingly, only one of the two ATPases in the complex is 
up-regulated suggesting that after damage there could a be a more specific set of BAF 
components activated. In order to confirm our results and understand further if the 
response is the result of a progenitor response, we validated the results by qPCR. As 
expected, the select components (labelled in red) were shown to have the same pattern 
of expression by qPCR. Furthermore, the peak of expression seen in the BAF complex 
after 6 days correlates with the peak of expression of progenitor and WNT signalling 
markers (hallmarks of the ductal progenitors) Lgr5 and Axin2 (Figure 3.1c). This 
provides some evidence that the BAF complex might be involved in the ductal 
progenitor response.   
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Figure 3.1 - Multiple components of the BAF complex are upregulated during CCl4 induced liver damage. A) 
Schematic of the liver damage protocol. Mice were injected with CCl4 at a dose of 1 ml/kg and whole liver samples 
were taken at 2.5 (T2.5), 6 (T6) or 12 (T12) days post-injection, as well as from non-injected controls (T0). B) Gene 
expression analysis was carried out by microarray and the G-median intensity score was plotted against the T0, T6 
and T12 timepoint for the different components of the BAF complex. Each timepoint was analysed in duplicate from 
two independent biological replicates, replicates are represented as dots with a bar to represent the group mean. C) 
Microarray analysis was validated by qPCR and several BAF components were compared to progenitor markers 
Lgr5 and Axin2. At least two independent biological replicates were analysed per timepoint (T0 n=3, T2.5 n=4, T6 
n=3, T12 n=2) represented as dots with a bar as the group mean. 
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It is important to note that as the gene expression data was derived from whole 
liver biopsies it is likely that the gene expression changes were heavily influenced by 
the bulk hepatocyte population. Therefore, it is impossible to tell whether the changes 
in gene expression identified are due to ductal progenitors rather than another cell type. 
To solve this problem and remove the confounding influence of the heterogeneous cell 
population found in the whole tissue biopsy and ensure we are only looking at the ductal 
response we want to study, we took advantage of the liver organoid model. Liver 
organoids are generated when quiescent or otherwise non-proliferative ductal cells are 
put in defined 3D culture conditions during which there is activation of proliferation 
and the cells enter a bi-potent state that are able to differentiate into ductal and 
hepatocyte-like cells (Huch, Dorrell, et al., 2013; Huch et al., 2015). As a result, by 
following liver organoids during their initial formation in vitro we can analyse the 
changes in ductal cells in isolation from other cell types. Thus, allowing us to better 
dissect the initial steps of progenitor activation before the onset of proliferation and bi-
potency.  
As a result, we isolated EpCAM+ ductal cells using a FACS strategy generated 
and optimised by Aloia and colleagues (Unpublished) and placed them in 3D culture 
before either immediately (0h), or after a specific time in culture isolating for gene 
expression analysis by RNA sequencing (Figure 3.2a). We initially looked at the 
changes in the ductal, proliferative and progenitor signature of the cell populations at 
each time point by analysing specific markers of each. Interestingly, there was a peak 
of expression of proliferative marker miKi67 at 48 hours before the peak of the 
expression of the progenitor markers Lgr5 and Trop2, which only happens after the 
organoids become established after 6 days. This suggests that perhaps the onset of 
proliferation and stem cell marker expression are uncoupled. Moreover, throughout 
organoid derivation we found there was a fascinating dynamic change in the expression 
pattern of certain ductal markers. Where in some cases there was down-regulation (Cftr, 
Ggt1), others were up-regulated (Krt7, Krt19) and some were transiently altered 
(Hnf1b) (Figure 3.2b). Taken together this suggests that although liver organoids 
remain largely ductal in nature, they do not resemble fully mature ductal cells from 
which they are derived. This highlights a potential problem with our model, these gen 
expression changes could indicate that organoid generation may represent the 
emergence of a non-physiological ductal cell population. Evidence against this idea has 
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been shown by Aloia and colleagues (in press) where the gene expression changes seen 
in organoid generation were observed to be similar to those in EpCAM+ cells isolated 
during liver damage, suggesting that the organoid generation does faithfully model 
ductal cells during damage.  
 
In any case, we next wanted to assess which genes could be responsible for such 
a large change in genetic programming, we therefore analysed changes in expression 
 
Figure 3.2 – Several epigenetic modifiers are dynamically regulated during organoid derivation.  A) 
Experimental scheme, EpCam+ cells were isolated from healthy livers and placed in 3D culture before RNA 
isolation either just after Matrigel embedding (0h) or 12 hours (12h), 1 day (24h), 2 days (48h) and 6 days 
(Organoid) of 3D culture. B) Hierarchical clustering of RPKM values of selected progenitor (red), proliferation 
(green) or ductal (brown) markers throughout the time course. Values were derived from two independent 
biological replicates. C) Hierarchical clustering of RPKM of selected epigenetic families or complexes 
throughout the time course. D) qPCR validation of RNAseq derived values. Error bars show stand error of the 
mean of two independent replicates. (Aloia et al. unpublished). 
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of candidate epigenetic regulators that have been previously implicated in fate changes, 
before or at the onset of the expression of proliferative markers at 48 hours. We began 
by analysing the expression of the BAF complex to validate previous evidence (Figure 
3.1) but also widened our search to other epigenetic modifiers that have been described 
as instrumental either in cell fate changes during development or adulthood. 
Remarkably, we found that several components of the BAF, NuRD, Polycomb 
complexes and Tet family of genes are dynamically expressed throughout organoid 
derivation (Figure 3.2c). These findings were further validated by qPCR which again 
showed that several components were significantly up regulated over the time course. 
Most interestingly, components of the BAF complex such as Arid1a and Brg1 and the 
Tet family member Tet1 had peaks of expression at 24 hours, before the onset of 
proliferation at 48 hours (Figure 3.2d). As a result, these candidates could be crucial for 
the activation of the proliferative response. 
To understand whether this was the case we carried out a small and targeted 
siRNA screen against each of the candidates. If the candidates were involved in the 
activation of proliferation during the generation of organoids knock down during 
isolation would result in fewer organoids being formed. Freshly sorted EpCAM+ cells 
were isolated and transfected with a pool of 4 siRNAs against one of the candidates as 
well as a non-targeting siRNA control (Figure 3.3a). After transfection cells were 
seeded in organoid culture conditions and then analysed for organoid formation 
efficiency. Interestingly, only Tet1, a member of the Tet family of enzymes, showed 
significant impairment in organoid formation, suggesting that Tet1 is crucial for ductal 
progenitor activation (Figure 3.1.3b-c). It is important to note that the lack of effect 
from the other epigenetic regulators in the screen may be as a result of insufficient 
siRNA mediated knockdown rather than a true lack of effect. However, it was shown 
that the pooled siRNA induced >50% knockdown in all genes when compared to 
control siRNA (data not shown, Aloia et al. in press). Despite this, if only a small 
amount of the target gene is required for function it may be possible that any level 
knockdown would still be insufficient to see the effect of the gene. In this case, full 
knockout through a strategy such as CRISPR may yield different results and more 
conclusive results. Finally, as siRNA knockdown may have off-target effects, 
something that is made more likely when using 4 pooled siRNAs, the reduced organoid 
formation observed with the knockdown of Tet1 may be as a result of knockdown of 
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an unknown gene.  To unravel this problem specific genetic ablation of Tet1 would be 
required to validate the result (see Chapter 3.3.1 for further details).    
 
Figure 3.3 - siRNA knockdown reveals organoid derivation is dependent on Tet1 expression. A) Experimental 
scheme: Freshly sorted EpCAM+ cells were transfected with a small library for epigenetic modifiers and put into 
3D culture. B) Colony formation efficiency of transfected populations after seeding at a density of 1x105. Values 
were normalised against a control siRNA derived from three independent biological replicates represented as dots 
with a box representing the group mean. Error bars show standard error of the mean. ** p>0.01 determined by one 
way ANOVA and Tukey HSD test. C) Representative images of the resultant colonies grown from cells transfected 
with control siRNA or siRNA against the Tet family of genes. (Aloia et al. unpublished). 
In our initial screen we found knock down of members of the BAF complex to 
have no effect on organoid establishment (Figure 3.3b-c), as explained above this may 
be as a result of insufficient knockdown. However, we wanted to understand whether 
different machinery was involved in the maintenance of proliferation after the initial 
generation of organoids. We therefore, repeated the screen on a smaller scale with a 
subtle change whereby instead of using freshly isolated EpCAM+ cells we used single 
cells dissociated from established organoids (Figure 3.4a). In this situation we found 
that knock down of certain components of the BAF complex including Arid1a and the 
APTase Brg1 resulted in an increase in organoid formation efficiency (Figure 3.4b-c). 
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As a result, components of the BAF complex may be involved in the maintenance of 
organoid culture rather than their establishment. It is important to note that this 
experiment was carried out once and further repetition would be required to make 
robust conclusions. However, considering several specific BAF components showed a 
similar result we could suggest a potential involvement of the complex as a whole.  
In summary, using initial gene expression and knockdown studies we have 
identified Tet1 as crucial for the establishment liver organoids, and members of the 
BAF complex such as Arid1a and Brg1 as important for correct maintenance of liver 
organoids. As a result, Tet1 and Arid1a were taken forward for further functional 
analysis in order to understand their underlying mechanism of action and overall 
importance in liver regeneration.   
Figure 3.4 - siRNA knockdown of components of the BAF complex enhances organoid survival. A) 
Experimental scheme: Established organoids were dissociated into single cells before being transfected with siRNA 
against specific BAF components and seeded into 3D culture to assess colony formation efficiency. B) Quantification 
of colony formation efficiency of organoids after transfection, values were normalised against control siRNA derived 
from a single experiment. C) Representative images of cells transfected with specific siRNAs after 4 days of 3D 




3.2 The role of Arid1a in ductal progenitor maintenance and differentiation. 
 
3.2.1 Dosage of Arid1a modulates the proliferative and differentiation capacity of 
ductal progenitors in vitro.   
 
siRNA mediated Arid1a knockdown showed altered progenitor dynamics only in 
established organoids and not during the derivation of organoids which suggests a role 
in progenitor state maintenance rather than acquisition.  We wanted to further 
understand the role of Arid1a in this phenomenon by manipulating Arid1a in 
established organoid lines. This will allow us to remove any confounding effects of 
Arid1a in de novo organoid generation as well as validate the siRNA studies ruling out 
any off-target effects. To achieve this, we took advantage of the CRISPR genome-
editing tool to mutate Arid1a in established organoids. Two independent clonal 
organoid lines with the same 11 bp deletion in the first exon of the longest isoform - 
isoform B of Arid1a (Figure 3.5a) were established (labelled Arid1a isoB-/-). The 
mutation results in a frame shifted transcript and ultimately a nonsense protein 
sequence. Since the mutation is identical in the two organoid lines we pooled the data 
from subsequent studies from the two clonal lines.  However, it is crucial to note that a 
second isoform of Arid1a exists that does not include the exon in which we targeted 
our mutation (Figure 3.5a). As a result, at the protein level we can detect ARID1A 
expression both by immunofluorescence and western blot (Figure 3.5b-c). 
Interestingly, there was a downward shift in size of ARID1A band in the western blot 
providing evidence that expression is due to the unaltered smaller isoform. Therefore, 
any observations derived from the Arid1a isoB-/- lines can only be attributed to the loss 




Figure 3.5 - CRISPR mediated deletion of ARID1a isoform B.  A) Schematic of the Arid1a Genetic locus showing 
an expanded region of exon 1b highlighting the deletion of two independent mutant clones. B) Representative 
immunofluorescent images of WT of mutant clones stained for ARID1A (red) and nuclear marker Hoechst (blue). 
Scale Bar = 50 µm. C) Western blot showing ARID1A and ACTIN protein expression, representative of two 
independent experiments. 
 The liver organoid progenitor capacity is down to two crucial properties, the 
ability to self-renew and differentiate towards a hepatocyte fate. Therefore, we wanted 
to understand how Arid1a may regulate these key progenitor features. As a primary 
read out of self-renewal either WT or Arid1a isoB-/- lines were dissociated into single 
cells and seeded in 3D culture conditions to understand how Arid1a mutation affects 
organoid formation efficiency (Figure 3.6a). In line with previously described siRNA 
data, mutation of Arid1a isoB results in significantly increased organoid formation 
efficiency (Figure 3.6b-c).  This suggests that partial loss of Arid1a either through 
siRNA-mediated knock down or by removal of one isoform results in increased 
organoid formation efficiency. However, this increased organoid formation may not be 
as a result of increased progenitor self-renewal but by some other non-specific pro-
proliferative pathway that is not involved in liver regeneration but results in an 
increased organoid formation in our in vitro system.   
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Figure 3.6 - Arid1a isoB-/- organoids have increased organoid formation efficiency. A) Experimental scheme: 
Either WT or mutant organoids were initially dissociated before being seeded at a density of 10,000 cells per well.  
The number of organoids was counted after 10 days.  B) Representative images of single wells after 10 days of 
organoid growth. C) Organoid formation efficiency expressed as the number of organoids formed over the total 
number of cells seeded. Boxplots show group median, interquartile range as well as the overall range of data. Boxes 
represent every individual well quantified from two independent experiments.  
 Therefore, in order to further understand whether the observed increased 
organoid formation efficiency can be explained by in enhanced self-renewal and 
survival and rule out non-physiological pathways we assessed the expression markers 
of liver progenitor activation.  Molecular characterisation of the Arid1a isoB -/- lines 
compared to WT organoids in normal expansion conditions showed that loss of isoform 
B causes a reduction in expression of Lgr5, Axin2 and Sox9 whilst showing increased 
expression of differentiation markers Alb and Ttr (Figure 3.7a-b). As a result, organoids 
lacking Arid1a IsoB are displaced from a ground liver organoid state and are seemingly 
pushed to a more hepatocyte fate when compared to WT organoids. This is contrary to 
the idea that the enhanced organoid formation efficiency is because of an enriched 
progenitor population. Instead, the opposite was true where increased organoid 
formation is linked to an increased differentiation state. This may represent a transit-
amplifying (TA) population much like what is observed in other organs such as the 
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small intestine where during differentiation cells go through a short phase of increased 
proliferation (Barker, van de Wetering and Clevers, 2008). Whether this is the case and 
crucially whether this TA population represents a true population in vivo requires more 
study.  
 
Figure 3.7 - Arid1a isoB-/- organoids have decreased expression of progenitor markers whilst increasing the 
levels of hallmark differentiation genes. Gene expression of progenitor markers Axin2, Lgr5 and Sox9 (A) or 
markers of early differentiation, Alb and Ttr (B) during normal organoid expansion. Data is expressed as fold change 
against WT organoids with each dot representing an individual reading, a box representing group mean (+/- 95% 
confidence interval). Data represents two experiments with a bulk WT population (n=1) and two independent mutant 
clones (n=2) carried out in duplicate. (Aloia et al. unpublished). 
 In any case, the increased expression of markers of differentiation may indicate 
an enhanced ability to differentiate, another key property of liver organoid culture. In 
vivo, ductal driven liver regeneration is dependent on the efficient and complete 
differentiation from the bi-potent ductal progenitor cell to either mature hepatocytes or 
ductal cells. Therefore, if manipulation of Arid1a either enhances or impairs complete 
differentiation it may ultimately lead to an altered liver regeneration capacity.  
Therefore, we next wanted to further understand the role of isoform B in the 
differentiation of ductal progenitors. To study this, we used liver organoids as a model 
of progenitor differentiation. Either WT or Arid1a isoB -/- organoids were initially 
seeded in normal expansion conditions before being switched to differentiation media 
for 14 days inducing organoids to acquire hepatocyte fate as described by Huch at 
colleagues (2013) (Figure 3.8a). After differentiation organoids were analysed for 
several markers of early and terminal differentiation.  
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 Gene expression analysis of progenitor markers revealed that after 
differentiation Axin2, Lgr5 and Sox9 expression was abolished both WT and Arid1a 
isoB -/- lines. This suggests that despite the loss of isoform B altering progenitor gene 
expression in organoid expansion conditions it does not alter their down regulation 
upon differentiation (Figure 3.8b). However, when considering the marker of early 
differentiation Alb, organoid differentiation results in further up-regulation of its 
expression resulting in markedly increased expression in expansion and differentiation 
when compared to their WT counter parts. Interestingly, another early differentiation 
marker, Ttr, has similar expression after differentiation between Arid1a IsoB -/- and 
WT organoids (Figure 3.8b). Taken together these data suggest that loss of IsoB does 
not affect the exit from progenitor state in liver organoids during differentiation and 
partially enhances the acquisition of the hepatocyte fate.  
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Figure 3.8 - Loss of isoform B results in altered gene expression after differentiation towards hepatocyte fate. A) 
Experimental scheme: Either WT or mutant organoids were initially seeded in expansion media and after two days 
switched to the differentiation protocol and analysed after fourteen days of differentiation. B) Gene expression of 
progenitor markers Axin2, Lgr5 and Sox9 or markers of early differentiation, Alb and Ttr during normal organoid 
expansion or after differentiation towards hepatocyte fate. Data is expressed as fold change against WT organoids in 
expansion media with each dot representing an individual reading with a line representing group mean. Data represents 





It is important to note that these changes in gene expression of Alb and Ttr are 
the earliest read outs of hepatocyte fate, to understand if mature hepatocyte markers are 
also altered during organoid differentiation terminal markers of differentiation need to 
be assessed.  The expression of mature hepatocyte markers Glu1 and Cyp3a11, whose 
expression is crucial for proper metabolic function of hepatocytes, were upregulated in 
both WT and IsoB mutant organoids after differentiation (Figure 3.9b). However, WT 
organoids showed an increased level of induction over isoB mutants. This data suggests 
isoB mutants might exhibit impairment in terminal differentiation.  
To further investigate the terminal differentiation capacity of Arid1a isoB -/- 
organoids, we analysed three different functional assays of hepatocyte differentiation: 
(1) The uptake of cholesterol by the use of a fluorescent analogue of LDL; (2) albumin 
production and secretion by ELISA; and (3) the activity of the cytochrome p450 family 
of enzymes by analysis of breakdown of a luminescent competent substrate.   
Qualitative analysis of LDL uptake showed that after differentiation both WT 
and IsoB mutants were able to uptake the fluorescent analogue (Figure 3.9c). IsoB 
mutants had a seemingly increased capacity to uptake LDL, however, an accurate 
quantification would be required to validate that both WT and isoB mutant’s uptake 
differing amounts of LDL. In line with the massively increased gene expression of Alb 
at the mRNA level in both expansion and differentiation conditions, IsoB mutants also 
showed significantly increased levels of albumin secretion in expansion and 
differentiation conditions compared to WT organoids (Figure 3.9d). Taken together 
with the LDL uptake, loss of IsoB results in the acquisition of increased functional 
hepatocyte features after differentiation. In contrast, loss of IsoB results in significantly 
lower cytochrome p450 activity after differentiation (Figure 3.9e). Therefore, as the 
activity of cytochrome enzymes is a crucial feature of fully mature hepatocytes, 
removal of isoform B limits organoid differentiation capacity making them unable to 
fully mature into functional hepatocyte-like cells.   
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Figure 3.9 - Arid1a mutation results in impaired terminal differentiation into hepatocyte fate. A) Experimental 
scheme: Either WT or mutant organoids were initially seeded in expansion media and after two days switched to the 
differentiation protocol and analysed after fourteen days of differentiation. B) Gene expression of markers of terminal 
Glu1 and Cyp3a11 during normal organoid expansion or after differentiation towards hepatocyte fate. Data is expressed 
as fold change against WT organoids in expansion media (unless not expressed in expansion, in which case the 
differentiation state is used) with each dot representing an individual reading with a line representing group mean. Data 
represents a single experiment with a bulk WT population (n=1) and two independent mutant clones (n=2) carried out in 
duplicate. C) Representation wholemount organoid images showing uptake of LDL by fluorescent analogue (red) and 
nuclei with the DRAQ5 DNA marker (blue) of WT or mutant organoids. Scale bar = 10 μm. D) Quantification of the 
amount of Albumin secreted from WT or mutant organoids in expansion or after differentiation determined by ELISA. 
Data is represented as ng/ml/well, with boxplots showing group median, upper and lower quartile and overall range with 
dots representing each reading. Representative of four experiments with a bulk WT population (n=1) and two independent 
mutant clones (n=2) carried out in duplicate. E) Quantification of Cytochrome p450 activity in WT or mutant organoids 
in expansion or after differentiation. Shown as RLU/ml/106 cells, with dots denoting each reading and group mean (+/- 
95% confidence interval). Representative of two experiments with a bulk WT population (n=1) and two independent 
mutant clones (n=2) carried out in duplicate. 
 76 
 
In summary, partial loss of Arid1a by removal of its longest isoform in 
organoids results in reduced expression of progenitor markers and an increased 
expression of markers of early differentiation coupled with a boost in survival in normal 
expansion conditions. These data suggest that correct expression of Arid1a is crucial 
for liver organoids to maintain their basal characteristics and manipulation of Arid1a 
levels results in a promotion of the hepatocyte fate. Furthermore, analysis of the 
differentiation capacity of mutant organoids revealed a reduced capacity to fully mature 
into functional hepatocyte-like cells suggesting that Arid1a may have more global role 
in controlling differentiation state and cell fate, while mis-regulation results in lost 
cellular identity. However, there are some limitations to this data that require 
consideration. First of all, the CRISPR generated mutants only remove a single isoform 
of Arid1a so it is impossible to tell whether any observation is due to partially removing 
Arid1a or improper function of the remaining full isoform. Furthermore, the CRISPR 
mutant creates a truncated protein which may have a spurious function that confounds 
our observations. Finally, the generation of CRISPR mutants relies on the specificity 
of your guiding RNA, if there was a similar complimentary sequence elsewhere in the 
genome, off target mutations could be caused. Therefore, our observations could be an 
artefact of non-specific mutation.  
As a result, to begin to rule out some of these limitations and generated more 
robust data we must generate better genetic models that result in the complete loss of 
Arid1a. To carry this out we took advantage of a CRE-loxP system to generate complete 
Arid1a null organoid lines. To achieve this, we bred mice that express the inducible 
CreERT2 recombinase from the Rosa26 locus (Rosa26CreERT2) with a mouse line that has 
loxP sites flanking a critical exon of Arid1a (Arid1aflx/flx) generating a 
Rosa26CreERT2/Arid1aflx/flx line allowing the ubiquitous deletion of Arid1a in response to 
tamoxifen treatment. To track recombination events, we bred these mice with the 
Rainbow multicolour reporter system generating a 
Rosa26CreERT2/Arid1aflx/flx/CAGRainbow2.1 line (Figure 3.10a). Organoids were generated 
from Rosa26CreERT2/ Arid1aflx/flx/ CAGRainbow2.1 and Rosa26CreERT2/Arid1aflx/+/CAGRainbow 
mice and recombination of Arid1a was followed by proxy of the reporter expression. 
Organoids that have not undergone recombination express RFP, whereas, any 
recombination event would lead to expression of CFP or YFP (Figure 3.10b). Taking 
advantage of this we treated the newly generated organoids with expansion media 
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supplemented with 5 μM OH-Tam for 48hrs before switching to normal conditions for 
7 days to recover and isolating recombined cells by FACS. Single CFP+ or YFP+ cells 
were grown clonally, before further downstream analysis (Figure 3.10c).   
To ensure that recombination of the reporter led to Arid1a deletion we analysed 
expression of the protein by western blot and immunofluorescence.  Organoids derived 
from Rosa26CreERT2/Arid1aflx/flx/CAGRainbow recombined cells showed complete loss of 
ARID1A and those from Rosa26CreERT2 /Arid1aflx/+ /CAGRainbow recombined cells 
showed a reduced level of ARID1A when compared to a bulk WT (Arid1aWT) 
population in line with homozygous (Arid1aHOM) and heterozygous (Arid1aHET) 
mutation respectively (Figure 3.10d and Figure 3.11). We also found that mutation of 
Arid1a does not affect the protein expression of the core catalytic BAF subunit BRG1, 
suggesting the BAF complex can still be function despite loss of ARID1A (Figure 
3.11).  However, it should be noted that, although BRG1 is expressed in the absence of 
ARID1A, we have no way of telling whether it is forming functional BAF complexes. 
It would therefore be interesting to pull down the protein and chromatin that is 
associated with BRG1 in the absence of ARID1A to assess the function of BRG1 and 
BAF complex. In any case, we have generated a robust model of total loss of Arid1a 




Figure 3.10 - Generation of total heterozygous and homozygous Arid1a mutant organoids. A) Schematic of 
transgenic alleles of Arid1a with loxP sites flanking exon 9 and the reporter allele Brainbow2.1 before and after CRE 
induced recombination. B) Experimental scheme: Organoids were derived from Arid1aflx/flx/Brainbow2.1 
/Rosa26CreERT2 or Arid1aflx/+/Brainbow2.1/Rosa26CreERT2 mice. Organoids were then treated with 5 μM Hydroxy-
tamoxifen (OH-TAM) for 2 days. After treatment organoids were dissociated, sorted by FACS and either CFP+ or 
YFP+ cells were selected. Organoids were grown clonally from single cells before being tested for Aird1a mutation 
and further downstream analysis. C) Representative FACS plots generated from organoids treated with 5 μM 
Hydroxy-tamoxifen (OH-TAM) or left untreated. D) Western blot showing ARID1A and ACTIN protein expression 





Figure 3.11 - Immunostaining of BAF components in total Arid1a mutant organoids. Maximum projection images 
representative of wholemount immunostaining of epithelial marker EpCAM (Cyan), BAF complex components BRG1 
(Red) and ARID1A (Yellow), and nuclear marker Hoechst (Blue) in Arid1aWT, Arid1aHET or Arid1aHOM organoids. 
Scale bar = 50 μm 
We started by by trying to understand whether total loss of Arid1a led to an 
increased organoid formation capacity as described from our CRISPR mutants. 
Remarkably, we found that only Arid1aHET organoid lines led to an increased organoid 
formation whereas homozygous mutants recovered to the WT levels (Figure 3.12b-c). 
This data suggests that dosage of Arid1a is crucial for ductal progenitor capacity and 
homozygous loss of Arid1a may lead to compensation through a pathway independent 
from Arid1a.   
 80 
 
Figure 3.12 - Dosage of Arid1a is crucial for organoid formation efficiency. A) Experimental scheme: Either WT 
or mutant organoids were initially dissociated before being seeded at a density of 10,000 cells per well.  The number 
of organoids was counted after 10 days. B) Representative images of single wells after 10 days of organoid growth. 
C) Organoid formation efficiency expressed as the percentage of organoids formed from the total number of seeded. 
Boxplots show group median, interquartile range as well as the overall range of data. Dots represent every individual 
well quantified of a bulk WT population WT (n=1), clonal heterozygous (n=2) or clonal homozygous (n=4) organoid 
lines from 3 independent experiments. p values were calculated using one-way ANOVA with TUKEY HSD tests, *** 
=p<0.001, NS = Not significant.  
To see whether the similarities extend to the molecular characteristics seen in 
the CRSPR mutants. Arid1aWT, Arid1aHET and Arid1aHOM organoid lines were grown 
in expansion media and analysed for expression of progenitor and early differentiation 
markers. To our surprise, homozygous loss of Arid1a had distinct effects on the 
expression of the two categories of genes.  Arid1aHOM organoids showed a similar 
expression of Axin2 and Lgr5 compared to the Arid1aWT line. Whereas, heterozygous 
mutation resulted in decreased expression of the same genes, mirroring the CRISPR 
generated clones (Figure 3.13 Upper panels). However, when considering markers of 
early differentiation homozygous mutation of Arid1a does not rescue expression back 
to WT levels. Rather, the effect is additive, homozygous mutants have increased 
expression of Alb and Ttr over Arid1aHET lines and in turn, Arid1aHET lines had 
increased expression over Arid1aWT organoids (Figure 3.13 Lower panels). Taken 
together with the organoid formation capacity of the organoid lines suggests that dosage 
of Arid1a is crucial for the liver organoid progenitor state, controlling self-renewal as 
well as the molecular characteristics where total loss of Arid1a is potentially rescued 
through an independent pathway. However, there is a negative dose dependent response 
of Arid1a levels and hepatocyte marker expression where less expression of Arid1a 
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results in increased expression of hepatocyte markers. This data does suggest that there 
may a pathway that can partially rescue the loss of Arid1a, however, we have no 
evidence to suggest what pathway that may be. Interestingly, Arid1a has two genetic 
homologues Arid2 and Arid1b under conditions of complete loss of Arid1a one or the 
other may substitute Arid1a restoring some BAF function. It would be fascinating, to 




As we observed with our CRISPR mutants an increase in expression of Alb and 
Ttr may not translate to increased expression of more mature functional markers of 
hepatocyte fate. Therefore, to elucidate the effect of the complete knockout of Arid1a 
on markers of terminal differentiation we analysed albumin secretion and cytochrome 
p450 enzyme activity. In line with expression data both Arid1aHET and Arid1aHOM lines 
had increased albumin secretion in both normal expansion conditions as well as after 
differentiation (Figure 3.14B). Much like our CRISPR mutant organoids, homozygous 
loss of Arid1a led to completely abolished cytochrome p450 activity after 
Figure 3.13 - Arid1a level controls expression of progenitor and differentiation markers. Gene expression of 
progenitor markers (Lgr5 and Axin2) and early differentiation markers (Alb or Ttr) of WT, heterozygous or 
homozygous mutants of Arid1a in organoid expansion conditions. Data is represented as a fold change of the WT 
organoids, each dot represents a single reading and the bar is the group mean. Data represents a single experiment 
with a bulk WT population WT (n=1), two clonal heterozygous (n=2) or four clonal homozygous (n=4) organoid 
lines carried duplicate. 
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differentiation. Interestingly, heterozygous mutation of Arid1a resulted in no difference 
in cytochrome activity after differentiation when compared to Arid1aWT organoids 
(Figure 3.14c). This is interesting as it suggests that isoform B of Arid1a may be 
directly required for up-regulation of cytochrome enzymes during acquisition of the 
hepatocyte fate as specific mutation of isoform B by CRISPR resulted in an impairment 
of cytochrome up-regulation, whereas, generic down-regulation of Arid1a by 
heterozygous mutation does not.  
 
 
Figure 3.14 - Arid1a is required for terminal differentiation. A) Experimental scheme: Either WT or mutant 
organoids were initially seeded in expansion media and after two days switched to the differentiation protocol and 
analysed after fourteen days of differentiation. Quantification of the amount of Albumin secreted (B) or cytochrome 
activity (C) from WT or mutant organoids in expansion or after differentiation determined by ELISA. Data is 
represented as ng/ml/well, with dots showing individual readings and a bar for group mean. Representative of a single 
experiment with a bulk WT population (n=1), two clonal heterozygous (n=2) or one clonal homozygous (n=1) 
organoid lines carried duplicate. 
Therefore, taken all together, manipulation of Arid1a by siRNA, CRISPR or 
CRE recombination results in a complex set of molecular characteristics surrounding 
liver organoid maintenance, their molecular characteristics and differentiation capacity. 
However, we have no evidence to implicate the BAF complex as a whole and the 
phenotypes we have observed may be as a result of a BAF independent function of 
Arid1a. To begin to answer this question we studied the promoter occupancy of Arid1a 
together with the catalytic ATPase of BAF complex Brg1 in order to validate that the 
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presence of Arid1a is in the context of the BAF complex. Chromatin 
immunoprecipitation coupled with qPCR (ChIP-qPCR) studies on WT organoids 
revealed that ARID1A and BRG1 bound directly to the Transcriptional Start Sites 
(TSS) of progenitor markers Axin2 and Sox9 as well as differentiation markers Alb and 
Ttr during normal expansion (Figure 3.15a). This suggests that Arid1a directly 
regulates genes crucial in liver organoid maintenance. 
  ARID1A or BRG1 were not found bound to the TSS of the key ductal 
progenitor marker Lgr5 (Figure 3.15b). However, as previous Arid1a depletion studies 
consistently found altered Lgr5 expression, Arid1a may indirectly regulate Lgr5 or 
binds a locus away from the TSS. To further explore the latter option, we designed 
several primer pairs to probe ARID1A and BRG1 binding along the Lgr5 gene body 
and enhancer regions. We specifically targeted a region in intron 1 as it was identified 
as an open chromatin region specifically in organoids in an ATAC-seq dataset 
generated previously in the lab (data not shown). Remarkably, we found ARID1A and 
BRG1 binding to be enriched in the intronic region specified by the ATAC-seq and no 
other intronic regions, TSS or an upstream enhancer region (Figure 3.15b). This 
provides evidence of a new regulatory region of the Lgr5 locus, in which Arid1a can 
bind and alter gene expression. Further studies would be required to validate this 
hypothesis. For instance, if we could artificially add the newly identified binding 
sequence to a reporter gene, we could directly assess its’ potential as a regulatory 
sequence. Furthermore, it is also important to note that all these ChIP studies were 
carried out in organoids with normal levels of Arid1a. It would be interesting to repeat 
these experiments in our Arid1a knockout models to confirm that ARID1A disappears 
from the identified sites as well as to understand whether the other components of the 
BAF are also lost from the regulatory regions of the genes. These further studies would 
greatly enhance our understanding of the role of Arid1a and the BAF complex, as a 




Figure 3.15 - Arid1a and BAF subunit Brg1 bind regulatory elements of crucial regulators of hepatocyte and 
progenitor identity.  A) Chromatin immunoprecipitation qPCR studies were used to assess the occupation of 
ARID1A and BRG1 on the transcriptional start sites (TSS) of progenitor (Axin2 and Sox9) and hepatocyte (Ttr and 
Alb) markers. Data representative of two independent experiments carried out in duplicate with dots showing each 
individual reading and a bar for group mean. B) ARID1A and BRG1 binding was assessed across the Lgr5 locus 
including an upstream enhancer, TSS and several intronic regions. Data representative of one experiment carried out 




3.2.2 Modulation of Arid1a specifically in ductal progenitors in vivo.  
 
Taking advantage of liver organoids, we were able to identify a potential role for Arid1a 
in their maintenance and differentiation potential. More specifically, as Arid1a 
depletion in liver organoids severely diminishes expression of markers of terminal 
hepatocyte differentiation and results in abnormal organoid formation we hypothesised 
that loss of Arid1a in proliferating ductal progenitors in vivo would result in impaired 
liver regeneration. However, this hypothesis assumes that liver organoids correctly 
model the ductal progenitor response after damage. Therefore, to confirm the role 
Arid1a in liver regeneration and our model of study we must validate our findings in 
an in vivo model of ductal cell driven regeneration. We therefore bred the previously 
described Arid1aflx/flx mouse line with a mouse line expressing an inducible CRE 
recombinase under the endogenous promoter of the progenitor marker Lgr5 
(Lgr5iresCreERT2). The resulting Arid1aflx/flx/Lgr5CreERT2 mice were bred with the 
Rosa26Tdtomato reporter system to trace recombination events. The resultant mouse strain 
would allow us to mark and trace ductal progenitors as the form and facilitate liver 
regeneration in the presence or absence of Arid1a.     
Arid1aflx/flx/Lgr5CreERT2/Rosa26Tdtomato, Arid1aflx/+/Lgr5CreERT2/Rosa26Tdtomato 
or Arid1aWT/Lgr5CreERT2/Rosa26Tdtomato counterparts were treated with food 
supplemented with 0.1% DDC, a potent hepatotoxic agent, for 5 days in order to 
activate ductal progenitors in response to damage. Deletion of Arid1a and reporter 
expression was then induced after onset of liver damage to only remove Arid1a after 
activation of the ductal progenitor fate (Figure 3.16a). Therefore, by following the 
reporter expression we can probe the ductal progenitor characteristics after recovery to 
determine their differentiation capacity. 
Unfortunately, there was no apparent recombination in the ductal compartment 
or portal region after analysis. The only apparent recombination events were in central 
vein hepatocytes determined by morphology (Figure 3.16b, asterix). These recombined 
hepatocytes likely represent a previously described Axin2+ population of hepatocytes 
(Wang et al., 2015) rather than a nascent ductal derived population. This suggests that 
the damage protocol does not induce sufficient Lgr5 expression in the ductal 
compartment to induce recombination and therefore little can be determined.  Altering 
the damage protocol to enhance the expression of Lgr5 in the ductal population may be 
a solution. However, a more pressing problem is that if we want to assess the emergence 
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of newly formed ductal derived hepatocytes to analyse differentiation capacity we need 
a way to unravel these hepatocytes from the resident Axin2+ hepatocyte population.  
As a result, it is unlikely that any Wnt target gene such as Lgr5 would not be appropriate 
to drive recombination and another Wnt independent ductal specific promoter should 
be used. Together this suggests, the Arid1aflx/flx/Lgr5iresCreERT2/Rosa26Tdtomato mouse 
line and DDC damage paradigm is inappropriate to understand the role of Arid1a in the 
differentiation of hepatocytes from ductal progenitors and both mouse line and mode 
of damage needs to be further optimised. Crucially, without an in vivo system we are 
unable fully understand to role of Arid1a in ductal progenitor liver regeneration despite 
observing interesting phenotypes in the liver organoid model. Further study is required 
both in vitro using liver organoids as well as concomitant in vivo validation before 
robust conclusions surrounding the role of Arid1a and the BAF complex in liver 





Figure 3.16 – Recombination by Lgr5iresCreERT2 after DDC treatment is not sufficient to facilitate Arid1a deletion 
in emergent ductal progenitors. A) Experimental scheme: Arid1aflx/flx/Lgr5iresCreERT2/RosaTd-Tomato mice were treated 
with 0.1% DDC for 5 days before being injected with 3 doses of 4 mg tamoxifen to induce recombination in emergent 
ductal progenitors. One week after DDC treatment mice were sacrificed and analysed. B) Representative images of 100 
µm liver sections stained for ductal marker Osteopontin (OPN, magenta), Td-Tomato expression (Red), proliferation 





3.3 The role of Tet1 in ductal driven liver regeneration.  
 
3.3.1 Generation of animal models to study the role of Tet1 in the liver. 
 
Following that siRNA knockdown of Tet1 in mature ductal cells abrogated organoid 
formation we wanted to further understand the role of Tet1 specifically in the activation 
of the ductal progenitor state. In order to achieve this, we took advantage of several 
different mouse models to further probe the role of Tet1 in ductal driven liver 
regeneration.  
 We initially imported the “Knock out first” Tet1tm1(KOMP)Wtsi (labelled as 
Tet1hypo) mouse line from the Knock-Out Mouse project (KOMP) which contains a 
gene trap cassette that is able to trap active transcription of the Tet1 locus and cause 
premature termination via the inclusion of a poly A sequence. (Figure 3.17a-b) 
However the allele includes the full exonic complement of Tet1 so if the gene trap is 
skipped during splicing normal transcription of Tet1 is possible. Furthermore, the 
Tet1hypo cassette includes loxP sites and Frt sites that on recombination result in 
permanent loss of exon 4 of Tet1 or removal of the gene trap component leaving only 
loxP sites flanking exon 4 of Tet1, respectively (Figure 3.17a). To generate the Tet1 
null (Tet1fKO) mouse line we crossed our Tet1hypo line with a mouse line expressing Cre 
recombinase under the Sox2 promoter (Sox2Cre). This facilitated recombination 
between the Tet1hypo loxP sites in the early stages of embryonic development and 
ultimately total removal of exon 4 of Tet1 (Figure 3.17d). In a similar fashion to 
generate our Tet1flx line we crossed the Tet1hypo line with a mouse expressing the Flp 
recombinase under the ubiquitous Rosa26 promoter (RosaFlpe). The resulting 
recombination between the resident Frt sites in the Tet1hypo line removed the gene trap 
allele leaving only loxP sites surrounding exon 4 of Tet1 (Figure 3.17c). Therefore, the 
Tet1f1lx will have normal expression of Tet1 until Cre mediated removal of exon 4 
allowing spatiotemporal control of Tet1 deletion based on Cre recombinnase 
expression. Tet1hypo, Tet1flx, or Tet1fKO allele generation was confirmed by genomic 
PCR (data not shown). 
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Figure 3.17 - Generation of Tet1 hypomophic, conditional and null mouse models. Schematics of the 
imported Tet1tm1(KOMP)Wtsi (known as Tet1hypo/hypo) mouse line (A-B) and derivative Tet1flx/flx (C) or Tet1fKO/fKO (D) 
mouse lines.  Tet1flx/flx and Tet1fKO/fKO lines were generated by breeding with a Flp recombinase or CRE 
recombinase expressed under ubiquitous promoters, respectively. 
 
There are several studies that show varied lethality in response to loss of Tet1, 
therefore, after generation of our models we wanted to test viability. To achieve this, 
we analysed the outcome of heterozygous crosses of each line against the expected 
1:2:1 ratio of homozygous, heterozygous and WT genotypes. As expected, due to the 
hypothetical nearly normal expression of Tet1 in the Tet1flx line, the observed genotype 
ratios did not differ significantly from the expected ratios (Figure 3.18b). However, the 
Tet1fKO had a significantly altered distribution of genotypes compared to what was 
expected. Specifically, there was a large reduction of observed homozygous animals 
compensated by an increased number of WT and heterozygous pups (Figure 3.18c). 
This suggests that the Tet1 line has partial embryonic lethality. Remarkably, the Tet1hypo 
line showed the expected distribution of genotypes, similar to the Tet1flx line, despite 
disrupting Tet1 expression by design (Figure 3.18a). This provided evidence that the 
Tet1hypo line was not completely effective at knocking out Tet1 expression thus avoiding 
embryonic lethality as observed in the Tet1fKO line.  
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Figure 3.18 - Viability of Tet1 mouse models generated. Tables showing genotype of offspring generated from 
heterozygous crosses of each mouse model. Values are a sum of 6 independent litters for Tet1hypo (A) and Tet1fKO 
(C) lines and 4 independent litters for the Tet1flx (B) line. p-values and Χ2-values calculated by chi squared 
analysis. 
 In summary, we generated several animal models to study the function of Tet1. 
However, due to the inefficient generation of homozygous mice in the Tet1fKO line we 




3.3.2 Reduction of Tet1 expression results in less ductal proliferation in vitro and 
in vivo. 
 
The increased viability of the Tet1hypo line over the Tet1fKO line provides some evidence 
that there was some residual expression of Tet1 allowing the mice to survive. This is 
possible through exon skipping of the gene trap of the Tet1hypo allele, as the full 
complement of Tet1 exons is present (Figure 3.19a). To confirm the level of protein 
expression of TET1 in Tet1hypo mice we sought to detect TET1 protein expression in 
whole liver homogenate by western blot. We found that Tet1hypo/hypo mice have a lower 
expression of TET1 when compared to Tet1hypo/+ and WT mice. Using liver organoids 
derived from Tet1hypo mice we were able to further show that Tet1hypo/hypo mice had 30% 
of the normal TET1 protein level (data not shown, Aloia et al. in press). Crucially, this 
shows that TET1 expression was not completely abolished, therefore, we have defined 
this line as hypomorphic for Tet1 (Figure 3.19b).  
 
Figure 3.19 - Tet1hypo/hypo mice show no major homeostatic defect compared to WT mice. A) Schematic of 
the Tet1hypo allele design and possible splice variants. B) Representative western blot of TET1 and ACTIN protein 
expression from liver homogenate of Tet1hypo/hypo, Tet1hypo/+ and WT mice. C) Adult mouse weights of 
Tet1hypo/hypo, Tet1hypo/+ and WT mice. Data is represented as a violin plot showing population density and box-
plots showing median, interquartile and range. Dots represent single mice, Tet1hypo/hypo n = 21, Tet1hypo/+ n=13 and 
WT n=27. Statistical analysis was by pairwise Wilcoxon test with Bonferroni correction. D) Representative 
images of H&E staining of the small intestine from one year old WT or Tet1hypo/hypo. Scale bar = 100 µm. 
 A recent study has shown that Tet1-null mutant mouse lines are not viable as a 
result of post-natal small intestinal defect (Kim et al., 2016). Therefore, we next wanted 
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to explore whether reduction of Tet1 expression in our Tet1hypo line resulted in altered 
small intestine architecture or mouse weight. However, unlike the previous study we 
found that there was no difference in average weight of adult mice (8-10 weeks old) 
between Tet1hypo/hypo Tet1hypo/+ and WT genotypes (Figure 3.19c). In line with this, we 
found that the small intestine had no overt architectural defects between aged (1 year 
old) WT and Tet1hypo/hypo mice, suggesting that even in old age small intestine 
maintenance is maintained (Figure 3.19d). Taken together this suggests that reduced 
levels of Tet1 expression does not result in fatal phenotypes described in the null mouse 
model by other.  
 Despite the lack of an overt homeostatic phenotype we wanted to examine 
whether the lack of normal expression of Tet1 resulted in altered liver organoid 
dynamics in a similar manner to our siRNA data (Figure 3.20a). We were initially able 
to derive organoids from EpCAM+ ductal cells from Tet1hypo/hypo mice suggesting that 
the reduced expression does not affect organoid formation. However, upon passage 
organoids derived from hypomorphic mice lost their expansion potential and after 
roughly 5 passages had lost self-renewal ability (Figure 3.20b). These data also help to 
validate our siRNA data by ruling out any confounding effect of off-target knockdown 
as our Tet1hypo line is specific for Tet1.  
 
Figure 3.20 - Reduced Tet1 expression results in organoids with reduced self-renewal capacity. A) 
Experimental design, EpCAM+ ductal cells were isolated from Tet1hypo/hypo mice and placed in 3D organoid 
expansion conditions. B) Representative images Tet1hypo/hypo organoids at passage 1 (p1) and passage 5 (p5). Bar 
chart shows organoid formation efficiency at passage 1, 3 and 5, values were normalised against p1 organoid 
formation. Data is represented as mean +/- S.D.  of three independent experiments and p3 and p5 values were 
compared to p1 values by two-sided students t-test analysis. p<0.05 =*. (Aloia et al. unpublished). 
 We next wanted to see whether the impaired liver organoid dynamics observed 
in Tet1 hypomorphic organoids translated to the bona fide ductal progenitors present in 
vivo and was not as a result of an artefact borne out of the in vitro system. In order to 
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carry this out we took advantage of 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine 
(DDC) treatment to induce liver damage. DDC induces the activity of δ-amino 
laevulinate synthetase, which controls an early and rate limiting step of haem 
biosynthesis, whilst simultaneously inhibiting a late stage of haem production by 
repressing ferrochelatase. The cumulative result is a reduced rate of haem production 
as well as hepatoxic deposition of porphyrin. In addition, DDC treatment in mice has 
been shown to model human variegate porphyria (Gayathri and Padmanaban, 1974). 
Crucially, DDC has been widely shown to induce significant proliferation in the ductal 
compartment of the liver (Preisegger et al., 1999). This acquisition of proliferation 
closely represents the process whereby mature EpCAM+ ductal cells acquire a 
progenitor state when grown in 3D conditions. As a result, we postulated that DDC 
induced liver damage may be a good model to study the role of Tet1 in the ductal 
progenitor response to damage.   
 Therefore, we treated WT and Tet1hypo/hypo mice with chow supplemented with 
0.1% DDC for 5 days (T5) and either analysed or switched the mice to normal diet and 
allowed to recover for 7 days (T12) (Figure 3.21a). Throughout the time course mouse 
weight was monitored and WT and Tet1hypo/hypo lost a similar amount of weight as a 
proportion of their starting weight during damage, and in a similar fashion, there was 
no difference in the rate at which the mice put on weight after switching back to normal 
diet (Figure 3.21c). Haematoxylin and eosin staining revealed that there was porphyrin 
deposition, characteristic of DDC treatment, in the livers of both WT and Tet1hypo/hypo 
after 5 days of damage (T5) (Figure 3.21b). This validated the treatment regimen of 
DDC but provided very little information about the behaviour of the cell populations 
after DDC induced liver damage. 
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Figure 3.21 - Tet1 hypomorphic and WT mice lose weight and accumulate porphyrin to a similar level in 
response to acute DDC treatment. A) Experimental scheme: Mice were left undamaged (T0) or treated with 
food supplemented with 0.1% DDC for 5 days and either analysed immediately (T5) or switched to normal chow 
for 7 days (T12). B) Representative H&E staining of liver sections of Tet1hypo/hypo and WT mice at T0, T5 and 
T12. Asterix show porphyrin deposition. Scale bar = 250 µm. C) Animal weight changes throughout the acute 
DDC damage protocol. Changes were expressed as a percentage of each individual mouse starting weight. Data 
is plotted as the group mean for every timepoint with error bars representing the 95% confidence interval (WT, 
n=5 and Tet1hypo/hypo, n=5) taken from three independent experiments. 
 
 To explore the ductal response to DDC induced liver damage we analysed the 
proliferative ductal fraction before (T0) and after DDC damage (T5) of WT and 
Tet1hypo/hypo mice. As previously described by others (MacDonald, 1961), undamaged 
WT mice (T0) had very little proliferative activity in the ductal compartment of the 
liver. The largely non-proliferative state of the ductal compartment is also maintained 
in Tet1 hypomorphic mice. However, after 5 days of DDC treatment (T5) a significant 
proliferative fraction emerged. In WT mice ~20% of the ductal compartment (marked 
by osteopontin, OPN) was positive for proliferation marker Ki67 (OPN+/Ki67+), 
however, Tet1hypo/hypo mice showed significantly less proliferation (Figure 3.22b-d). 
Therefore, reduced expression of Tet1 results in impaired activation of proliferation 
after damage, mirroring observations in organoid models. 
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Figure 3.22 - TET1 is crucial for initiation of ductal proliferation in response to DDC damage. A) 
Experimental scheme, mice were left undamaged (T0) or treated with food supplemented with 0.1% DDC for 5 
days and either analysed immediately (T5) or switched to normal chow for 7 days (T12). B) Representative 
images of 100um liver sections stained with the ductal marker Osteopontin (OPN) and the proliferation marker 
Ki67 in undamaged (T0) and DDC damaged (T5) WT and Tet1hypo/hypo mice. Scale bar = 25um. PV = portal vein. 
C) Box-and-whisker plot showing median and inter-quartile range and the overall range of values of proliferating 
ductal cells (Ki67+/OPN+).  Each dot represents an outlier from a single counted field of view (FOV). D) 
Histogram showing the population distribution of proliferating ductal cells (OPN+/Ki67+) by plotting frequency 
density of counts across the sample range (bar) and the kernel density estimate (line). Dashed lines show median 
values. C-D) Graphs are representative of values obtained from 55 fields of view (FOV) for WT (n=3) and 56 
FOV for Tet1hypo/hypo mice (n=3) at T0 (undamaged) and 253 FOV for WT (n=7) and 169 FOV for Tet1hypo/hypo 
(n=6) at T5 of DDC damage. p values have been obtained by using Kolmogorov-Smirnov test. ***= p<0.001. 
 
 Further analysis, of the distribution of proliferation in the portal regions we 
found that WT mice have two distinct populations. A population with a large 
proliferative fraction (~40%) and a second with fewer proliferative ductal cells (~10%). 
Interestingly, hypomorphic mice did not have the same distribution across their portal 
regions. Rather, there was a single population closely matching the lower proliferative 
fraction seen in WT mice (Figure 3.22d). It would be interesting to speculate that the 
two populations seen in the WT mice represent two populations of ductal cells that have 
different proliferative potential and reduced Tet1 expression results in the population 
with highest proliferative potential not emerging upon damage. To more conclusively 
answer this question, we would need to understand if there are distinct spatial or 
molecular populations of ductal cells through single cell resolution studies in 
combination with advance imaging techniques, for further discussion see chapter 3.7. 
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 We next sought to understand whether the impaired ductal proliferation of 
Tet1hypo/hypo mice at T5 was detrimental to the overall ductal population upon recovery. 
Therefore, we initially treated mice with 5 days of 0.1% DDC before allowing them to 
recover for 7 days on normal diet (T12) (Figure 3.23a). We found that the ductal 
population was significantly reduced in Tet1hypo/hypo mice compared to WT mice (Figure 
3.23b-d). Thus, reduced Tet1 expression results in a smaller expansion of the ductal 
population in response to DDC damage, likely due to impaired proliferation. 
 
Figure 3.23 - Tet1 hypomorphic mice have a smaller ductal population after recovery from acute DDC 
damage. A) Experimental scheme: Mice were left undamaged (T0) or treated with food supplemented with 0.1% 
DDC for 5 days and either analysed immediately (T5) or switched to normal chow for 7 days (T12). B) 
Representative immunohistochemistry images showing ductal cells marked by pan-cytokeratin in undamaged 
mice and upon recovery from DDC damage (T12). Nuclei are stained with Haematoxylin. Scale bar = 100μm. C) 
Box-and-whisker plot showing median and inter-quartile range and the overall range of values of ductal cell 
populations (OPN+/FOV).  Each dot represents an outlier from a single counted field of view (FOV). D) 
Histogram showing the population distribution of the total ductal cell number (OPN+) by plotting frequency 
density of counts across the sample range (bars) and the kernel density estimate (line). Dashed lines show median 
values. C-D) Both graphs are representative of values obtained from 55 FOV (n=3) for WT and 56 FOV for 
Tet1hypo/hypo (n=3) mice at 0  (T0) and 110 FOV for WT (n=3) and 153 FOV for Tet1hypo/hypo mice (n=4) at day 12 
(T12). p values have been obtained by using Kolmogorov-Smirnov test. ***= p<0.001. 
 It is important to note that this data could be explained if the Tet1hypo/hypo mice 
experience a lower level of global liver damage compared to WT mice and therefore, 
elicit a reduced regenerative response. Taken together with the fact that the hypomorph 
is not tissue specific and may have several indirect affects we must attempt to rule out 
confounding factors. At all time points analysed (T0, T5 or T12), we took blood 
samples and analysed the serum levels of alanine transaminase (ALT) and glutamate 
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dehydrogenase (GLDH) to assess liver damage. At all time points Tet1hypo/hypo mice had 
similar levels of both markers of liver damage when compared to WT mice (Figure 
3.24b).  Therefore, despite the system wide reduction of Tet1 expression DDC 
treatment resulted in a similar level of global liver damage in hypomorphic mice 
compared to WT mice. As the route of DDC treatment is via food intake we also wanted 
to examine the effect of DDC treatment on the small intestine to rule out any defects in 
the Tet1 hypomorph, which would compromise DDC uptake. We found no major 
defects in the architecture in the small intestine of Tet1hypo/hypo when compared to WT 
mice after 5 days of DDC damage (Figure 3.24c). As a result, a reduced level of Tet1 
expression does not alter the effect of DDC on the liver. However, we still cannot rule 
out other direct or indirect affects that the loss of Tet1 in other cell types may have on 
our observations. For instance, in response to liver damage there is not only ductal and 
hepatocyte regeneration but also significant inflammation which aids in repair. It would 
be therefore, interesting and important to also rule out any involvement of Tet1 in this 
inflammatory response. In any case, even if we could achieve this it is unlikely that we 
will be able to fully rule out all possible sources of potential confounding affects in this 
model. A more prudent method to validate the role of Tet1 would be to specifically 
ablate Tet1 in the ductal population. See Chapters 3.3.4 and 4.3.3 for further discussion. 
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Figure 3.24 - Impaired ductal response is not due to decreased global liver damage in Tet1 hypomorphic mice. 
A) Experimental scheme: Mice were left undamaged (T0) or treated with food supplemented with 0.1% DDC for 5 
days and either analysed immediately (T5) or switched to normal chow for 7 days (T12). B) Serum levels of alanine 
transaminase (ALT) and glutamate dehydrogenase (GLDH) of Tet1hypo/hypo of WT mice at T0, T5 and T12 timepoints. 
Bar represents group median and dots are individual readings from independent mice. C) Representative H&E 




3.3.3 Reduced Tet1 expression leads to impaired liver regeneration after chronic 
liver damage.  
 
 The short 5-day DDC damage (acute) model is good for activating ductal 
proliferation but does not model some aspects of chronic liver damage such as liver 
fibrosis. In order to create a better model of chronic liver damage, we decided to 
administer eight sequential doses of 5-day DDC treatments, each with a 3-day recovery 
periods between each dose of DDC. After this extensive damage protocol, mice were 
left to recover for 3 months before analysis in order to assess how fibrosis was resolved 
after damage (Figure 3.25a). Throughout the damage protocol, mouse weight was 
monitored. Mouse weights between Tet1hypo/hypo mice and WT mouse were similar 
throughout the experiment (Figure 3.25b). Furthermore, after 3 months of recovery 
extensive porphyrin deposition was evident throughout the livers of WT and 
Tet1hypo/hypo mice (Figure 3.25c).   
 
Figure 3.25 - Chronic DDC damage results in cyclic weight loss and recovery in Tet1 hypomorphic and WT 
mice. A) Experimental scheme, mice were treated with eight 5 day doses of 0.1% DDC treatment each with a 3 
day interval of normal diet. Mice were then allowed to recover on normal diet for 3 months before analysis 
(T150).  B) Animal weight changes throughout the chronic DDC damage protocol. Changes were expressed as a 
percentage of each individual mouse starting weight. Data is plotted as the group mean for every timepoint with 
error bars representing the 95% confidence interval (WT, n=3 and Tet1hypo/hypo, n=3) taken from two independent 
experiments. B) Representative images of H&E stainings of liver sections of Tet1hypo/hypo and WT mice at T0, and 
T150. Asterix show porphyrin deposition. Scale bar = 250 μm. 
 After chronic DDC treatment and recovery we analysed ductal proliferation in 
a similar manner to the previous acute DDC model to examine whether there were 
similar observations. However, in this case we found that there was marginal 
proliferation in both WT and Tet1hypo/hypo mice and no difference in ductal population 
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(Figure 3.26b-c). In terms of proliferation, it is not surprising that the ductal 
compartment is largely non-proliferative at this stage, due to the long recovery period 
allowing the damage phase to resolve. However, if indeed there was a proliferative 
defect during the damage phase, in similar fashion to that observed in the acute DDC 
model, we would expect the ductal population to be smaller in the Tet1 hypomorphic 
mice after recovery, but this was not the case (Figure 3.26b-c). One possible 
explanation for this it that due to the chronic nature of the damage protocol the residual 
expression of Tet1 is able to eventually rescue the ductal regenerative response. This 
would suggest that the ductal proliferation impairment seen in the acute DDC model is 
due to a delayed response rather than an absolute defect. Another explanation could be 
that as it is a long-term recovery that the at one point expanded population has already 
returned to undamaged levels where there was no difference between WT or Tet1hypo/hypo 
mice (Figure 3.23). In order to understand these results further it would be interesting 
to analysis more time points within the damage and recovery phase to dissect the ductal 
response in more detail.  
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Figure 3.26 - Reduced levels of TET1 does not alter ductal proliferation or ductal population size after 
recovery from chronic DDC damage. A) Experimental scheme: Mice were treated with eight 5 day doses of 0.1% 
DDC treatment each with a 3 day interval of normal diet. Mice were then allowed to recover on normal diet for 3 
months before analysis (T150). B) Representative images of 100um liver sections stained with the ductal marker 
Osteopontin (OPN) and the proliferation marker Ki67 in undamaged (T0) and DDC damaged (T150) WT and 
Tet1hypo/hypo mice. Scale bar = 50 μm. C) Quantification of ductal proliferation (OPN+/Ki67+) and ductal population 
size (OPN+/FOV). Data is represented as violin plots showing population density with box-plots showing median, 
interquartile and overall range. Values are derived from Tet1hypo/hypo (n=1) and WT (n=1) mice from a single 
experiment. p values have been obtained by using Kolmogorov-Smirnov test, NS – Not significant. 
 In any case, even though we are unable to conclude whether or not there has 
been a ductal proliferative defect with this model we are still able to analyse other 
aspects of liver regeneration. Therefore, to assess whether long-term recovery from 
DDC damage resulted in complete liver regeneration we analysed the extent of fibrosis. 
We treated mice with our chronic DDC model and allowed them to recover for 3 months 
before assessing collagen deposition by picrosirius red staining and quantified with a 
macro developed in Fiji. Tet1hypo/hypo mice had a significantly increased fibrotic area 
when compared to WT mice after recovery from chronic DDC damage (Figure 3.27b-
c). Moreover, WT mice exposed to chronic damage and allowed to recover did not have 
a significantly increased level of fibrosis compared to undamaged controls. This 
suggests that WT mice were able to largely recover from chronic DDC damage after 3 
months whereas prominent fibrosis was still evident in hypomorphic mice. Taken 
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together, reduced Tet1 expression results in an impaired resolution of fibrosis after 
chronic DDC damage. 
 
Figure 3.27 - Tet1 hypomorphic mice have increased fibrosis after recovery from DDC chronic damage. A) 
Experimental scheme: Mice were treated with eight 5 day doses of 0.1% DDC treatment each with a 3 day interval 
of normal diet. Mice were then allowed to recover on normal diet for 3 months before analysis (T150).  B) 
Representative images of thin paraffin embedded liver sections stained by picrosirius red marking collagen (red) 
and cytoplasm (yellow) of undamaged (T0) and recovered (T150) WT and Tet1hypo/hypo mice.  C) Collagen 
deposition was quantified using a plugin developed in Fiji and represented as violin plots showing population 
density with box-plots showing median, interquartile and overall range. Values are derived from Tet1hypo/hypo 
(n=3) and WT (n=3) mice undamaged (T0) and recovered mice (T150) from two independent experiments. 
Medians from each mouse are shown as boxes. p values were calculated by two-way ANOVA and Tukey HSD 
post hoc test.  p<0.001 = ***. 
 In summary, we found that reduced Tet1 expression results in impaired ductal 
progenitor expansion using in vitro organoid models. Remarkably, the defect was 
rescued by full-length human Tet1 overexpression but not by a catalytic inactive variant 
directly implicating TET1 enzymatic activity in ductal progenitor maintenance in vitro 
(data not shown, Aloia et al. in press). Moreover, reduced Tet1 expression resulted in a 
smaller proliferative response in the ductal compartment in the liver after DDC induced 
damage and ultimately after a week recovery a smaller ductal population. On the other 
hand, chronic, DDC treatment did not show altered ductal dynamics after recovery from 




3.3.4 Ductal specific genetic ablation of Tet1 causes diminished function of bona 
fide bi-potent ductal progenitors in vitro and in vivo.  
 
Our Tet1hypo mouse model combined with DDC treatment described in Chapter 3.3.2 
and 3.3.3 suffers from several flaws such as the lack of spatiotemporal control of Tet1 
deletion and the inability to trace the fate of ductal progenitors. Furthermore, as DDC 
treatment on its own has not widely been shown to generate ductal derived hepatocytes 
to understand the role of Tet1 in bona fide bi-potential ductal progenitors a modified 
model would be required. 
 To solve the problems associated with the lack of spatiotemporal control we 
took advantage of our Tet1flx model crossed with two inducible Cre drivers. We bred 
our Tet1flx line with a RosaCreERT2 line in order to facilitate the ubiquitous and complete 
deletion of Tet1.  Despite lacking tissue specificity, the resultant Tet1flx/flx/RosaCreERT2 
mice allowed us to avoid lethality seen in our Tet1fko/fko mice and study the effect of 
complete Tet1 deletion in adult mice.   
 As described above, reduced expression of Tet1 allows the successful derivation 
of organoids, however impairs organoid expansion potential after passage. We 
therefore hypothesised that complete deletion of Tet1 would result in a more potent 
phenotype. To test this, mature EpCAM+ ductal cells were isolated from adult (8-12 
week old) Tet1flx/flx/RosaCreERT2 or Tet1flx/flx and placed in 3D culture conditions 
supplemented with 5 uM OH-tamoxifen (Figure 3.28a). We found that Tet1 deletion 
nearly completely abolished organoid formation (Figure 3.28b). This suggests that Tet1 
is crucial for the generation of organoids from mature ductal cells and that the residual 
expression of Tet1 in Tet1hypo/hypo organoids is enough to sustain organoid formation but 
not long-term expansion.    
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Figure 3.28 - Tet1 ablation abolishes organoids formation from mature EpCAM+ cells. A) Experimental 
scheme: FACS-sorted EpCAM+ ductal cells derived from RosaCreERT2 x Tet1 flx/flx mouse livers were plated in 
organoid isolation medium supplemented with 5 μM hydroxytamoxifen or left untreated in vitro. B) Organoid 
formation efficiency was evaluated after 6 days in culture.  Representative bright field pictures are shown. Each 
dot represents the average of the count from 3 wells coming from an independent biological experiment. Graphs 
represent mean +/- SD of 3 independent experiments. p value was calculated by two-side students t-test statistical 
analysis:  *= p<0.05; ***= p<0.001. (Aloia et al. unpublished). 
 
 We next wanted to study the effect of complete deletion of Tet1 on ductal driven 
liver regeneration to see whether the proliferative defects seen in Tet1flx/flx/RosaCreERT2 
organoid lines translate to similar effects in liver ductal progenitors. Therefore, adult 
Tet1flx/flx/RosaCreERT2 mice were treated with three doses of 4 mg tamoxifen delivered 
intraperitoneally to induce Tet1 deletion before treating with liver damaging agents 
(Figure 3.30a). Unfortunately, we found that 7-9 days after tamoxifen induction several 
mice begun to show severe clinical signs and had to be culled on ethical grounds. To 
understand the cause of this emergent lethality we assessed the architecture of the small 
intestine (SI). We found that the SI of mice that had shown signs of ill health was 
severely compromised (Figure 3.29b). This was in line with a recent study showing that 
Tet1 null animals, which have been shown to be viable in a mixed background, exhibit 
postnatal lethality in a pure background due to a collapse of the stem cell pool in the SI 
(Kim et al., 2016). Interestingly, the penetrance of the lethal phenotype was not 
complete, 33% of treated Tet1flx/flx/RosaCreERT2 mice showed the SI defect. 
Furthermore, no lethal phenotypes were seen in controls either lacking the Cre driver 
or not treated with tamoxifen (Figure 3.30). Together this suggests Tet1 expression is 
essential in the adult mouse to maintain SI integrity.  
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Figure 3.29 - Ubiquitous postnatal deletion of Tet1 is lethal and results in collapse of the small intestine. A) 
Experimental scheme: Mice were treated with 3 doses of 4mg tamoxifen delivered intraperitoneally and 
developed sickness and were culled on welfare grounds between 7-9 days later. B) Representative pictures of 
Haematoxylin and eosin staining of the small intestine of conditional knock-out mice RosaCreERT2 x Tet1flx/flx and 
controls Tet1flx/flx treated or untreated with tamoxifen. Scale bar = 100μm. 
 
 
Figure 3.30 - Prominence of lethality after ubiquitous Tet1 deletion. A table showing the different genotype, 
gender, viability and tamoxifen dose of mice injected. N/A, not analysed. A, affected. U, unaffected. 
Tet1 expression may be crucial in other tissues such as the liver but analyses of 
those tissues were impaired by the lethal collapse of the SI in the Tet1flx/flx/RosaCreERT2 
model. We therefore need a more restricted mode of deletion to target only our tissue 
of interest and avoid any indirect effects of Tet1. We took advantage of a inducible Cre 
under the promoter of Prominin1 (Prom1CreERT2) whose expression has been shown to 
be restricted to the ductal compartment of the liver as well as many other epithelial 
tissues (Zhu et al., 2016). We confirmed this by crossing Prom1CreERT2 mice with 
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RosalslZsGreen reporter mice and treating the resulting Prom1CreERT2/RosalslZsGreen with a 
single dose of 4mg tamoxifen. This allowed us to analyse the recombination pattern of 
the Prom1CreERT2 by following ZsGreen expression. We found that in the liver ZsGreen 
expression was completely restricted to the ductal compartment; all ZsGreen+ cells 
were co labelled with ductal marker osteopontin (Figure 3.31b).  Due to the severe 
intestinal defect we analysed recombination the SI. We found that there was indeed 
ZsGreen expression in the SI epithelium, however, the pattern was sporadic and not 
ubiquitous (Figure 3.31b). As a result, we hypothesised that without total coverage the 
prominence of the lethal phenotype should be significantly reduced.  
 
 
Figure 3.31 - Prom1CreERT2 driven recombination is restricted to the ductal compartment in the liver and is 
not ubiquitous in the small intestine. A) Experimental scheme: Mice were treated with a single dose of 4mg 
tamoxifen delivered intraperitoneally. Recombination pattern was assessed after 7 days. B) Representative images 
of 10um frozen sections of portal regions of Tet1WT/RosalslZsGreen/Prom1CreERT2 mouse livers and small intestine 
after tamoxifen induced recombination stained for ductal marker osteopontin (OPN, liver only) or b-Catenin (Small 
intestine only), endogenous ZsGreen expression and Hoechst. Scale bar = 25 μm. 
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We then bred the Prom1CreERT2/RosalslZsGreen with our Tet1flx line to generate 
Prom1CreERT2/RosalslZsGreen/Tet1flx/flx mice.  This line allowed us to specifically delete 
Tet1 in the ductal compartment of the liver whilst simultaneously marking recombined 
cells with ZsGreen facilitating lineage tracing to follow fate of the ductal cells, solving 
many of the flaws of the Tet1hypo line such as: the lack of control of Tet1 deletion; and 
the inability to trace the fate of Tet1 mutant cells.  
Furthermore, it has been argued that acute DDC damage as a liver damage 
model does not fully model bi-potent ductal progenitors as new hepatocytes are not 
formed. Therefore, we wanted to combine our new ductal specific Tet1 deletion mouse 
line with a mode of liver damage that generated bona fide bi-potential ductal 
progenitors. It has been recently described that by forcing the hepatocytes into 
senescence abolishing their ability to contribute to liver regeneration, results in a potent 
ductal reaction in response to toxic liver damage whereby the ductal compartment was 
shown to significantly contribute to the hepatocyte pool, providing an excellent 
paradigm to study bi-potential progenitors (Raven et al., 2017). This was achieved 
through either genetic ablation of β1-integrin or viral induced over expression of p21, 
a potent repressor of proliferation. In our case the β1-integrin would be inappropriate 
as it relies on the same Cre-lox knock out system as our Tet1 condition allele therefore 
it would be impossible to delete either independently. As a result, we opted to use the 
p21 overexpression model which instead relies on expression via a viral vector allowing 
us to easily in conjunction with our genetic model of Tet1 deletion.  
Therefore, we initially treated either Prom1CreERT2/RosalslZsGreen/Tet1flx/flx or 
Prom1CreERT2/RosalslZsGreen/Tet1WT mice with three doses of 0.2mg/g tamoxifen to 
generate a WT (Prom1Tet1WT) ductal compartment or a ductal compartment depleted for 
Tet1 (Prom1ΔTet1). In both genotypes the ductal compartment was also labelled with 
ZsGreen to follow the fate of the ductal cells. After induction of Tet1 deletion, 
following tamoxifen treatment, we induced hepatocyte specific senescence by over 
expression of p21. To carry this out we treated mice with an adeno-associated viral 
vector with a liver specific tropism (AAV8) and p21 under the thyroxine binding globin 
(TBG) promoter ensuring hepatocyte specific expression of p21. Prom1Tet1WT and 
Prom1ΔTet1 mice were treated with the AAV8-TBG-p21 virus at a dose of 7.5 x1011 gc 
by tail vein injection. Following p21 overexpression we induced liver damage in 
animals by carrying out three 5 day 0.1% DDC doses in order to induce a significant 
ductular reaction as reported by Raven et al. (2017). Finally, the mice were allowed to 
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recover for two weeks before being culled and assessed for ductal contribution to the 
hepatocyte compartment (Figure 3.32a).  
 
Throughout the p21/DDC damage protocol Prom1Tet1WT and Prom1ΔTet1 had 
similar body weight dynamics, suggesting no overt intolerance of the protocol as a 
result of Tet1 deletion (Figure 3.32b). We then validated Tet1 deletion in the 
EpCAM+/ZsGreen+ ductal population after the damage protocol. We found that 
Prom1ΔTet1 mice showed an average reduction of ~60% in the expression of Tet1 when 
compared to Prom1Tet1WT control mice, indicating a good recombination efficiency 
(Figure 3.32c-d). It is important to note that if loss of Tet1 has a negative effect on the 
ductal compartment in a similar manner to what we observed in the Tet1hypo model, the 
WT ductal cells may out compete a ΔTet1 population. Therefore, by checking deletion 
after the damage protocol it may not correctly reflect the original deletion efficiency as 
the WT ductal population may have expanded more than the deleted population. To 
 
Figure 3.32 – Efficient Tet1 deletion in the context of hepatocyte specific p21 overexpression and DDC damage. 
A) Experimental scheme: Tet1 depletion and ZsGreen lineage tracing were induced by three doses of 0.2 mg/g 
tamoxifen delivered intraperitoneally. After one week wash out, overexpression of p21 was mediated by tail vein 
injection of AAV8-TBG-p21 viral vector resulting in hepatocyte specific p21 overexpression. Mice were fed with 3 
cycles of 5 day DDC treatments in order to monitor the regenerative response of Prom1Tet1WT and Prom1∆Tet1 ductal cell 
when hepatocytes are compromised. B) Animal weight changes throughout p21 overexpression and DDC damage 
protocol. Changes are expressed as a percentage of each individual mouse starting weight. Data is plotted as the group 
mean for every time point with error bars representing the 95% confidence interval (Prom1Tet1WT, n= 4 and Prom1ΔTet1, 
n= 4). Arrows represent either tamoxifen or viral injections and orange boxes denote each dose of 0.1% DDC. C) 
Tet1 expression in EpCAM+ ductal cells isolated by FACS-sorting from Prom1∆Tet1 (n=4) compared to those isolated 
from Prom1Tet1WT (n=4) mice at the end of the recovery phase after 3x DDC doses.  Two-sided students t-test 
statistical analyses were performed: ***= p<0.001. 
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further investigate this, it would be prudent to induce only Tet1 deletion before 
analysing recombination efficiency. We also then confirmed hepatocyte specific p21 
protein overexpression by immunohistochemistry (Figure 3.33).  
 
 
Figure 3.33 - AAV8-TBG-p21 induced p21 overexpression is restricted to the hepatocyte compartment. A) 
Representative images of 5 μm paraffin sections of livers from either Prom1Tet1WT or Prom1ΔTet1 mice after p21 
over expression and DDC damage protocol compared to a mock-injected mouse. Scale bar = 200 μm. 
After confirming that the p21/DDC damage model induced the required tet1 
deletion and p21 over expression we next wanted to investigate the effect of ductal 
specific loss of Tet1 on the ductal population after p21/DDC treatment. To carry this 
out, we quantified the number of ZsGreen+/OPN+ cells per field of view before 
normalising by mouse specific recombination efficiency. We found that the ZsGreen+ 
ductal population of Prom1Tet1WT mice was on average ~50% larger than the ductal 
population observed in Prom1ΔTet1 mice (Figure 3.34b-c). This is very similar to 
observations from Tet1hypo/hypo mice after recovery from 5 days of DDC, suggesting that 
the smaller ductal population in the p21/DDC model may be down to a similar 
proliferative defect in the ductal compartment. Alternatively, this result could also be 
explained by increased cell death in Prom1ΔTet1 mice. Analysis of further time points in 
the damage phase of the protocol would help to understand the underlying mechanism 




Figure 3.34 - Ductal specific deletion of Tet1 led to reduced ductal expansion after DDC damage in the context 
of hepatocyte senescence. A) Experimental scheme: Tet1 depletion and ZsGreen lineage tracing were induced by 
three doses of 0.2 mg/g tamoxifen delivered intraperitoneally. After one week wash out, overexpression of p21 was 
mediated by tail vein injection of AAV8-TBG-p21 viral vector resulting in hepatocyte specific p21 overexpression. 
Mice were fed with 3 cycles of 5 day DDC treatments. B) Representative images of 10um liver frozen sections 
stained for ductal marker Osteopontin (OPN-red), endogenous ZsGreen expression (Green) and Nuclei with Hoechst 
(Blue) of Prom1Tet1WT or Prom1∆Tet1 mice. Scale bar =100 μm c, Quantification of ZsGreen+ and OPN+ double 
positive population per field of view normalised against mouse specific recombination efficiency shows Tet1 
deletion results in a significantly reduced ductal ZsGreen population size. Data plotted as violin plots representing 
population density, and boxplots showing median, upper and lower quantiles and the range. Boxes represent median 
value for each individual mouse (Prom1Tet1WT, n = 8 Prom1∆Tet1, n = 8) from three independent experiments ***= 
p<0.001 was determined by Mann Whitney U test. 
 Interestingly, we found that although p21 protein expression in was restricted 
in the hepatocytes in all injected animals and not in mock injected controls, we observed 
that there were p21-ve hepatocytes surrounding the portal regions (Figure 3.33). These 
negative patches of hepatocytes could be explained by either a poor infection rate by 
the virus or by the emergence of ductal derived hepatocytes, which would lack p21 
expression. To untangle the two scenarios, we used the ZsGreen reporter to follow the 
cell fate of the ductal compartment to understand whether there was a significant ductal 
contribution to the hepatocyte pool. 
 Prom1Tet1WT mice readily formed clusters of regenerative ZsGreen+ hepatocytes 
of between 1 to 156 cells in size after p21/DDC treatment. However, Prom1ΔTet1 mice 
had a vastly different cluster size distribution with >90% of all Zsgreen+ hepatocyte 
clusters being either 1 or 2 cells in size. Therefore, ductal cell specific loss of Tet1 
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severely alters the dynamics of bi-potent ductal progenitors in response to liver damage 
(Figure 3.35b-c).   
As loss of Tet1 leads to smaller regenerative clusters in would be interesting to 
hypothesis that fewer emergent hepatocytes and as a result ultimately poorer liver 
regeneration. However, this may not be the case if the smaller clusters were 
compensated by a larger number of nascent hepatocyte clusters. To deconvolute these 
two hypotheses and count overall number of ductal derived we carried out volume 
analysis of thick liver sections to quantify the nascent hepatocytes across the liver.  
Remarkably, we observed that there was no significant difference in the overall number 
of traced hepatocytes between Prom1ΔTet1 and Prom1Tet1WT. However, Prom1ΔTet1 did 
show a hugely increased number of traced clusters defined as a continuous group of 
cells over Prom1Tet1WT mice. Considering the similar levels of absolute hepatocytes but 
the larger number of clusters in the Prom1ΔTet1 it is not surprising that Prom1ΔTet1 have 
smaller hepatocyte clusters as the same number of hepatocytes are spread amongst 
many more tracing events (Figure 3.36). This provides interesting insights as it shows 
that loss of Tet1 seemingly does not interfere with the differentiation capacity of ductal 
progenitors but rather the expansion of regenerative clusters. Although, we cannot rule 
out that the larger Prom1Tet1WT clusters are formed from fusion of several tracing events, 
which doesn’t occur in mutant mice. It would be interesting to further analyse the clonal 
dynamics of the traced hepatocyte populations at several timepoints during damage and 
recovery to see how Tet1 truly effects ductal derived hepatocyte generation. In 
conjunction in would be fascinating to undertake molecular characterisation of the 
nascent hepatocytes in mice with or without Tet1. This would allow us to investigate 
whether the loss of Tet1 results in impaired hepatocyte function (see Chapter 4.3.3 for 




 In summary, ubiquitous deletion of Tet1 in EpCAM+ ductal cells inhibited the 
generation of organoids in 3D culture conditions in vitro. However, similar conditional 
deletion in vivo resulted in a collapse in the SI epithelium, before any liver specific 
analysis could take place. In order to avoid such lethality, we took advantage of a ductal 
specific Prom1CreERT2 combined with a reporter to delete Tet1 in a specific manner and 
follow the fate of resulting cells. Mice were then treated with a damage protocol shown 
to activate bona fide bi-potential ductal progenitors and Tet1 was found to dramatically 
reduce the size of the ductal pool after damage and severely decrease the size of 
emergent ductal derived hepatocyte clusters.  Taken together, our observations provide 
significant evidence that Tet1 plays a pivotal role in the activation and dynamics of bi-






Figure 3.35 - Loss of Tet1 results in smaller ductal derived hepatocyte regenerative clusters. A) 
Experimental scheme: Tet1 depletion and ZsGreen lineage tracing were induced by three doses of 0.2 mg/g 
tamoxifen delivered intraperitoneally. After one week wash out, overexpression of p21 was mediated by tail vein 
injection of AAV8-TBG-p21 viral vector resulting in hepatocyte specific p21 overexpression. Mice were fed with 
3 cycles of 5 day DDC treatments. B) Representative images of 50 µm frozen liver sections stained for ductal 
marker Osteopontin (OPN-Red), endogenous ZsGreen expression (Green) and nuclei with Hoechst (Blue) 
showing regenerative hepatocyte clusters in Prom1Tet1WT and Prom1∆Tet1 mice. Hepatocytes were identified by 
morphology and the lack of OPN expression. Scale bar = 100 μm. C) Cumulative relative frequency plots 
combined with box plots showing median, upper and lower quantiles and the range (dots represent outlier values) 
of Zsgreen+ hepatocyte cluster size of Prom1Tet1WT (n=3) and Prom1∆Tet1 (n=6) mice from three independent 









Figure 3.36 - Prom1∆Tet1 mice have a significantly larger number of hepatocyte clusters but similar number 
of overall newly derived hepatocytes. Box plots showing median, upper and lower quantiles and the range 
(dots represent outlier values) of number of traced hepatocytes (Left) per mm3 and the number of individual 
clusters per mm3 of tissue (Right) of Prom1Tet1WT (n=3) and Prom1∆Tet1 (n=6) mice from three independent 
experiments ** = p<0.01, determined by the Kolomogorov-Smirnov test. 
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3.3.5 Ductal cells undergo significant global changes in levels of 5mC and 5hmC 
DNA modification upon liver damage. 
 
Data presented in chapters 3.3.2 and 3.3.3 suggests that Tet1 has a crucial role in the 
activation and proliferation of ductal progenitors in response to DDC induced damage. 
However, there is little evidence that the catalytic activity of Tet1 is directly required 
for ductal progenitor activation in vivo. To rule out an indirect role for Tet1 we first 
assessed the proliferation and global 5mC and 5hmC dynamics during DDC damage to 
understand when ductal proliferation is activated and whether there are significant 
changes to the methylome. To carry this out we treated mice with 0.1% DDC for 0, 2, 
3, or 5 days and split the liver for analysis of ductal proliferation and global ductal 5mC 
and 5hmC levels by immunofluorescence. 
We found that significant proliferation in the ductal compartment was triggered 
after 3 days of DDC damage (T3) that peaks after 5 days (T5) with an average of ~20% 
ductal proliferation (Figure 3.37a-c). Interestingly, global levels of 5hmC are increased 
after DDC treatment with a peak at 2 days of DDC treatment (T2) with a ~2.5 fold 
increase in 5hmC levels as compared to healthy mice (T0). Coupled to this increase in 
5hmC levels there was a concomitant a decrease in global 5mC levels in response to 
DDC damage with lowest global levels of 0.25 fold after 3 days of DDC damage 
(T3)(Figure 3.37d-e). Crucially, the biggest changes of 5hmC and 5mC were apparent 
in the early stages of DDC damage and crucially before major proliferation was seen at 
T5. This is significant as proliferation is a key component of passive demethylation so 
taken together with a peak in 5hmC levels suggests that active demethylation by the 
Tet family (the only known family of DNA demethylases) of enzymes could play a 




Figure 3.37 - Global 5mC and 5hmC DNA modification levels are dynamic during DDC induced activation 
of ductal proliferation. A) Experimental scheme: Tet1WT mice were treated with DDC diet for two (T2), three (T3), 
five days (T5) or left on control diet (T0). B) Representative images of 100um thick liver sections of T0, T2, T3 and 
T5 mice stained with proliferation marker Ki67 (Red), ductal marker osteopontin (OPN, Green) and Hoechst (Blue). 
scale bar = 50 µm. C) Quantification of ductal proliferation (Ki67/OPN) throughout DDC timecourse. Quantification 
shows the group mean of at least 14 fields of view per liver and error bars represent the 95% confidence interval. 
Each box represents a different liver (T0 n=3, DDC T2 n=3, DDC T3 n=4, DDC T5 n=4). p values were calculated 
using ANOVA analysis and corrected by doing the Tukey HSD test: ***=p<0.001 vs T0. D) Experimental scheme, 
Tet1WT mice were treated with DDC diet for two (T2), three (T3), five days (T5) or left on control diet (T0) before 
EpCAM+ ductal cells were isolated and stained for global 5mC and 5hmC levels. E) Representative images of 
EpCAM+ cells stained for 5hmC (Green, upper panel) or 5mC (Red, lower panel) and DAPI (Blue). Scale bar = 10 
µm. Violin plots shows fold change of 5mC/DAPI (upper panel) or 5hmC/DAPI (lower panel) with each box 
representing a different biological experiment coming from a single mouse. The fluorescence intensities of 5hmC 
was initially normalised with DAPI and then, each value was normalised against the median level of the T0 liver 
(where T0 is centred around 1). Boxplots show the group median, interquartile range and highest and lowest values. 
p values were calculated by comparing all time points against T0 using the Kruskal-Wallis test: ***= p<0.001. 
(Panel E, Aloia et al. unpublished). 
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 As Tet2, Tet3 as well as Tet1 are also able to induce demethylation through 
oxidation of 5mC to 5hmC the global dynamics seen could be as a result of any of the 
Tet enzymes individually or a combination of all and not directly as a result of Tet1 
activity. To investigate the role of Tet1 activity specifically we isolated EpCAM+ 
ductal cells from Tet1WT and Tet1Hypo/Hypo before and after 5 days of DDC damage (T0 
and T5) and assessed the gene expression of the key progenitor marker Lgr5 and Tet1, 
as well as the Tet1 occupancy and 5hmC levels at the Lgr5 transcriptional start site 
(TSS).  We found that the expression of both Tet1 and Lgr5 was increased upon damage 
in the EpCAM+ ductal population of Tet1WT mice (Figure 3.38a). In line with the design 
of the mouse model the expression of Tet1 at T0 and T5 was reduced compared to 
Tet1WT mice. Remarkably, Lgr5 expression was also abolished at T5 in Tet1Hypo/Hypo 
mice when compared to Tet1WT mice (Figure 3.38b). Implying that the proliferation 
defects seen in Tet1Hypo/Hypo mice may be the result of a failure to activate the progenitor 
fate through genes such as Lgr5.  
 Furthermore, TET1 was found to bind the TSS of Lgr5 specifically after DDC 
damage (T5), which correlated with an increased level of 5hmC at the TSS. Both TET1 
occupancy and 5hmC deposition were then abolished in Tet1Hypo/Hypo mice, suggesting 
that the Lgr5 specific 5hmC deposition is exclusive to Tet1 activity (Figure 3.38b). 
Together with the expression data, Tet1 is crucial for the activation of a key progenitor 
marker Lgr5 during DDC induced liver damage likely due to deposition of permissive 
5hmC marks.  
These data do not fully rule out a mechanism of Tet1 that is independent of the 
oxidative enzymatic activity. To further explore this hypothesis, it would be interesting 
to generate mouse models where Tet1 is ectopically expressed either as a full transcript 
or as catalytically inactive construct, in a similar fashion to organoid experiments 
described by Aloia et al. (Unpublised). This would allow us to explicitly determine if 
Tet1 dependent 5hmC deposition is crucial for ductal progenitor activation in vivo as 







Figure 3.38 - Reduced expression of Tet1 abolishes the activation of stem cell marker Lgr5 after DDC 
induced liver damage. A) Experimental scheme: Tet1WT or Tet1hypo/hypo mice were treated with DDC for 5 days 
(T5) or left on control diet (T0) before EpCAM+ cells were isolated from the whole liver. Isolated cells were 
analysed for gene expression, TET1 occupancy and 5hmC localisation. B) Lgr5 and Tet1 mRNA levels (upper 
panels) and TET1 ChIP and hMedIP (bottom panels) on Lgr5 TSS in undamaged and DDC damaged WT and 
Tet1hypo/hypo mice are shown. Graphs are representative of mean +/- SD of values obtained from 3 mice. Data is 
presented as relative to Hprt (mRNA) or % of input (ChIP and hMedIP). p values have been obtained by 
comparison to the corresponding WT value in undamaged or DDC by performing two-sided students t-test 




3.4 Optical tissue clearing can provide insights into the proliferative heterogeneity of 
the ductal compartment.  
 
Further analysis of the proliferative dynamics of Tet1WT mice after acute DDC damage 
(originally discussed in section 3.3.2) showed evidence of two populations of ductal 
cells with different proliferative potential. In response to acute DDC damage the 
majority of portal regions had a proliferative fraction of ~10% (blue) or ~40% (green) 
with an overall group median of ~20% (Figure 3.39a-b). The bimodal relationship 
suggests the existence of different populations within the ductal compartment, which 
may be spatially defined within the ductal tree.  
The biliary ductal tree is a massively divergent structure with a larger central 
trunk and branching lumen extending to the periphery of the tissue. As result we can 
consider several models of regeneration that would create such a system that requires 
at least two populations of cells, such as tip driven branching morphogenesis (as has 
been described during the development of several tissues including the kidney and 
mammary gland (Hannezo et al., 2017)), trunk driven regeneration or a combination of 
both (Figure 3.40).   
 
Figure 3.39 - Tet1WT mice showed two proliferative responses in the ductal compartment in after acute 
DDC damage.  A) Experimental scheme: Tet1WT mice were treated with DDC for five days before ductal 
proliferation was assessed by immunostaining. B) Histogram showing the population distribution of proliferating 
ductal cells (OPN+/Ki67+) by plotting frequency density of counts across the sample range (bar) and the kernel 
density estimate (line). Dashed lines show median values, lower population and higher population marked in blue 
and green respectively. C) Scatter plot describing absolute number of Ki67+ cells and OPN+ cells of each FOV 
of Tet1WT and Tet1Hypo/Hypo mice. Line of best was calculated, and shaded region represents the 95% confidence 
interval. B-C) Graphs are representative of values obtained from 253 FOV for Tet1WT (n=7) and 169 FOV for 
Tet1hypo/hypo (n=6). 
To further explore these hypotheses and undertand the localisation of the 
bimodal distribution of the ductal compartment after damage we plotted the number of 
proliferative ductal cells in each portal region against the size of the ductal compartment 
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in that FOV from Tet1WT and Tet1Hypo/Hypo. We found that there was a positive 
relationship between size of proliferative fraction and size of the ductal compartment 
in each FOV of Tet1WT mice. Interestingly, Tet1Hypo/Hypo showed a lesser relationship of 
proliferation against size likely reflecting the overall lower proliferative response after 
damage as described in Chapter 3.4 (Figure 3.39c).As a result of the larger proliferative 
fractions being restricted to larger ductal populations it would be interesting to 
hypothesise that the highest level of proliferation is localised to the larger ductal trunk.  
However, the data was derived from imaging 30-40 μm of tissue within a 100 
μm section, resulting in the FOVs being made up of small cross sections of portal 
regions rather than a representation of the overall ductal structure. Therefore, the size 
of the ductal population in each FOV is dependent on orientation of the cross-section 
rather than the localisation within the ductal tree. 
 
Figure 3.40 - Models of ductal tree regeneration in response to DDC damage. Schematics of trunk driven 
(left) and tip driven (right) models of ductal tree regeneration with arrows representing the direction of growth. 
In order to properly understand if the proliferative dynamics are spatially 
localised within the ductal tree optical clarity of thick liver sections would be required 
to resolve the whole or a large volume of the ductal tree. We decided to investigate 
different tissue clearing to techniques that would allow enhanced ductal imaging. 
Healthy mice were euthanised, and heparinised saline was pumped through the liver’s 
vasculature prior to dissection to help remove excess blood. After perfusion, livers were 
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fixed overnight and sectioned at several thicknesses between 100 μm and 800 μm 
before being immunostained and cleared by SeeDB, CUBIC with either reagent 1 or 
1a, or the standard glycerol gradient used in previous imaging experiments.  
 
Figure 3.41 - Tissue clearing performance of refractive index matching by Glycerol gradients or SeeDB.  
Stereoscope images of liver sections of between 100um to 800um in thickness as well as an unsectioned partial 
lobe throughout staining protocol using either a Glycerol gradient (A) or SeeDB (B). Images are representative 
of 2 independent experiments. Each grid square has a length of 1 mm.   
SeeDB and glycerol gradients rely on refractive index matching as the primary 
source of optical clearing. However, in both cases only slight clarity was seen in 100 
μm thick sections. Thicker liver sections showed little affect from either technique, this 
is likely due to the fact that liver tissue is highly pigmented and requires more active 
clearing to achieve enhanced optical clearing (Figure 3.41). CUBIC tissue clearing is 
reliant on incubating tissue in two solutions. The first of which (reagent 1 or 1a) is made 
up of a high concentration of detergent and a chelating agent that remove tissue 
pigment. A second solution (Reagent 2, R2) is then used which is made up of urea and 
sucrose that facilitates refractive index matching. The combination of both reagents 
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showed massive optical clearing of liver sections of up 800 μm in thickness and was 
even able to partially clear an unsectioned lobe of the liver. Both reagent 1a and 1 had 
similar clearing capacity so all further experiments were carried out with reagent 1a as 
the lower concentration of detergent will likely allow better epitope preservation 
(Figure 3.42). 
 
Figure 3.42 - Tissue clearing performance of CUBIC reagents 1 or 1a on liver sections. Stereoscope images 
of liver sections of between 100um to 800um in thickness as well as an unsectioned partial lobe throughout the 
CUBIC staining protocol using either reagent 1 (A) or 1a (B). Images are representative of 3 independent 
experiments.  Each grid square has a length of 1 mm. 
To confirm this, 100 µm liver sections were cleared with CUBIC and compared 
to the original glycerol treatment after imaging with confocal microscopy. CUBIC 
cleared sections allowed for imaging throughout the whole 100μm section maintaining 
cellular resolution along the z-axis. Glycerol treated samples were limited to only ~30 
μm resolution in the z-axis. The enhanced imaging capacity of CUBIC treated samples 
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allowed for a large ductal structure to be clearly resolved. Crucially, it was sufficiently 
resolved to identify key features such as branch points at ductal trunks (Figure 3.43A, 
Asterix and Arrow). Therefore, CUBIC tissue clearing represents an enhanced strategy 
that can enable future study into the proliferative dynamics of the ductal tree on the 
scale of whole organ (Figure 3.43).   
In summary, we found that there was a bimodal distribution of proliferation in 
the ductal compartment upon acute DDC damage. We then developed a CUBIC 
imaging strategy that will allow us to better understand how proliferation is spatially 
distributed through the ductal tree in future studies. However, it is important to note 
that it may be the case that there is no specific spatial organisation of the ductal 
compartment and rather the bimodal distribution is defined by unique molecular 
characteristics. It would be interesting to carry out gene expression profiling of the 
ductal population after damage to understand if there are distinct molecular populations 





Figure 3.43 - CUBIC clearing allows significantly increased imaging depth and reveals large ductal 
structures. A) Representative max projection of a CUBIC cleared 100 μm liver section stained for osteopontin 
(OPN). Arrow shows ductal trunk and * denotes branch points. Scale bar = 100 μm. B) Representative plots of 





4.1 Organoids as a model of ductal cell-driven liver regeneration 
 
In this work we have taken advantage of organoid models first characterised by Huch 
and colleagues (2013) to model the bi-potent ductal progenitors which have been shown 
to contribute to liver regeneration under certain conditions (Huch, Dorrell, et al., 2013). 
We have identified Arid1a and Tet1 as potential candidates for further analysis by 
performing siRNA knockdown and gene expression analysis either in established 
organoid lines or during organoid formation from mature ductal cells (Figures 3.2, 3.3 
and 3.4). However, we make the assumption throughout these experiments that 
organoid formation will faithfully reproduce the molecular changes which occur in vivo 
during the transition of a ductal cell to a bi-potent ductal progenitor. 
Given this assumption, it is essential to discuss the how well organoids truly 
model ductal progenitors. Therefore, we must benchmark the model against the true in 
vivo counterparts. In the first instance, it would be interesting to isolate RNA from the 
ductal compartment of damaged livers at several timepoints and compare the gene 
expression changes in vivo to those seen during organoid formation in order to further 
validate organoid formation as a model for the emergence of bi-potent ductal 
progenitors following liver damage. Such studies carried out by our group, currently in 
press, reveal that remarkably similar changes in gene expression occur in vitro during 
the transition from mature ductal cells to organoids to those changes seen in ductal cells 
in vivo during the first five days following DDC-induced damage (Aloia et al., in press). 
Furthermore, the same study showed that ductal cells isolated from a liver after five 
days of DDC-induced damage generate significantly more organoids than ductal cells 
isolated from undamaged livers, and we therefore conclude that DDC-induced damage 
enhances the organoid-forming potential of the ductal compartment. These data support 
our original assumption and further validate organoid formation as an accurate model 
of the intrinsic molecular characteristics of bi-potent ductal progenitors.  
Despite the benchmarking of liver organoids, it is important note that as models 
they are a simplification of the true nature of liver regeneration. Therefore, we must 
validate any observations derived from organoids in an in vivo model of liver 
regeneration before robust conclusions can be made, in a similar manner to those 
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carried out here to investigate the role of Tet1 (Chapters 3.3.2, 3.3.3 and 3.3.4). 
However, the true power of organoids as hypothesis generating tools should not be 
overlooked. Organoids are amenable to high throughput studies that can help narrow 
down the field of study before candidates are taken forward and validated using in vivo 
models, which may better represent the process of liver regeneration, but are 
prohibitively expensive and time intensive for large scale studies. Therefore, work 
presented here forms a powerful framework for future studies where genes are selected 
for study by taking advantage of organoids before further validation.      
However, there is a pressing limitation of this framework, the ductal cells are 
cultured in isolation from the other cell types usually found in the liver during organoid 
formation. As a result, we can only use liver organoids to study cell characterises 
intrinsic to the ductal cell. As liver regeneration is carefully orchestrated response of 
several different cell types liver organoids are insufficient to model how these processes 
are regulated. One possible solution to this would be to generate more complex co-
culture systems that incorporate all the other cell types resident to the liver. However, 
creating such a system may prove technically and practically difficult. For instance, it 
wouldn’t be surprising that the different cell populations require different culture 
conditions that were inherently incompatible. Furthermore, even if such a culture 
system was technically possible there would be no guarantee the cells would organise 
and interact in a similar manner to that seen in vivo. In any case, the hypothetical model 
could allow the investigation of the role of extrinsic signalling pathways during ductal-
driven liver regeneration. 
Despite the obvious technical difficultly of creating co-culture systems there 
has been success in the generation of culture systems of single cell types that reflect the 
heterogeneous nature of liver regeneration. Here, we have used liver organoids of ductal 
origin to specifically assess the role of our candidate genes in ductal-driven 
regeneration. However, liver organoids of hepatocyte origin have also recently been 
described and it would be interesting to investigate whether common molecular 
pathways regulate liver organoid formation independent of the cell of origin; expanding 
our analyses beyond the use of organoids of ductal origin may provide interesting 
insights into common or ductal/hepatocyte-specific molecular changes occurring upon 
organoid generation (Hu et al., 2018; Peng et al., 2018). Furthermore, organoid cultures 
derived from adult stem cell populations have been described in numerous other tissue 
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types, including, but not limited to; the colon, pancreas, stomach, lung and prostate 
(Sato et al., 2009; Barker et al., 2010; Jung et al., 2011; Huch, Bonfanti, et al., 2013; 
Karthaus et al., 2014; Barkauskas et al., 2017). Therefore, experiments and analyses 
similar to those described here could be extended to organs other than the liver to 
investigate the gene expression changes occurring upon organoid formation in an even 
broader sense. It will be important, however, to define the regenerative process being 
investigated for each tissue in order to integrate the data in a meaningful way and 
potentially reveal exciting and broad insights into the regulation of adult stem cell fate 
decisions.   
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4.2 The role of Arid1a in bi-potent ductal progenitor maintenance and differentiation. 
 
4.2.1 Arid1a gene dosage regulates bi-potent ductal progenitor proliferation. 
 
We found that reduction of Arid1a expression either by siRNA knockdown, genetic 
ablation of one isoform or by heterozygous knock-out of all isoforms resulted in 
increased efficiency of organoid formation from liver ductal cells (Figures 3.4, 3.6 and 
3.12). This is perhaps not surprising, as Arid1a has been described as a prominent 
tumour suppressor in several different cancer types (Wang et al., 2011; Biankin et al., 
2012; Muzny et al., 2012; Chan-on et al., 2013). Furthermore, Arid1a has recently been 
directly implicated in the positive regulation of E2F proteins, which usually act as 
repressors of cellular proliferation (Sun et al., 2016). Therefore, it would be interesting 
to further probe this phenotype to see if the increased efficiency of organoid formation 
is indicative of the first stages of cellular transformation into a tumour-like state. Recent 
work by Shen and colleagues has shown that Arid1a co-operates with the DNA damage 
regulator, ATR, and is essential for the resolution of double strand breaks (Shen et al., 
2015). It would therefore be interesting to investigate whether the increase in efficiency 
of organoid formation is accompanied by an increase in chromosome instability and 
DNA damage. This could be performed readily by analysing the karyotype of late 
passage organoid lines deficient in activity of Arid1a to directly detect any significant 
aneuploidy which may have arisen as a result. Whole genome sequencing of a clonal 
population at multiple timepoints would provide higher resolution detection of genetic 
changes to further understand if deficiency in Arid1a results in the acquisition of further 
mutations, and whether these might reflect the evolution of Arid1a-deficient tumours. 
Further experiments might consider the role of DNA damage by investigating whether 
DNA damage is increased in Arid1a-deficient organoid lines through assessment of the 
levels of the histone variant γH2AX, a prominent marker of DNA damage (Mah, El-
Osta and Karagiannis, 2010). The results of such studies would provide insights into 
whether organoid cultures could be used to accurately model tumour evolution 
following the loss of Arid1a activity.     
 The increased efficiency of organoid formation could be due to increased 
cellular survival, increased proliferation or a combination of both. Recent evidence 
would suggest that deficiency in Arid1a would result in increased proliferation (Sun et 
al., 2016), however, the data presented here do not allow us to determine the underlying 
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cause(s) of the increase in efficiency of organoid formation. Therefore, further analysis 
of the rate of proliferation and survival of Arid1a-deficient organoids is required. The 
rate of proliferation could be determined by quantification of the proportion of Ki67+ 
cells during organoid formation. Cell death could be quantified during organoid 
formation to assess whether increased cell survival contributes to the increase in 
efficiency of organoid formation observed in Arid1a-deficient organoids. Taken 
together, such studies would increase our understanding of the precise role of Arid1a 
during organoid formation and maintenance. 
 One final, interesting observation is that total genetic ablation of Arid1a does 
not cause an increase in efficiency of organoid formation when compared to normal, 
wild type efficiency. This result conflicts with a previous study, where ubiquitous and 
total deletion of Arid1a results in significantly increased proliferation in vivo following 
liver damage (Sun et al., 2016). We may reconcile our data with the previously 
published literature in several ways. For instance, we have modulated Arid1a in an 
isolated ductal organoid population only, whilst the previous study modulated Arid1a 
in total liver or in hepatocytes, so it is possible that the precise phenotype arising upon 
loss of Arid1a may be cell-type specific. It would therefore be interesting to study loss 
of Arid1a in the recently described organoids of hepatocyte origin to attempt to address 
this question. Furthermore, Sun and colleagues focus on the proliferation of the 
hepatocyte compartment and do not investigate the proliferative dynamics of the ductal 
compartment in their study, and thus the possibility remains that there is a ductal 
phenotype in vivo which is similar to that observed in our Arid1a-deficient organoid 
models, as their study provides no assessment of ductal phenotypes. In contrast, as 
organoid formation occurs in isolation from extrinsic signalling, the phenotype we 
observe in Arid1a-deficient organoids may be an artefact of the system which does not 
occur in vivo. However, our data strongly imply that gene dosage of Arid1a is crucial 
for the regulation of organoid formation and maintenance, which itself has been further 
validated as a model for the generation of bi-potent ductal progenitors through our 
unpublished analyses of gene expression changes (Aloia et al., Unpublished). It has 
been shown that embryonic, neural and cardiac development take advantage of unique 
compositions of the BAF complex, of which Arid1a is a component, in order to 
facilitate cell fate transitions. Therefore, we hypothesise that differing gene dosage of 
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Arid1a may result in different BAF complex compositions that result in our observed 
phenotypes (Ho and Crabtree, 2010), discussed in greater detail below. 
4.2.2 Arid1a regulates could cell fate transitions through modulating hallmarks of 
ductal progenitor state 
 
Our data suggest that Arid1a plays a dual role in the maintenance of liver organoid 
culture. Arid1a deficiency results in reduced expression of both ductal progenitor 
markers as well as functional markers of mature hepatocytes (Figures 3.7, 3.8, 3.9, 3.13 
and 3.14). Interestingly, similar data was presented by Sun and colleagues, where their 
model of liver-specific Arid1a deletion resulted in reduced expression of the p450 
family of cytochromes both during homeostasis and following liver damage (Sun et al., 
2016). Taken together, the data suggest that Arid1a is crucial for stable lineage 
commitment to either a ductal progenitor like state or, upon differentiation, a mature 
hepatocyte fate. Furthermore, it is important to note that several models of liver 
damage, such as treatment with CCl4, rely on production of metabolites by the 
cytochrome p450 family. As a result, any assessment of the level of regeneration 
observed in the absence of Arid1a may have as a confounding factor a lesser amount of 
overall liver damage, as Arid1a-deficient hepatocytes may lack the metabolic 
machinery to induce full toxicity.  
 The presence of ARID1A, ARID1B or ARID2 in the BAF complex is mutually 
exclusive. Therefore, in the absence of ARID1A either ARID1B or ARID2 may take 
its place, a switch which may lead to differential modulation of a unique set of genes 
(Tang, Nogales and Ciferri, 2010). Interestingly, it has been shown that ARID1B 
represses Wnt pathway signalling in a BRG1-dependent manner (Vasileiou et al., 
2015). Taken together with data presented here, it is possible that ARID1B takes the 
place of ARID1A in the BAF complex of Arid1a-deficient organoids, leading to the 
reduced expression of progenitor markers and the Wnt target genes Lgr5 and Axin2 as 
observed. To further validate this hypothesis, assessing promoter occupancy by 
ARID1B in Arid1a-deficient organoids would allow a comparison with promoter 
occupancy by ARID1A and ARID1B in wild type organoids to determine if ARID1B 
can directly replace ARID1A at the promoter level (Figure 3.15). Such studies would 
provide insight into how Arid1a directs stable lineage commitment in hepatocytes or 
ductal cells.  
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As mentioned above, embryonic, neural and to some extent cardiac 
development is dictated by the orchestrated inclusion of mutually exclusive 
components of the BAF complex to create several transient, specialised and distinct 
complex compositions (Ho and Crabtree, 2010). Arid1a has here proved crucial for the 
stable acquisition of markers of bi-potent ductal progenitor and hepatocyte fates 
(Figures 3.7, 3.8, 3.9, 3.13 and 3.14) and, taken together with data from others, Arid1a 
itself may be a crucial component of the BAF complex for those fates (Sun et al., 2016). 
However, our data do not exclude the contribution of other components being included 
in a regulated manner as ductal cells acquire a progenitor fate in vitro or during liver 
damage. Therefore, it would be interesting to determine the composition of the BAF 
complex in parallel during organoid formation in vitro and in the ductular reaction in 
vivo during liver damage. This could be achieved by immunoprecipitation (IP) of an 
invariant structural component of the BAF complex at several timepoints during liver 
damage and/or organoid formation, followed by determination of the composition of 
the complex by proteomics techniques, such as mass spectrometry, in a manner similar 
to that described by Ho and colleagues (Ho et al., 2009b). Furthermore, using a similar 
experimental design, analysis of chromatin IP rather than IP of BAF-associated proteins 
should provide insight into how the genetic targets of the BAF complex change during 
liver damage and/or organoid formation. Finally, by integrating proteomics, chromatin 
occupancy and gene expression changes during said processes, specific gene expression 
changes could be associated with specific complex compositions and so provide a 
thorough readout on the dynamics of the complex and how these are associated with 
the dynamics of the acquisition and maintenance of specific cell fates.     
4.2.3 A model for the role of Arid1a in bi-potent ductal progenitor maintenance 
and differentiation 
 
To summarise, the data demonstrate that dosage of Arid1a is crucial for stable lineage 
commitment in vitro showing altered expression of markers of both bi-potent ductal 
progenitor and hepatocyte fates (Figures 3.7, 3.8, 3.9, 3.13 and 3.14).  In conjunction 
with the reduction in stable cellular identity, there was a concomitant increase in 
organoid formation, which may be as a result of the prominent tumour suppressor 
activity of Arid1a (Figures 3.4, 3.6 and 3.12). Remarkably, organoid formation and 
progenitor identity, but not differentiation capacity, was restored in Arid1a-null 
organoids, suggesting an Arid1a-independent mechanism for maintaining progenitor 
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marker expression (Figures 3.12 and 4.1). However, it is important to note that in order 
to ensure that the cellular dynamics we have observed truly reflect bona fide bi-potent 
ductal progenitors we need to model Arid1a deletion in an in vivo system. We attempted 
to carry this out by driving Arid1a deletion by expression of progenitor marker Lgr5 in 
the context of DDC induced liver damage. This model proved insufficient to induce 
Arid1a deletion in the ductal progenitor compartment, as a result, further study is 
required to generate a viable in vivo model and ultimately validate the data we have 




Figure 4.1 – Working model for the regulation of bi-potent ductal progenitors by Arid1a in organoid culture. 
Arid1a-deficient organoids have an increased efficiency of organoid formation (OFE) but lose cellular identity and 
express markers of both hepatocyte and progenitor fate, potentially being unable to commit to either fate. We 
hypothesise that long term passaging may result in tumour initiation through increased DNA damage and increased 
rate of acquisition of further mutations.   
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4.3 The role of Tet1 in ductal cell-driven liver regeneration. 
 
4.3.1 Global reduction of Tet1 levels results in impaired activation of ductal cell-
driven regeneration following acute damage 
 
In contrast to several previously described animal models of Tet1 deletion, our 
hypomorphic model did not show significant post-natal lethality or a significant, overt 
homeostatic phenotype (Figures 3.18 and 3.19), suggesting that the reduced level of 
Tet1 expression in this model is permissive for normal development and adult viability 
(Dawlaty et al., 2011; Kim et al., 2016). However, Tet1 hypomorphic mice show 
impaired activation of ductal cell proliferation at the peak of the damage response 
following DDC-induced liver damage, resulting in a smaller ductal compartment upon 
recovery (Figures 3.22 and 3.23). Therefore, although levels of Tet1 expression in this 
model are sufficient for normal homeostatic function, levels are insufficient to direct 
normal ductal cell-driven liver regeneration. In line with this, organoid formation from 
mature ductal cells is impaired in the presence of hypomorphic levels or following full 
genetic ablation of Tet1 (Figures 3.20 and 3.28). Taken together, the data support a 
requirement for TET1 activity both in vivo and in vitro during the acquisition of a 
proliferative, bi-potent ductal progenitor fate.  
 TET1-driven active demethylation has been implicated in the generation of 
pluripotent and totipotent cell populations in vivo during embryonic development and 
in vitro during somatic reprogramming (Costa et al., 2013; Hackett et al., 2013). 
Therefore, a similar mechanism of epigenetic reprogramming may underlie the 
transition of a mature ductal cell to a bi-potent ductal progenitor. Additional data have 
demonstrated that a catalytically active variant of TET1 is required for rescue of the 
Tet1-deficient phenotype in organoid culture, implicating active demethylation in the 
acquisition of bi-potent ductal progenitor fate (Aloia et al. Unpublished). However, it 
is currently unknown as to whether TET1 catalytic activity is required in vivo as part of 
the ductal cell-driven regenerative response in the liver. It has been shown that Vitamin 
C is able to enhance the oxidative activity of TET1 (Minor et al., 2013), providing a 
way of increasing TET1 activity and assessing its effect on bi-potent ductal progenitor 
fate. If TET1 activity is essential for ductal cell-driven regeneration, it should be 
sensitive to modulation by Vitamin C treatment, whereas we would expect that Tet1 
mutants would be refractory to treatment. A caveat to this methodology, however, is 
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that Vitamin C treatment is not specific for the modulation of TET1 activity, leaving 
genetic rescue of TET1 activity in vivo as the gold standard in terms of experimental 
approaches.     
 Although our hypomorphic model has the advantage of being permissive for 
normal development, in contrast to previously described null mutant models, there are 
still limitations of the model that should be borne in mind. For example, Tet1 deficiency 
in this model is global, with no spatial or temporal control of Tet1 deletion, resulting in 
constitutive Tet1 deficiency in all tissue types. Therefore, although it is reasonable to 
assume that the ductal cell phenotype results from the reduction of Tet1 within that 
compartment, confounding affects resulting from Tet1 deficiency in other cellular 
compartments cannot be ruled out. To address this limitation, deletion of Tet1 could be 
localised to the ductal compartment by using a conditional, floxed allele in combination 
with ductal cell-specific expression of Cre. The Tet1flx/Prom1CreERT2 model generated 
and described herein could be used to provide such specific deletion of Tet1 in the 
ductal epithelium. If impaired ductal cell proliferation and regeneration were to be 
observed in this model following acute DDC-induced damage also, then we could 
conclude with much greater certainty that this phenotype is intrinsic to the ductal 
compartment. The conditional allele would lend itself to further combinations with 
other tissue-specific Cre drivers to assess the role of Tet1 in other cellular 
compartments, such as in hepatocytes, during ductal cell-driven regeneration.           
4.3.2 Tet1 is crucial for the resolution of fibrosis following chronic liver damage 
 
When challenged with chronic liver damage induced by 8 repeated doses of DDC, it 
was observed that hypomorphic mice had significantly increased fibrotic collagen 
deposition when compared to wild type mice (Figure 3.27). Interestingly, it has been 
shown that fibrosis in the liver as a result of chronic damage can be attenuated by 
transplantation of isolated Lgr5+ progenitor cells, and that, conversely, upon knock-
down of Lgr5 fibrosis is more extreme (Lin et al., 2017), directly implicating bi-potent 
ductal progenitors in the resolution of fibrosis following chronic injury. Furthermore, 
as Tet1 is crucial for the generation of Lgr5+ organoids in vitro and Lgr5 expression 
was reduced in hypomorphic mice following acute DDC-induced damage (Figures 
3.20, 3.28 and 3.38), I hypothesise that the increased fibrosis observed in the 
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hypomorphic mice results from the impaired generation of Lgr5+ progenitors in these 
animals.  
Only a single recovery time point was assessed in our hypomorphic mice 
(Figure 3.27) and therefore, it is not possible to assess the dynamics of fibrosis. For 
instance, we are unable to understand whether the observed increase in fibrosis results 
from reduced fibrotic resolution or gradual increase in collagen deposition over time. 
Each possibility has subtle but distinct biological meaning; either the hypomorphic 
mice are unable to repair the damage, resulting in slower fibrotic resolution, or liver 
function remains impaired, resulting in continuing collagen deposition. To determine 
fibrotic dynamics and address this question, it will be necessary to analyse several time 
points from the onset of recovery to, and beyond, the recovery time point analysed here.        
 As above, it is important for us to consider the limitations imposed by the global 
nature of Tet1 reduction in a similar fashion to our acute DDC-induced damage model. 
With chronic damage, the global nature of Tet1 reduction is potentially more 
problematic when interpreting the data, as fibrosis itself is regulated by the activity of 
the stellate cells in the space of Disse (Mederacke et al., 2013). The potential effect of 
reduced levels of Tet1 in these cells upon fibrosis has not been described, and we cannot 
rule out that it will affect the level of fibrosis independently from the reduction of Tet1 
in the ductal compartment. Again, an elegant solution would be to use the 
Tet1flx/Prom1CreERT2 model to localise deletion of Tet1 to the ductal compartment, and, 
in combination with chronic DDC treatment, to deconvolute the contribution of 
different cell types to the increased fibrosis observed.    
4.3.3 Epithelial cell-specific genetic ablation of Tet1 inhibits normal ductal cell-
derived hepatocyte generation. 
 
By taking advantage of a model of liver damage that induces significant ductal cell 
contribution to the hepatocyte compartment, first characterised by Raven and 
colleagues (Raven et al., 2017), in combination with our model of ductal cell-specific 
Tet1 deletion and lineage tracing, it was possible to assess the role of Tet1 in bona fide 
bi-potent ductal progenitor-driven regeneration. Ductal cell-specific deletion of Tet1 
results in the generation of significantly smaller regenerative hepatocyte clusters 
(Figure 3.35). However, despite the smaller clusters, Tet1 deletion did not result in a 
significantly reduced overall number of ductal cell-derived hepatocytes, with the 
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significantly increased number of discrete clusters in Tet1 mutants explaining the 
discrepancy (Figure 3.36). Whilst these data suggest that the process of ductal cell-to-
hepatocyte differentiation is not affected by Tet1 deletion, but rather the dynamics of 
hepatocyte generation are altered, we cannot rule out that the nascent, ductal cell-
derived hepatocytes are not fully functional in the absence of Tet1. To determine 
whether the nascent hepatocytes are indeed functional, we can take advantage of the 
lineage tracing induced in this model to isolate the newly derived hepatocytes and to 
further determine their molecular characteristics and functionality.  
 Around 90% of ductal cell-derived hepatocyte clusters in Tet1 mutant mice are 
only a single cell in size, whereas clusters of five or more hepatocytes were readily 
observed in wild type mice (Figure 3.35). These data strongly imply that proliferation 
of nascent hepatocytes is impaired, and therefore that Tet1 depletion doesn’t directly 
affect hepatocyte differentiation but inhibits further proliferation of the nascent 
hepatocyte. One prediction resulting from this interpretation is that lineage-labelled 
hepatocytes would not be maintained during homeostasis and would eventually be 
replaced through competition by wild type hepatocytes which are competent to undergo 
proliferation. To explore this, it would be interesting to quantify the number of lineage-
labelled hepatocytes remaining after long term recovery from damage. These data 
would highlight any proliferative defect present in Tet1-depleted hepatocytes.      
The above interpretation relies on the assumption that the larger, wild type 
clusters are clonal in nature and have arisen as a result of expansion from single, ductal 
cell-derived hepatocytes rather than being generated by the parallel differentiation of 
several closely associated bi-potent ductal progenitors, so creating a continuous, 
polyclonal regenerative cluster. Our lineage tracing model relies on a single colour 
reporter with a high recombination efficiency, and therefore we cannot distinguish 
between monoclonal clusters or polyclonal cluster generation arising from the merging 
and splitting of several clonal populations. Several options exist for addressing this 
problem. Firstly, recombination efficiency can be reduced to ensure that any labelled 
cluster is clonal in origin. However, as recombination efficiency will be very low, any 
phenotype may be more difficult to discern as the loss of Tet1 may be compensated for 
the large number of non-recombined cells in the ductal compartment. Therefore, a more 
elegant experimental design would be to take advantage of a multi-colour lineage 
tracing system to facilitate the analysis of clonality whilst maintaining a high overall 
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recombination efficiency. Furthermore, it would be interesting to assess the role of Tet1 
in hepatocyte expansion and regeneration independent of its role in the ductal 
compartment. This could be achieved in vivo by hepatocyte-specific deletion of Tet1 in 
combination with models of hepatocyte-driven regeneration, such as partial 
hepatectomy, whilst the hepatocyte-derived organoid culture system would be an 
excellent tool for in vitro studies of the role of Tet1 in hepatocyte proliferation and 
function. By combining the results of such studies with the clonal dynamics revealed 
by analysis of ductal compartment-specific studies, a more thorough understanding 
would be achieved of the role of Tet1 in both ductal and hepatocyte compartments 
during liver regeneration. 
It is remarkable that, despite the altered dynamics in the generation of ductal 
cell-derived hepatocytes, the loss of Tet1 does not affect the overall number of new 
hepatocytes. Assuming that the larger cluster sizes observed in wild type animals are 
clonal in origin, this could point towards an impressive range of response at the level 
of an individual cell during regeneration. Such data suggest that, given a certain loss of 
tissue as a result of damage, assumed to be the same irrespective of genotype, the 
number of cells required to compensate for that loss can be generated either by fewer 
differentiation events and subsequent expansion of nascent cells or by an increased 
number of differentiation events but less subsequent proliferation of nascent cells. It 
would be interesting to investigate the signalling that monitors the generation of new 
tissue and the regulation of such decisions to uncover ways of modulating different 
mechanisms of regeneration in different cell populations, particularly for cell 
populations with diminished regenerative capacity.   
4.3.4 Is Tet1 a regulator of proliferation or of progenitor activation? 
 
It is important to note that the phenotypes described in the animal models can be 
explained by two distinct hypotheses. Tet1 deficiency could inhibit the transition to the 
bi-potent ductal progenitor state, reflected in the reduced ductal regeneration observed 
in the Tet1 hypomorphic DDC-induced acute damage model and the reduced size of 
the ductal compartment and smaller regenerative hepatocyte clusters observed in our 
ductal cell-specific AAV8-p21 model (Figures 3.22, 3.23, 3.34 and 3.35). However, 
several studies have linked Tet1 to the regulation of cell cycle progression and 
highlighted a role in promoting oncogenic transformation in haematological cancer 
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(Huang et al., 2013; Chrysanthou et al., 2018). Therefore, Tet1 deficiency could have 
a more generic role in negatively regulating proliferation, the same phenotypes being 
explained by failure to enter the cell cycle. On the other hand, Tet1 has also been shown 
to be a tumour suppressor in liver cancer (Thomson et al., 2016), and as a result it is 
therefore likely that the effect of Tet1 on the cell cycle is highly context-dependent and 
further studies would be required to understand the exact mode of action of Tet1 in 
ductal cell-driven liver regeneration. 
 Weng and colleagues showed that Tet1 and Tet3 are crucial for axonal 
regeneration in response to central and peripheral nervous system injury, respectively. 
Remarkably, the study shows that the roles of Tet1/3 are intrinsic to the mature neurons 
and that axonal regeneration is not dependent on proliferation (Weng et al., 2017). 
Rather, Tet1/3 upregulate the expression of the regenerative machinery in the injured 
neuron. This paradigm is partially mirrored in ductal cell-driven liver regeneration, 
where mature ductal cells acquire a progenitor fate upon damage. Therefore, it would 
be tempting to speculate that the mechanism by which Tet1 facilitates liver regeneration 
is independent of proliferation.          
Recent work from Kim and colleagues showed that Tet1 expression is essential 
to maintain the intestinal epithelium by ensuring correct expression of Lgr5 in the stem 
cell compartment (Kim et al., 2016). Taken together with the data here, where Tet1 is 
observed to bind the TSS of Lgr5 and hypomorphic levels of Tet1 result in reduced 
Lgr5 expression following liver damage (Figure 3.38), this suggests that Tet1 directly 
regulates the acquisition of bi-potent ductal progenitor fate at least in part by regulating 
expression of Lgr5. Furthermore, Tet1 expression is upregulated prior to cell division 
according to the gene expression profiling performed during organoid generation from 
ductal cells, suggesting that Tet1 may act before cell division is initiated. These data 
provide some evidence that Tet1 acts to regulate progenitor activation rather than cell 
cycle progression during ductal cell-driven liver regeneration. Further work will be 
required to differentiate between cell cycle-dependent and -independent roles of Tet1 
in this setting. Cell cycle inhibitors may be helpful in uncovering phenotypes resulting 
upon loss of Tet1 which are not a result of changes in cell cycle progression, but such 
inhibitors will frequently affect a number of cellular processes which may hinder 
interpretation of the data. Moreover, cell cycle progression may be essential for ductal 
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progenitor activation, and thus the use of cell cycle inhibitors may further confound 
investigation of the mechanism of action of Tet1.   
  Global levels of 5mC and 5hmC were investigated to gain insight into the 
overall balance of the epigenetic network underlying the acquisition of bi-potent ductal 
progenitor fate. Upon liver damage, there is a wave of global 5hmC observed which is 
linked to a concomitant but delayed decrease in global 5mC levels. Both changes are 
transient, suggesting that Tet1 may induce a global redistribution of 5mC in the ductal 
compartment during liver regeneration (Figure 3.37). Interestingly, 5hmC levels peak 
after 2 days of DDC-induced damage and, crucially, prior to any proliferation, further 
implying that the role of Tet1 is independent of proliferation (Figure 3.38). However, 
we are unable to exclude the contribution of the other Tet family members in this 
process, as they also catalyse oxidation of 5mC. It would be interesting to repeat the 
study using the Tet1flx/Prom1CreERT2 model to directly isolate the contribution of Tet1 
to the global changes in methylation levels. 
 Remarkably, we observed that the TSS of Lgr5 becomes marked with 5hmC in 
ductal cells in a Tet1-dependent manner during liver damage (Figure 3.39). 
Furthermore, the appearance of the 5hmC mark during liver damage correlates with 
Tet1 binding and increased expression of Lgr5, directly linking Tet1 activity to the 
increased expression of Lgr5 during liver damage. Genome wide analysis of Tet1 
binding, 5hmC levels and gene expression could provide more detailed insight into the 
targets of TET1 activity and the gene regulatory network of ductal cell-derived liver 
regeneration.     
4.3.5 A model for the role of Tet1 in ductal cell-driven liver regeneration 
 
Knock-down of Tet1 by either siRNA or gene trap (hypomorph model) or its complete 
deletion impairs the transition of mature ductal cells to bi-potent ductal progenitors and 
their further growth in organoid culture (Figures 3.3, 3.20 and 3.29). Negative 
regulation of the progenitor state is further reflected in animal models of liver damage, 
where hypomorphic levels of Tet1 lead to an impaired ductal response to DDC-induced 
acute damage and increased fibrosis following chronic damage (Figure 3.22, 3.23, 3.27 
and 4.2a). Furthermore, genetic ablation of Tet1 in a ductal cell-specific manner 
resulted in a reduced ductal compartment and altered ductal cell-derived hepatocyte 
generation following severe liver damage (Figures 3.34 and 3.35). The role of Tet1 in 
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these processes results at least in part from the Tet1-dependent regulation of Lgr5 
expression (Figure 3.38). Taken together, the data highlight a crucial role of Tet1 in the 
acquisition and function of bi-potent ductal progenitor fate during ductal cell-driven 
liver regeneration (Figure 4.2b).  
 
 
Figure 4.2 – The role of Tet1 in ductal cell-driven liver regeneration. A) A schematic showing the effect of 
reduced Tet1 expression in response to acute and chronic DDC treatment. Hypomorphic levels of Tet1 result in a 
lower ductal proliferative response after acute DDC damage. In a chronic DDC setting reduced expression results 
in increased fibrotic collagen deposition. B) A schematic showing the ductal cell-specific role of Tet1 in the 
generation of ductal cell-derived hepatocytes in response to extensive liver damage. In this scenario ductal specific 
depletion of Tet1 results in a smaller ductal population and significantly smaller clusters of nascent hepatocytes in 
p21/DDC induced liver damage.  
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4.3 Ductal proliferation dynamics suggest the existence of a heterogenous population 
with differing proliferative capacities. 
 
Bimodal proliferative dynamics were observed following DDC-induced acute damage, 
potentially reflecting the existence of a heterogenous population of ductal cells with 
differing proliferative capacities (Figure 3.39). Previously described tissue clearing 
methods were adapted to allow the visualisation of the ductal tree on a larger scale to 
identify if functionality correlates with particular morphological characteristics (Ke, 
Fujimoto and Imai, 2013; Susaki et al., 2016). CUBIC clearing allowed a sufficient 
depth of imaging and could be used to assess proliferative dynamics of the ductal 
compartment (Figures 3.42 and 3.43). It would be interesting to combine this method 
with the use of lineage tracing or label retention studies to visualise ductal 
morphogenesis during liver regeneration. In addition, similar methodologies could be 
used to analyse the growth of the ductal compartment during development, and by 
integrating the two datasets it would be possible to assess whether morphogenetic 
processes occur in the ducts in the embryo during development and in the adult in 
response to damage.  
Whilst such imaging studies could provide great insight into the spatial and 
morphological determinants of regeneration by the ductal compartment, it is important 
to note that they will provide no information on the molecular characteristics of any 
heterogenous populations. Therefore, molecular analysis at the single cell level in 
conjunction with imaging studies could reveal the molecular components underlying 
the apparent bimodal proliferation dynamics of the ductal population during 






In this work we have investigated the molecular machinery underlying ductal cell-
driven liver regeneration using animal models in vivo and in vitro culture of ductal cell-
derived organoids as a suitable model for the bi-potent ductal progenitor state. As a 
result, we have identified two epigenetic modifiers, Arid1a and Tet1, which are required 
for transition to the progenitor state and differentiation to functional hepatocytes 
following induction of liver damage. This work highlights the importance of 
orchestrated epigenetic changes in responding to and resolving liver damage and 
describes the development of animal models and techniques for investigating the role 
of these epigenetic modifiers in greater detail.   
 Recent work by our group and others have found evidence that Arid1a and Tet1 
may work in a unified system to modulate liver regeneration. Li and colleagues have 
shown that Arid1a is essential for binding of YAP to its targets stopping the expression 
of key progenitor markers (Li et al., 2019). In a similar manner, it was shown targets 
of Tet1 were enriched in the YAP/Hippo pathway. Furthermore, conditional knockout 
of Tet1 also reduced the expression of components of the of the YAP pathway. 
Interestingly, expression was restored with overexpression of Tet1 in a hypomorphic 
background (Aloia et al. in press). Therefore, Tet1 expression may promote liver 
regeneration by activating the YAP/Hippo pathway. The YAP pathway itself has been 
shown to be essential for ductal liver regeneration and liver cell fate, therefore, our 
work here combined with others have potentially unveiled another level of regulation 
upstream of YAP (Yimlamai et al., 2014; Pepe-Mooney et al., 2019). These data 
suggest in order for YAP to activate the regenerative response there needs to be a 
permissive chromatin state laid down by regulators such as Tet1 and Arid1a. Therefore, 
we can begin to hypothesise a novel mechanism of liver regeneration whereby some 
extrinsic or intrinsic signal of liver damage activates an epigenetic change, facilitated 
in part by Tet1 and Arid1a, which allows a permissive chromatin state that promotes 
the YAP pathway and ultimately ductal progenitor driven liver regeneration. Such a 
pathway would require future validation but provides an interesting framework for 
future study. One particularly interesting line of study would be to begin to understand 
the signalling that activates this potential regenerative pathway. In any case, data 
presented here combined with progress in the field as a whole have shed light on novel 
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pathways of liver regeneration which may lead to fascinating applications in the 
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